Novel biocatalyst compositions and processes for use

ABSTRACT

The microorganism-containing biocatalysts disclosed have a large population of the microorganisms irreversibly retained in the interior of the biocatalysts. The biocatalysts possess a surprisingly stable population of microorganisms and have an essential absence of debris generation from metabolic activity of the microorganisms. The biocatalysts are composed of highly hydrophilic polymer and have an internal, open, porous structure that promotes community phenotypic changes.

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

The use of biocatalysts for the continuous degradation of 1,4-dioxane inultralow concentrations in water was first reduced to practice usingGovernment support under Contract 1R43ES022123-01, awarded by theNational Institutes of Health. The Government has certain rightsthereto.

CROSS-REFERENCE TO RELATED APPLICATIONS

Priority is claimed to U.S. Provisional Patent Application Nos.

-   -   61/689,921, filed on Jun. 15, 2012;    -   61/689,922, filed on Jun. 15, 2012;    -   61/689,923, filed on Jun. 15, 2012;    -   61/689,924, filed on Jun. 15, 2012;    -   61/689,925, filed on Jun. 15, 2012;    -   61/689,929, filed on Jun. 15, 2012;    -   61/689,930, filed on Jun. 15, 2012;    -   61/689,932, filed on Jun. 15, 2012;    -   61/689,933, filed on Jun. 15, 2012;    -   61/689,935, filed on Jun. 15, 2012;    -   61/689,939, filed on Jun. 15, 2012;    -   61/689,940, filed on Jun. 15, 2012;    -   61/689,943, filed on Jun. 15, 2012;    -   61/689,945, filed on Jun. 15, 2012;    -   61/689,953, filed on Jun. 15, 2012;    -   61/849,725, filed on Feb. 1, 2013;    -   61/850,631, filed on Feb. 20, 2013;    -   61/851,467, filed on Mar. 8, 2013; and    -   61/852,451, filed on Mar. 15, 2013,    -   each of which is hereby incorporated by reference in its        entirety. A right is hereby reserved to have patentability        determinations made on the basis of the applicable sections of        Public Law 112-29.

FIELD OF THE INVENTION

This invention pertains to novel biocatalysts and their use.

BACKGROUND

Metabolic processes have long been proposed for anabolic and catabolicbioconversions. Microorganisms of various types have been proposed forthese bioconversions and include bacteria and archaea, both of which areprokaryotes; fungi; and algae. Metabolic processes are used by nature,and some have been adapted to use by man for millennia for anabolic andcatabolic bioconversions ranging from culturing yogurt and fermentationof sugars to produce alcohol to treatment of water to removecontaminants. Metabolic processes offer the potential for low energyconsumption, high efficiency bioconversions in relatively inexpensiveprocessing equipment and thus may be and are often viable alternativesto chemical synthesis and degradation methods. Often anabolic processescan use raw materials that are preferred from a renewable orenvironmental standpoint but are not desirable for chemical synthesis,e.g., the conversion of carbon dioxide to biofuels and otherbioproducts. Catabolic bioconversions can degrade substrates and havelong been used for waste water treatment. Considerable interests existin improving metabolic processes for industrial use and expanding thevariety of metabolic process alternatives to chemical syntheses anddegradations.

Numerous types of process techniques have been proposed for anabolic andcatabolic bioconversions. These processes include the use of suspendedmicroorganisms, i.e., planktonic processes. Also, process techniqueshave been disclosed where the microorganisms are located on or within asolid support.

Workers are faced with various challenges in improving metabolicprocesses and in providing metabolic processes that are sufficientlyeconomically viable to be of commercial interest. Some problems may beinherent with the feedstock itself including the presence of toxins,phages, and adventitious competitive microorganisms. Other problems mayarise from the microorganism to be used for the bioconversion such aslow metabolic conversion rate, low population growth rate, automutation,significant consumption of substrate to support population growth, theneed for inducers, co-metabolites, promoters and performance enhancingadditives, and the lack of a microorganism that has the sought metabolicconversion. And yet further problems may arise from the process used forthe bioconversion such as costs in recovering bioproducts from anaqueous fermentation broth. Especially with supported microorganisms,problems can arise from instability of the biofilms, including theirphysical degradation; overgrowth of the population of microorganismscausing suffocation; sloughing off of the microorganisms from thesupport; and susceptibility to competitive microorganisms. Additionally,metabolic processes are characterized as generating solid debris fromdead or lysed cells, and the debris needs to be accommodated in theprocess to remove these solids. In some instances, the debris have valueas feed supplements such as distillers grains from the manufacturing ofethanol, but in other metabolic processes such as for the treatment ofmunicipal waste water, costs may have to be incurred to dispose of thedebris in an environmentally acceptable manner. Genetic engineering,which has been proposed to overcome one or more of these problems, canitself be problematic.

Microorganisms, including but not limited to, bacteria, archaea, fungiand algae, are capable of becoming attached or adhered to a surface.Studies have been conducted pertaining to the effect of a change fromplanktonic growth to growth of microorganisms on surfaces, including theformation of biofilms on surfaces. A number of workers have investigatedpreventing or degrading biofilms in an animal or human body to enhancethe efficacy of antibiotic treatments to cure the animal or human body.

Tuson, et al., in “Bacteria-surface Interactions”, Soft Matter, Vol. 1,issue 608 (2013) citable as DOI: 10.1039/c3sm27705d, provide a review ofwork in the field of bacterial-surface interactions. The authorsdescribe the processes involved in attaching a microorganism to asurface and recite that attachment to surfaces causes phenotypicswitches in the cells and that the surface can provide benefits to theattached cells. The authors recite that organic matter can concentrateat horizontal surfaces stimulating growth of bacteria associated withthe surface, and increasing substrate surface area provides more area onwhich nutrients can absorb, enabling cells to grow at nutrientconcentrations that would normally be too low to support growth. Theauthors further state that in addition to surface attachmentfacilitating nutrient capture, some bacteria obtain necessarymetabolites and co-factors directly from the surfaces to which theyadhere.

Some of the observations reported in this article include thatnucleating cell growth into communities on surfaces protect cells frompredation and other environmental threats and facilitate theconservation of the genotype. The authors recite that where themicroorganisms form biofilms, resistance to antibiotic treatment hasbeen observed. This resistance has been attributed to one or more of thebarrier function of the biofilm matrix; the presence of dormantpersister cells and highly resistant colony variants, and upregulationof several biofilm-specific antibiotic resistance genes. One group ofworkers have postulated that some adhering cells not associated withbiofilms have resistance to antibiotics due to primary mechanisms ofreducing the net negative charge on bacterial cells and enhancing thestability of the membrane. Tuson, et al., points to a conclusion drawnin one article that the attachment of bacteria to surfaces alters theirmetabolic state and reduces antibiotic susceptibility, which is a commonfeature of bacteria during the stationary phase of cell growth.

In respect of cell activities pertaining to association of bacteria withsurfaces, the authors discuss that surface sensing is a precursor toswarming which is an important adaptive behavior in which contactbetween cells and surfaces programs morphological changes thatfacilitate cooperative behavior, rapid community growth, and migrationof communities. The cells in bacterial communities such as swarms orbiofilms interact with each other in several different ways. Bacteriaare able to communicate through the use of small molecule chemicalmessengers in a process referred to as quorum sensing.

-   -   “The dense packing of cells in bacterial communities facilitates        and increase in the concentration of small molecules that        transfer information between cells and trigger physiological        changes. The shape of chemical gradients in close proximity to        surfaces enhances the exchange of chemical information within        biofilms and communities attached to surfaces.”

Cho, et al., in “Self-Organization in High-Density Bacterial Colonies:Efficient Crowd Control”, PLOS Biology, Vol. 5, Issue 11, November 2007,pages 2614 to 2623, relate their findings that E. coli in microchamberscommunicate to provide colony growth towards an escape from the confinesof the microchambers without a potentially “stampede”-like blockage ofthe exit and to provide channels to facilitate nutrient transport intothe colony.

Tuson, et al., further describe the steps for the formation of anattachment of a cell to a surface. The initial attachment is reversibleand involves hydrodynamic and electrostatic interactions and the secondstep of the attachment is irreversible and involves van der Waalsinteractions between the hydrophobic region of the outer cell wall andthe surface. Irreversible attachment is facilitated by the production ofextracellular polymeric substance.

-   -   “Thermodynamics plays a central role in regulating the binding        of bacteria to surfaces. Cells attach preferentially to        hydrophilic materials (i.e., materials with a large surface        energy) when the surface energy of the bacterium is larger than        surface energy of the liquid in which they are suspended. The        surface energy of bacteria is typically smaller than the surface        energy of liquids in which the cells are suspended, and this        mismatch causes cells to attach preferentially to hydrophobic        materials (i.e., materials with lower surface energies).        Bacteria are able to attach to a wide variety of different        materials, including glass, aluminum, stainless steel, various        organic polymers, and for needed materials such as Teflon™.”

Tuson, et al., report that surface sensing triggers a variety ofcellular changes. Many of the changes are morphological and facilitateattachment to surfaces. They state:

-   -   “Interestingly, the physical properties of surfaces may        influence cell morphology and community structure.” . . . “Cells        adhere uniformly to hydrophobic surfaces, form microcolonies,        and grow into tightly packed multi-layer biofilms. Fewer cells        attach to hydrophilic surfaces, and changes in cell division        lead to the formation of chains of cells that are >100 μm long.        These chains become loosely entangled to form relatively        unstructured and less densely packed biofilms.”

Tuson, et al., in their concluding remarks state:

-   -   “Our understanding of the interaction of bacteria was surfaces        is remarkably incomplete. This topic seems ideally suited for        collaborations between microbiologist and materials scientists,        chemists, and engineers as it is poised to benefit from        multidisciplinary approaches that are formulated to penetrate        into a range of areas, including: (1) identifying the properties        of surfaces that are sensed by bacteria; (2) elucidating the        molecular mechanisms bacteria used to send surfaces and their        biochemical responses; and (3) determining how to modulate        surface properties to provoke a desired cellular response,        including changes in morphology, alterations in bioenergetics,        or cell death.”

Many proposals exist for using a solid carrier or support formicroorganisms to effect a plethora of anabolic and catabolicbioconversions; however, despite the potential process advantagesprovided by using a solid, commercial success has been limited to arelatively few applications. Proposals have been proffered for themicroorganisms to be supported on the surface of a carrier or in poresof a carrier and for the microorganisms to be located within thecarrier. See, for instance, Zhou, et al., “Recent Patents on ImmobilizedMicroorganisms Technology and Its Engineering Application in WastewaterTreatment, Recent Patents on Engineering, 2008, 2, 28-35.

As a general rule, solid debris are generated as a result of thebiological activity, e.g., from the instability of the biofilm formed onthe carrier and from the death and deterioration of cell mass. Forinstance, Sato, et al., in U.S. Pat. No. 6,610,205, disclose processesfor nitrifying and denitrifying organic waste water using athermoplastic microbe carrier. The patentees assert that a singlecarrier can affect both bioconversions requiring aerobic and anaerobicconditions. The carrier, once formed, is contacted with activated sludgecontaining microorganisms. The patentees state that the nitrifyingbacteria are “thickly grown” on the surface of the carrier and thedenitrifying bacteria are “adsorbed onto the carrier and thereby arefirmly immobilized thereon”. Their FIG. 1 depicts an apparatus using thecarrier and includes settling tank 9 to remove sludge. Accordingly, suchprocesses appear to require a means to remove debris from the support orcarrier.

Several workers have formed an aqueous mixture of microorganisms andpolymer as a solution, dispersion or emulsion. Some workers spray driedthe mixture and others proposed crosslinking to obtain a solid structurecontaining microorganisms within the interior of the solid structure.The following discussion is provided as an illustration of proposals toform solid structures from an aqueous medium also containingmicroorganisms.

Hino, et al., in U.S. Pat. No. 4,148,689 disclose the use ofmicroorganisms in a hydrophilic complex gel by dispersing microorganismsin a certain homogeneous sol and then gelling the mixture and treatingit chemically or by drying to obtain a xerogel. The xerogel is said topossess desired strength and is composed of gelled water solublepolymer, such as natural polymers, polyvinyl alcohol, polyethyleneglycol and polyethylene imine, and silica. The xerogels used in theexamples appear to provide bioconversion, but at lesser activities thansuspended cell fermentations. Most of the examples appear to demonstratebioactivity over a short duration, e.g., less than 30 hours. Thoseexamples that appear to report activity over longer durations alsoindicate deactivation over time. Indeed, the patentees contemplate thatan advantage of their xerogel is that the polymer can be recovered andrecycled upon deactivation. See column 9, lines 66 et seq.

Fukui, et al., in U.S. Pat. No. 4,195,129, disclose mixing microbialcells with photo-curable resin and irradiating the mixture to provide acured product containing immobilized cells. The product, according tothe examples, does not have the bioactivity of a free cell suspension.The patentees do not provide any data regarding the performance of theimmobilized cells over a long duration.

Yamada, et al., in U.S. Pat. No. 4,546,081 disclose a process forcontinuous fermentation with yeast to produce alcohol. The yeast isimmobilized in a thin film which is then positioned within a vessel forthe fermentation. The patentees recite a number of different techniquesfor making the film containing the yeast. Although a process in which amixture of yeast and polyvinyl alcohol is gelled by radiation and formedinto the desired shape, no performance differences among the filmsprepared by the various techniques are specifically recited in thepatent.

Ishimura, et al., in U.S. Pat. No. 4,727,030, have as an objectiveobtaining a molded, porous article containing microbial cells. Theydisclose a process for immobilizing enzymes or cells wherein the enzymesor cells are mixed with polyvinyl alcohol and activated carbon, and thenthe mixture is partially dried then molded and further dehydrated underspecified conditions. The porous gel is said to have little expansionupon hydration.

In the 1990's a process was developed in Japan called the PegasusProcess, see, for instance, Stowa Pagasus/Pegazur/Bio-tube ProcessSheets, Jun. 13, 2006, that uses organic gel pellets composed of amixture of polyethylene glycol and nitrifying activated sludge. Seealso, U.S. Pat. No. 4,791,061 which is in the same patent family asKR9312103 referenced in this document. The pellets are said to have adiameter of 3 millimeters and a polyethylene glycol fraction of 15percent and a microorganism fraction of 2 percent with a biofilmthickness of about 60 micrometers. The patent discloses preparing thepellets from a mixture containing an activated sludge and prepolymer anddropping the mixture into a water solution of polyvalent metal ion andpersulfate to form particles with immobilized microorganisms. Theprocess is asserted to reduce the loss in activity of the microorganismsin forming the pellets.

Chen, et al., in U.S. Pat. No. 5,290,693 immobilizing microorganisms orenzymes on beads of polyvinyl alcohol. They form a mixture of polyvinylalcohol and microorganisms and then conduct a two stage gelation andhardening step using boric acid and then phosphoric acid or phosphate.The patentees state that their process provides strong beads withoutbeing detrimental to the microorganisms or enzymes immobilized. Theexamples are instructive. Example 1, for instance, pertains to makingand using beads for denitrification of water containing 100 ppmpotassium nitrate. They state at column 5, lines 7 to 11:

-   -   “On the seventh day, denitrification rate of the immobilized        microorganisms reached 0.65 mg NO₃ ¹-N/g gel/h (sic), which        remained unchanged until the 30^(th) day. The biochemical        vitality of microorganisms remained stable.”        The solution used to make the beads contained about 25 g/L of        denitrifying sludge microorganisms. This example appears to        indicate that 7 days of growth of the population of        microorganisms were required to achieve the activity, and that        after 30 days, the stable activity was lost. The comparative        control reported in this example, which used boric acid only to        gel and harden the PVA, provided a denitrification rate of 0.55        mg NO₃ ⁻—N/g gel/h and became unstable after 15 days. Examples 2        and 3 report data for continuous operations that extended for 10        and 20 days respectively. Example 4 pertains to the production        of ethanol using Sacchramyces cerevisa (about 15 g/L in the        mixture with the polyvinyl alcohol) and only 8 hours of use were        reported with the beads containing the immobilized        microorganisms being slightly inferior in ethanol production        than unsupported yeast.

Nagadomi, et al., in “Treatment of Aquarium Water by DenitrifyingPhotosynthetic Bacteria Using Immobilized Polyvinyl Alcohol Beads”,Journal of Bioscience and Bioengineering, 87, 2, 189-193 (1999), confirmthe observations of Chen, et al. They found that boric acid isdeleterious to microorganisms. They also observed the growth of thepopulation of microorganisms immobilized in alginate beads and inpolyvinyl alcohol beads. The data reported by the authors did not extendmuch over 15 days of operation.

Willuwait, et al., in U.S. Pat. No. 7,384,777 B2, immobilize bacteria inpolymeric matrices. The matrices are used for the controlled release ofthe microorganisms. As explained at column 3, lines 63 to 67:

-   -   “By means of the cleaning process, the microorganisms multiply        until the holding capacity of the capsules/spheres or the gel        has been reached and the wall bursts, i.e., the microorganisms        are released.”

It is not surprising, therefore, that the large bulk of activitiesdirected towards improving metabolic processes have focused on changingthe genotype of the microorganism, e.g., through genetic engineering.Genotypic alterations often come at significant expense and requiresubstantial time to obtain the sought performance from a microorganism.Typically most genetically engineered microorganisms lack robustness,e.g., are slow growing and are competitively disadvantaged againstinvasive microorganisms and are subject to losing plasmids during scaleup for quantities sufficient to fill commercial-scale bioreactors andduring the bioconversion process itself. Additionally, geneticallyengineered microorganisms may have to be carefully contained so as notto escape to the environment, and disposal of debris from metabolicprocesses using genetically engineered microorganisms may be treated ashazardous waste.

SUMMARY

The microorganism-containing biocatalysts of this invention have a largepopulation of the microorganisms irreversibly retained in the interiorof the biocatalysts, and the biocatalysts possess a surprisingly stablepopulation of microorganisms, and hence stable bioactivity, and anessential absence of debris generation from metabolic activity of themicroorganisms, and the biocatalysts can exhibit these phenomenon overextended periods of time. These phenomena are contrary to conventionalexpectations are that microorganisms either escape from physicallyrestricted regions or that the physically restricted region becomesclogged or over populated leading to loss of metabolic activity andultimate death of the population of microorganisms.

The microorganisms in the biocatalysts of this invention exhibitphenotypic alterations that, in combination with an internal,cavity-containing structure of the biocatalyst, provide highlyadvantageous biocatalysts including, but not limited to, a metabolicshift from growth of the microorganisms and their population tobioconversion activity (anabolic or catabolic); enhanced tolerance totoxins; enhanced ability to enter a substantial state of stasis even forextended periods of time; and enhanced ability to efficiently bioconvertsubstrate. These phenotypic changes significantly add to the fact thatthe microorganisms effecting the bioconversion are retained in theinterior of the biocatalyst to provide advantageous metabolic processes,especially metabolic processes where the biocatalysts of this inventionprovide desirable bioconversion activity over extended periods of time,preferably at least about 3, preferably at least about 6, and frequentlyin excess of 12 or 24, months, and sometimes as much as 5 years or more.

While not wishing to be limited to theory, it is believed that theability of the biocatalysts of this invention to possess the stablepopulation of microorganisms in its interior is due to phenotypicchanges to the microorganisms that occur during making the biocatalysts.These phenotype changes are believed to be due to the confluence ofthree primary factors. First is the use of a high concentration ofmicroorganisms to make the biocatalyst, e.g., at least about 60,preferably at least about 100, grams of cells per liter, such thatcommunication can occur among the cells at the time of formation of thebiocatalyst. All references herein to the mass of cells are to the massof wet cells. The high concentration of cells is also preferred as uponthe phenotypic change occurring, little, if any, net growth in thepopulation of the microorganisms occurs in the biocatalyst. In someinstances, the net growth in population of microorganisms can be up tothree or four fold until the steady-state population occurs. However, inmost instances, the population of microorganisms at steady-state is plusor minus about 50, frequently plus or minus about 30, percent of theconcentration of the cells initially used in preparing the biocatalyst.

The second major factor is that the biocatalyst when formed containsmicroorganisms in a plurality of interconnected major cavities ofbetween about 5 and 100 microns in the smallest dimension. Preferably ona volumetric basis, at least about 20, and preferably at least about 50,percent of the interior structure of the biocatalyst (excluding themicroorganisms) is composed of major cavities in this range. Althoughlarger major cavities may be present, preferably less than about 25percent of the interior of the solid structure is composed of theselarger major cavities. Preferably the interconnected cavities in thebiocatalyst are quiescent. It is believed that the high preponderance ofthe interconnected major cavities have a smallest dimension of betweenabout 5 and 100 microns enhances the ability of the microorganismslocated in the cavities to communicate such that the microorganisms, asa community, undergo phenotypic alteration.

The third major factor resides in the polymeric material component ofthe biocatalyst being hydrated and hydrophilic. It is believed that themicroorganisms located in the interior of the biocatalyst as it is beingmade, especially those in the major cavities and smaller cavities, sensethe hydrophilicity of the surface and this sensing of the environmentalso contributes to the phenotype change. The polymeric material ishighly hydrated but yet contains sufficient hydrophobicity that thepolymeric material in the biocatalyst is not dissolved or dispersed inwater under the anticipated conditions of use. The hydrophilicity andthe hydrophobicity of the polymer are such that the microorganismsbecome substantially irreversibly retained in the interior of thebiocatalyst. As the retention of the microorganisms in the biocatalystis due to a sensing by the microorganisms and their response, thisirreversibly retention can be described as a metabolic retention. Thebiocatalysts can be characterized by having a Hydration Expansion Volume(HEV) of at least about 1,000, preferably at least about 5,000, and mostoften at least about 10,000. The Hydration Expansion Volume isindicative of the hydrophilicity of the polymeric material, and thehigher the HEV, the greater is the hydrophilicity of the polymericmaterial.

Accordingly, in its broad aspects, the biocatalyst composition of thisinvention comprises:

-   -   a solid structure of hydrated hydrophilic polymer defining an        interior structure having a plurality of interconnected major        cavities having a smallest dimension of between about 5 and 100        microns and an HEV of at least about 1000, preferably at least        about 5000, and    -   a population of microorganisms substantially irreversibly        retained in the interior structure, said microorganisms being in        a concentration of at least about 60 grams per liter based upon        the volume defined by the exterior of the solid structure when        fully hydrated,    -   wherein the microorganisms maintain a their population        substantially stable.

Preferably the hydrophilic polymer also forms a skin on the exterior ofthe biocatalyst composition. Although the microorganisms have been foundto become substantially irreversibly retained in the interior of thebiocatalyst, generally the case is that the microorganisms are notsignificantly, if at all, in direct contact with the polymer althoughthey can be in contact through fibrils, e.g., of extracellular polymericsubstance, or strands of polymer. It is believed that the highhydrophilicity of the polymer reduces the ability of the microorganismsto adhere to the exterior surfaces of the biocatalyst under conditionsof physical stress such as the flow of fluid over the exterior of thebiocatalyst.

Another broad aspect of this invention pertains to methods for makingbiocatalyst compositions comprising:

a. forming a liquid dispersion, preferably an aqueous dispersion, ofsolubilized precursor for hydrophilic polymer and microorganisms forsaid biocatalyst wherein the concentration of microorganisms in theliquid dispersion is at least about 60, preferably at least about 100,grams per liter;b. subjecting said dispersion to solidification conditions to form asolid structure of the hydrophilic polymer wherein the solid structurehas an interior structure having a plurality of interconnected majorcavities containing said microorganisms, said major cavities having asmallest dimension of between about 5 and 100 microns and wherein thesolid structure has an HEV of at least about 1000, preferably at leastabout 5000, said solidification conditions not unduly adverselyaffecting the population of said microorganisms; andc. maintaining the solid structure containing microorganisms underconditions that do not adversely affect the population of saidmicroorganisms in the interior of the solid structure for a timesufficient to enable the microorganisms to undergo a phenotypicalteration to maintain their population substantially stable and tobecome substantially irreversibly retained in the interior of the solidstructure.

The solidification conditions may, in some instances, include thepresence of a cross-linking agent, and the precursor is a solubilizedprepolymer. Alternatively, the solidification conditions may comprise areduction in temperature of the liquid dispersion such that polymerbecomes solidified to form the solid structure. Often, the liquiddispersion not encompassed within the solid structure formed in step (b)is separated during or prior to step (c).

Other broad aspects of this invention pertain to metabolic processes inwhich the biocatalysts of this invention are subjected to metabolicconditions including the presence of substrate to bioconvert saidsubstrate to bioproduct. The metabolic processes may be anabolic orcatabolic. In the preferred processes, the microorganisms evidence ametabolic shift as compared to planktonic metabolism under substantiallythe same metabolic conditions.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an SEM image of a portion of a cross-section of a biocatalystin accordance with this invention.

FIG. 2 is an SEM image of a portion of a cross-section of anotherbiocatalyst in accordance with this invention.

FIG. 3 is a schematic depiction of a photo-bioreactor using biocatalystsin accordance with this invention.

FIG. 4 is a schematic depiction of an apparatus suitable for treatingmunicipal wastewater using the biocatalysts of this invention.

FIG. 5 is a schematic depiction of a bioreactor used for thenitrification of wastewater which also contains a zone for collectingsolid debris for hydrolysis in the treatment of wastewater.

FIG. 6 is a schematic depiction of an apparatus using five fluidizedbioreactor assemblies containing biocatalysts of this invention suitablefor removing phosphate anion from water.

FIG. 7 is a schematic depiction of a bioreactor assembly contained inthe apparatus illustrated in FIG. 6.

FIG. 8 depicts the sequencing of the modes of operation of eachbioreactor assembly contained in the apparatus illustrated in FIG. 6.

FIG. 9 is a schematic depiction of an apparatus containing biocatalystsof this invention which is suitable for treating water to minimizemacroorganism growth and which contains an optional, self-cleaning watersupply system.

FIG. 10 is a schematic depiction of an apparatus suitable for usingbiocatalysts of this invention for making succinic acid, which apparatususes sequential reactors.

FIG. 11 is a schematic depiction of another apparatus suitable formaking succinic acid wherein reactors are cycled from PEP generation tosuccinate anion generation using carbon dioxide.

FIG. 12 is a schematic depiction of an apparatus for making butanol inwhich the butanol is phase separated for recovery.

DETAILED DESCRIPTION

All patents, published patent applications and articles referenced inthis detailed description are hereby incorporated by reference in theirentireties.

DEFINITIONS

As used herein, the following terms have the meanings set forth belowunless otherwise stated or clear from the context of their use.

The use of the terms “a” and “an” is intended to include one or more ofthe element described. Lists of exemplary elements are intended toinclude combinations of one or more of the element described. The term“may” as used herein means that the use of the element is optional andis not intended to provide any implication regarding operability.

Adhering to the solid structure of the biocatalyst means that themicroorganisms are located in cavities in the interior of thebiocatalyst and are substantially irreversibly retained therein althoughextraordinary conditions and treatments (i.e., not normal bioconversionconditions for bioconversion using the microorganisms) might be able insome instances to cause the microorganism to exit the biocatalyst.Adhering includes surface attachment to the polymer forming the walls ofthe porous matrix as well as where the retained microorganisms areproximate to a polymeric surface, e.g., within about 10 or 20 microns,but not directly contacting the surface. Adhering thus includes physicaland electrostatic adherence. In some instances, the polymer used to makethe biocatalyst may become embedded in the extracellular polymericsubstance around a cell or even in or on the cell wall of themicroorganism.

Ammonium cation includes ammonium cation and dissolved ammonia. One testfor determining ammonium cation concentration is the salicylate methodtest N tube, Hach Method 10031, DOC316.53.01079, 7^(th) edition.

BTT Test is a batch toxicity tolerance test. The BTT Test compares thetolerance of a free suspension of the microorganism to a toxin in anaqueous medium under metabolic conditions with the tolerance of the samemicroorganism but provided in a substantially the same aqueous mediumunder substantially the same metabolic conditions but in porous matricesto provide substantially the same starting cell density. The subjecttoxin is added to the aqueous medium at a concentration such that thebioconversion of the substrate after 24 hours is approximately 50percent of that in the absence of the toxin (or in the case of asubstrate that can be toxic, a concentration having substantially noadverse effect on the microorganism). It is not essential that thebioconversion be precisely 50 percent less, but it should be in therange of between about 35 and 65 percent of that in the absence of thetoxin. The same concentration of the toxin is added to the aqueousmedium containing the microorganisms in the porous matrices and thebioconversion of the substrate after 24 hours is determined. It isunderstood that the metabolic conditions may, in some instances, affecthow much of an effect the toxin has on the microorganism. In suchinstances, the metabolic conditions should be selected to be generallymidrange of those suitable for the bioconversion. Also, it is understoodthat the degree of improvement provided by this invention can vary withdifferent toxins. Accordingly, the toxin used should be the toxin atissue for the specific metabolic process. For instance, if the processis to make isobutanol as the bioproduct, the toxin used should becontained in the aqueous medium for the bioconversion and should not bea toxin such as sodium hypochlorite which is not expected to be in themedium. For phage as toxins, the toxin added may be infected cells.

Biochemical oxygen demand (BOD) is the amount of oxygen required formetabolic conversion of organic carbon in water to carbon dioxide and isan indication of the organic compounds available for food. BOD isreported as milligrams per liter. BOD can be determined by StandardMethod 5210B, revision Nov. 16, 1999, as published by the U.S.Environmental Protection Agency

Bioconversion activity is the rate of consumption of substrate per hourper gram of microorganism. Where an increase or decrease inbioconversion activity is referenced herein, such increase or decreaseis ascertained under similar bioconversion conditions includingconcentration of substrate and product in the aqueous medium.Bioconversion activity to bioproduct is the rate of production of thebioproduct per hour per gram of microorganism.

Biofilm means an aggregate of microorganisms embedded within anextracellular polymeric substance (EPS) generally composed ofpolysaccharides, and may contain other components such as one or more ofproteins, extracellular DNA and the polymer used to make thebiocatalyst. The thickness of a biofilm is determined by the size of theaggregate contained within a continuous EPS structure, but a continuousEPS structure does not include fibrils that may extend between separatedbiofilms. In some instances, the biofilm extends in a random, threedimensional manner, and the thickness is determined as the maximum,straight line distance between the distal ends. A thin biofilm is abiofilm which does not exceed about 10 microns in any given direction.

Bioproduct means a product of a bioconversion which may be an anabolicproduct or a catabolic product and includes, but is not limited to,primary and secondary metabolites.

Contaminating microorganisms are microorganisms that compete with themicroorganisms for the bioconversion of substrate and may beadventitious or from an up-stream bioconversion process. With referenceto the biocatalysts of this invention, contaminating microorganisms alsoinclude those that can foul the surface of the biocatalyst even thoughthey may not compete for substrate.

Chemical oxygen demand (COD) is the amount of oxygen required to convertorganic carbon in water to carbon dioxide and thus is an indication ofthe organic compound content of the water. COD is reported as milligramsper liter. One procedure for determining COD is Hach Method 8000,February 2009, Ninth Edition.

A state of essential stasis means that a microorganism population hasundergone a substantial cessation of all metabolic bioconversionactivity but can be revived. The existence of an essential stasiscondition can be ascertained by measuring bioconversion activity. Theessential stasis condition may be aerobic, anoxic or anaerobic which mayor may not be the same as that of normal operating conditions for themicroorganism. Where stasis is sought, the temperature is typically inthe range of about 0° C. to 25° C., say, 4° C. to 15° C. which may bedifferent from the temperatures used at normal operating conditions.

An exo-network is a community of spaced-apart microorganisms that can bein the form of individual cells or biofilms that are interconnected byextracellular polymeric substance in the form of strands. The spacingbetween the microorganisms or biofilms in the exo-network is sufficientto enable the passage of nutrients and substrates there between and isoften at least about 0.25, say, at least about 0.5, micron and may be aslarge as 5 or 10 microns or more.

Exterior skin is an exterior layer of polymer on the biocatalyst that isless open than the major channels in the interior structure of thebiocatalyst. A biocatalyst may or may not have a skin. Where a skin ispresent, it may or may not have surface pores. Where no surface poresare present, fluids diffuse through the skin. Where pores are present,they often have an average diameter of between about 1 and 10 microns.

Fully hydrated means that a biocatalyst is immersed in water at 25° C.until no further expansion of the superficial volume of the biocatalystis perceived.

The “Hydration Expansion Volume” (HEV) for a biocatalyst is determinedby hydrating the biocatalyst in water at 25° C. until the volume of thebiocatalyst has stabilized and measuring the superficial volume of thebiocatalyst (V_(w)), removing the biocatalyst from water and removingexcess water from the exterior, but without drying, and immersing thebiocatalyst in ethanol at 25° C. for a time sufficient that the volumeof the biocatalyst has stabilized and then measuring the superficialvolume of the biocatalyst (V_(s)).

-   -   The HEV in volume percent is calculated as the amount of        [V_(w)/V_(s)]×100%.        To assure dehydration with the ethanol, either a large volume        ratio of ethanol to biocatalyst is used or successive immersions        of the biocatalyst in fresh ethanol are used. The ethanol is        initially dehydrated ethanol.

Irreversibly retained and substantially irreversibly retained mean thatthe microorganisms are adhering to polymeric structures defining open,porous cavities. Irreversibly retained microorganisms do not includemicroorganisms located on the exterior surface of a biocatalyst. Amicroorganisms is irreversibly retained even if the biocatalyst hasexterior pores of sufficient size to permit egress of themicroorganisms.

Highly hydrophilic polymers are polymers to which water is attracted,i.e., are hydroscopic. Often the polymers exhibit, when cast as a film,a water contact angle of less than about 60°, and sometimes less thanabout 45°, and in some instances less than about 10°, as measured by thesessile drop method using a 5 microliter drop of pure distilled water.

Highly hydrated means that the volume of the biocatalyst (excluding thevolume of the microorganisms) is at least about 90 percent water.

An isolated enzyme is an enzyme removed from a cell and may or may notbe in a mixture with other metabolically active or inactive materials.

Macroorganisms include, but are not limited to, mollusks, such asbivalve mollusks including mussels and clams; barnacles; bryozoan;polychette; and macroalgae.

A matrix is an open, porous, polymeric structure and is an article ofmanufacture having an interconnected plurality of channels or cavities(herein “major cavities”) defined by polymeric structures, said cavitiesbeing between about 5 and 100 microns in the smallest dimension(excluding any microorganisms contained therein), wherein fluid canenter and exit the major cavities from and to the exterior of thematrix. The porous matrix may contain larger and smaller channels orcavities than the major cavities, and may contain channels and cavitiesnot open to the exterior of the matrix. The major cavities, that is,open, interconnected regions of between about 5 or 10 to 70 or 100microns in the smallest dimension (excluding any microorganism containedtherein) have nominal major dimensions of less than about 300,preferably less than about 200, microns, and sometimes a smallestdimension of at least about 10 microns. The term open, porous thusrefers to the existence of channels or cavities that are interconnectedby openings therebetween.

Metabolic conditions include conditions of temperature, pressure,oxygenation, pH, and nutrients (including micronutrients) and additivesrequired or desired for the microorganisms in the biocatalyst. Nutrientsand additives include growth promoters, buffers, antibiotics, vitamins,minerals, nitrogen sources, and sulfur sources and carbon sources wherenot otherwise provided.

A metalate is an oxyanion, hydroxyl or salt of a metal or semiconductorelement.

Municipal wastewater is collected wastewater from two or more sourceswherein wastewater is generated by human activity including, but notlimited to, human and animal excrement; domestic, commercial,agricultural, mining and industrial wastes and drainage; storm runoff;foodstuffs; and product, intermediate and raw materials disposal.

Oxygenated organic product means a product containing one or moreoxygenated organic compounds having 2 to 100, and frequently 2 to 50,carbons and at least one moiety selected from the group consisting ofhydroxyl, carbonyl, ether and carboxyl.

Permeable means that a component can enter or exit the major cavitiesfrom or to the exterior of the biocatalyst.

Population of microorganisms refers to the number of microorganisms in agiven volume and includes substantially pure cultures (axenic) and mixedcultures.

A phenotypic change or alternation or phenotypic shift is a change in amicroorganism's traits or characteristics from environmental factors andis thus different from a change in the genetic make-up of themicroorganism.

Quiescent means that the aqueous medium in a biocatalyst is still;however, flows of nutrients and substrates and bioproducts can occurthrough the aqueous medium via diffusion and capillary flow.

Retained solids means that solids are retained in the interior of thebiocatalyst. The solids can be retained by any suitable mechanismincluding, but not limited to, restrained by not being able to passthrough pores in the skin of a biocatalyst, by being captured in abiofilm or a polysaccharide structure formed by microorganisms, by beingretained in the polymeric structure of the biocatalyst, or by beingsterically entangled within the structure of the biocatalyst or themicroorganisms.

Smallest dimension means the maximum dimension of the shortest of themaximum dimensions defining the length, width and height of a majorcavity. Usually a preponderance of the major cavities in a matrix aresubstantially width and height symmetrical. Hence the smallest dimensioncan be approximated by the maximum width of a cavity observed in a twodimensional cross section, e.g., by optical or electronic microscopy.

A solubilized precursor for the polymer is a monomer or prepolymer orthe polymer itself that is dissolved or dispersed such that solidscannot be seen by the naked eye and is stable. For instance, a solid canbe highly hydrated and be suspended in an aqueous medium even though thesolid is not dissolved.

Sorption means any physical or chemical attraction and can be adsorptionor absorption and may be relatively weak, e.g., about 10 kilojoules permole or a chemical interaction with a sorbent. Preferably the sorptiveattraction by the sorbent is greater than that between water and thesubstrate, but not so great that undue energy is required to desorb thesubstrate. Frequently the sorptive strength is between about 10 and 70,say, 15 and 60, kilojoules per mole. A sorbent is a solid havingsorptive capacity for at least one substrate.

A stable population of microorganisms means that the population ofmicroorganisms does not decrease by more than 50 percent nor increase bymore than 400 percent. The stability of the microorganism population canusually be ascertained from the change, or lack of change, inbioconversion activity of the biocatalyst in its intended use.

Sterilization means any process that kills all forms of microbial life,and a sterilizing agent means one or more chemicals or processes thatcan effect sterilization. Sterilization is thus a nonselective processas it affects all forms of microbial life. Disinfection may besterilization or may affect microbial life without killing themicroorganisms. A disinfecting agent means one or more chemicals orprocesses that can effect disinfection.

Substrates are carbon sources, electron donors, electron acceptors andother chemicals that can be metabolized by a microorganism, whichchemicals, may or may not provide sustaining value to themicroorganisms.

Sugar means carbohydrates having 5 to 12 carbon atoms and includes, butis not limited to, D-glyceraldehyde, L-glyceraldehyde, D-erythrose,L-erythrose, D-threose, L-threose, D-ribose, L-ribose, D-lyxose,L-lyxose, D-allose, L-allose, D-altrose, L-altrose 2-keto-3-deoxyD-gluconate (KDG), D-mannitol, guluronate, mannuronate, mannitol,lyxose, xylitol, D-glucose, L-glucose, D-mannose, L-mannose, D-gluose,L-gluose, D-idose, L-idose, D-galactose, L-galactose, D-xylose,L-xylose, D-arabinose, L-arabinose, D-talose, L-talose, glucuronate,galacturonate, rhamnose, fructooligosaccharide (FOS),galactooligosaccharide (GOS), inulin, mannan oligosaccharide (MOS),oligoalginate, mannuronate, guluronate, alpha-keto acid, or4-deoxy-L-erythro-hexoselulose uronate (DEHU).

Typical Bioreactor Systems are those operated on a continuous,semi-continuous or batch mode of operation and include bioreactordesigns such as, but are not limited to, ponds (in the case ofphotosynthetic processes), bubble column reactors, stirred reactors,packed bed reactors, trickle bed reactors, fluidized bed reactors, plugflow (tubular) reactors, and membrane (biofilm) reactors. In conductingphotosynthetic bioconversions, the reactors may be designed to permitthe transfer of photo energy. The biocatalyst may be freely mobile inthe aqueous medium or fixed, e.g., to a structure in the reactor vessel,or may itself provide a fixed structure. More than one reactor vesselmay be used. For instance, reactor vessels may be in parallel or insequential flow series.

Typical Mesophilic Conditions are metabolic conditions that include atemperature in the range of between about 0° C. and 50° C. or moredepending upon the temperature tolerance of the microorganism, mostfrequently, about 5° C. or 10° C. to 40° C. or 45° C.; a pressure in theranges from about 70 to 500, say, 90 to 300, kPa absolute due toequipment configurations although higher and lower pressures could findapplicability; and a pH in the range of between about 3 and 9. TheTypical Mesophilic Conditions can be aerobic or anaerobic.

Typical Separation Techniques for chemical products include phaseseparation for gaseous chemical products, the use of a still, adistillation column, phase separation (liquid-liquid and solid-liquid),gas stripping, flow-through centrifuge, Karr column for liquid-liquidextraction, mixer-settler, or expanded bed adsorption. Separation andpurification steps may proceed by any of a number of approachescombining various methodologies, which may include centrifugation,filtration, reduced pressure evaporation, liquid/liquid phaseseparation, membranes, distillation, and/or other methodologies recitedherein. Principles and details of standard separation and purificationsteps are known in the art, for example in “Bioseparations Science andEngineering,” Roger G. Harrison et al., Oxford University Press (2003),and Membrane Separations in the Recovery of Biofuels and Biochemicals—AnUpdate Review, Stephen A. Leeper, pp. 99-194, in Separation andPurification Technology, Norman N. Li and Joseph M. Calo, Eds., MarcelDekker (1992).

The wet weight or wet mass of cells is the mass of cells from which freewater has been removed, i.e., are at the point of incipient wetness.

References to organic acids herein shall be deemed to includecorresponding salts and esters.

References to biocatalyst dimensions and volumes herein are of fullyhydrated biocatalyst unless otherwise stated or clear from the context.

Biocatalyst

A. Biocatalyst Overview

The biocatalysts of this invention have a polymeric structure (matrix)defining interconnected major cavities, i.e., are open, porous matrices,in which the microorganisms are metabolically retained in the interiorof the matrices, that is, the microorganisms promote the adherencerather than being physically restrained by an external structure. In thebiocatalysts of this invention, the microorganisms and theircommunities, inter alia, regulate their population. Also, in conjunctionwith the sensed nature of the microenvironment in the matrices, it isbelieved that the microorganisms establish a spatial relationship amongthe members of the community.

The community communication among the microorganisms and the behavior ofthe microorganisms thus are important to achieving and maintaining themetabolically retained microorganisms. The communication among themicroorganisms is believed to occur through emitting chemical agents,including, but not limited to, autoinducers, and communication includescommunications for community behavior and for signaling. Often, thepreparation of the biocatalysts used in the processes of this inventioncan result in a population of microorganisms being initially located inthe interior of the biocatalyst that is substantially that which wouldexist at the steady-state level. At these densities of microorganisms inthe biocatalysts, community communications are facilitated which arebelieved to commence during the formation of the biocatalysts, andphenotypic shifts occur to enable the metabolic retention and modulatethe population of microorganisms.

The environment to achieve the metabolically-retained, stable populationof microorganisms is characterized by a highly hydrated structure ofhydrophilic polymer, which structure defines a plurality ofinterconnected cavities of between about 5 and 100 microns in thesmallest dimension and has a Hydration Expansion Volume (HEV) of atleast about 1000. The structure thus defines the microenvironments forthe microorganisms. These microenvironments not only facilitatecommunication among the microorganisms but also in some instancesmodulate the environmental stresses on the microorganisms and modulatethe supply of substrate and nutrients to the microorganisms. The highlyhydrated and expanded structure of the porous matrices and its opennessalso can accommodate the metabolic retention of a large population ofmicroorganisms and accommodate community behaviors associated with themetabolic retention.

Without wishing to be limited to theory, it is believed that the veryhigh HEV of the matrices means that that water exists within the solidstructure itself. The absorbed water is believed to act through van derWaals interactions or hydrogen bonding with the hydrophilic polymer tointerconnect polymer chains and strengthen the polymeric structure inthe expanded state. When water is removed by dehydration, the polymerstrands can collapse in such a manner as to enable significant shrinkageof the structure. The hydrated polymeric structure is believed to have alow average surface energy while still being able to provide sites forattachment by the microorganisms. In some instances the highly hydratedpolymeric surface which itself may be a source of water and nutrientsdue to the hydration.

The microorganisms that are retained in the matrices have the ability toform an exo-network. The quiescent nature of the cavities facilitateforming and then maintaining any formed exo-network. A discernableexo-network is not believed essential to achieving phenotypicalterations in the microorganism population such as populationmodulation and metabolic shift. Where an exo-network develops, oftenstrands of EPS interconnect proximate microorganisms and connectmicroorganisms to the surface and form the exo-network. In someinstances, the microorganisms form thin biofilms and these thin biofilmsare encompassed in the exo-network. The biocatalysts of this inventionhave a substantial absence of biofilms in their interiors that arelarger than thin biofilms. Hence, any biofilms that may ultimately formin the biocatalysts are relatively thin, e.g., up to about 10, andpreferably up to about 2 or 5, microns in thickness, and stable in size.Thus, each thin biofilm is often only a few cells and is connected in anexo-network.

FIGS. 1 and 2 are SEM images illustrating two potential configurationsof microorganisms within major cavities in the interior of biocatalystsof this invention. These images are not in limitation of the broadaspects of the invention. Each biocatalyst is used in a bioconversionfor extended periods of time prior to being prepared for SEM analysis.The bioconversion activity of each biocatalyst remains substantiallyconstant over the duration of the bioconversion: The biocatalyst of FIG.1 comprises Saccharomyces cerevisiae and had been used to make ethanolfrom sugar over about a 2 week period. The biocatalyst during its useevidenced that the microorganisms were irreversibly retained and ametabolic shift towards higher conversion efficiency to ethanol hadoccurred. The biocatalyst of FIG. 2 comprises Achromobacterdenitrificans and was used for nitrate and perchlorate degradation forabout 1 month of continuous flow operation. This biocatalyst alsoevidenced that the microorganisms were irreversibly retained in thebiocatalyst and effectively degraded perchlorate and nitrate anionswithout the generation of solids. Each image depicts that themicroorganisms are in a high population density but have a spatialconfiguration that does not evidence overgrowth or the formation ofthick biofilms. The exo-network observable in FIG. 1 further evidencesthat an additional phenotypic has occurred in that the interconnectionof the microorganisms is not characteristic of yeasts used inbioconversion processes. FIG. 2 illustrates the formation of anexo-network. In general, more extensive exo-networks, when themicroorganism generates EPS, occur over the duration of use of thebiocatalyst.

It is believed that in some instances the spatial configuration of theinterior of the biocatalyst and any exo-network promotes communicationamong the microorganisms. The communications may be able to extend tospaced apart exo-networks and thin biofilm units. As a general rule, thestrength, or concentration, of autoinducers is amplified bymicroorganisms in response to that autoinducer being emitted by anothermicroorganism. This amplification is enhanced by the spatialconfiguration of the microenvironment in the interior of the biocatalystand in some instances, the chemical composition of the polymer formingthe biocatalyst. The import of the spacial configuration of the majorcavities to the phenotypic alteration and population stability has beendemonstrated by examination of biocatalysts containing large cavities,e.g., greater than about 1000 microns in the smallest dimension.Although the biocatalyst exhibits bioconversion activity, the surface ofthe large cavities appeared to be substantially devoid of anymicroorganisms in contrast to a large, stable population ofmicroorganisms in smaller cavities.

The communications are believed to result in the community ofmicroorganisms maintaining a relatively constant population in theinterior of the biocatalyst. Another phenotypic alteration occurring inthe biocatalysts of this invention, which is believed to be a result ofthis communication, is a metabolic shift, i.e., the metabolic functionsof the community towards reproduction are diminished and the soughtbioconversion continues. The population of microorganisms in thebiocatalyst may tend to have an old average age due to this shift in themetabolic activity. Older microorganisms also tend to provide a morerobust and sustainable performance as compared to younger cells as theolder cells have adapted to the operating conditions.

Additional benefits of this communication can be an increase incommunity-level strength or fitness exhibited by the community inwarding off adventitious microorganisms and maintaining strain-typeuniformity. In some instances, the microorganisms during use of thebiocatalyst may undergo natural selection to cause the strain-type inthe community to become heartier or provide another benefit for thesurvival of the community of microorganisms. In some instances, thecommunication among the microorganisms may permit the population ofmicroorganisms to exhibit multicellularity or multicellular-likebehaviors. Thus the population of microorganisms in a biocatalyst ofthis invention may have microorganisms adapting to differentcircumstances but yet working in unison for the benefit of thecommunity.

In some instances the porous matrix may provide modulation of thesubstrate and nutrients to the microorganisms to optimize metabolicpathways involving substrates that are available, and these pathways mayor may not be the primarily used pathways where ample substrate andother nutrients are available. Accordingly, microorganisms in thebiocatalysts may exhibit enhanced bioactivity for a primarily usedpathway or metabolic activity that is normally repressed.

It is also believed that the microenvironments may promote geneticexchange or horizontal gene transfer. Conjugation or bacterial matingmay also be facilitated, including the transfer of plasmids andchromosomal elements. Moreover, where microorganisms lyse, strands ofDNA and RNA in the microenvironments are more readily accessible to betaken up by microorganisms in these microenvironments. These phenomenacan enhance the functional abilities of the microorganisms.

The biocatalysts exhibit an increased tolerance to toxins. In someinstances, communications among microorganisms and any exo-network mayfacilitate the population establishing defenses against toxins. Thecommunity response to the presence of toxins has been observed in thebiocatalysts of this invention. For instance, the biocatalysts survivethe addition of toxins such as ethanol and sodium hypochlorite and theoriginal bioconversion activity is quickly recovered thus indicating thesurvival of essentially the entire community.

If desired, the biocatalysts may be treated to enhance the formation ofthe exo-network, and if desired, thin biofilms, prior to use in themetabolic process. However, performance of the biocatalyst is notgenerally dependent upon the extent of exo-network formation, and oftenbioconversion activities remain relatively unchanged between the timebefore the microorganisms have attached to the polymeric structure andthe time when extensive exo-network structures have been generated.

B. Physical Description of the Porous Matrices

The biocatalysts of this invention comprise a matrix having open, porousinterior structure with microorganisms irreversibly, metabolicallyretained in at least the major cavities of the matrix.

The matrices may be a self-supporting structure or may be placed on orin a preformed structure such as a film, fiber or hollow fiber, orshaped article. The preformed structure may be constructed of anysuitable material including, but not limited to, metal, ceramic,polymer, glass, wood, composite material, natural fiber, stone, andcarbon. Where self-supporting, the matrices are often in the form ofsheets, cylinders, plural lobal structures such as trilobal extrudates,hollow fibers, or beads which may be spherical, oblong, or free-form.The matrices, whether self-supporting or placed on or in a preformedstructure, preferably have a thickness or axial dimension of less thanabout 5, preferably less than about 2, say, between about 0.01 to 1,centimeters.

The porous matrices may have an isotropic or, preferably, an anisotropicstructure with the exterior portion of the cross section having thedensest structure. The major cavities, even if an anisotropic structureexists, may be relatively uniform in size throughout the interior of thematrix or the size of the major cavities, and their frequency, may varyover the cross-section of the biocatalyst.

The biocatalyst of this invention has major cavities, that is, open,interconnected regions of between about 5 or 10 to 70 or 100 microns inthe smallest dimension (excluding any microorganisms contained therein).For the purposes of ascertaining dimensions, the dimensions of themicroorganisms include any mass in the exo-network. In many instances,the major cavities have nominal major dimensions of less than about 300,preferably less than about 200, microns, and sometimes a smallestdimension of at least about 10 microns. Often the biocatalyst containssmaller channels and cavities which are in open communication with themajor cavities. Frequently the smaller channels have a maximumcross-sectional diameter of between about 0.5 to 20, e.g., 1 to 5 or 10,microns. The cumulative volume of major cavities, excluding the volumeoccupied by microorganisms and mass associated with the microorganisms,to the volume of the biocatalyst is generally in the range of about 40or 50 to 70 or 99, volume percent. In many instances, the major cavitiesconstitute less than about 70 percent of the volume of the fullycatalyst with the remainder constituting the smaller channels and pores.The volume fraction of the biocatalyst that constitutes the majorcavities can be estimated from its cross-section. The cross section maybe observed via any suitable microscopic technique, e.g., scanningelectron microscopy and high powered optical microscopy. The total porevolume for the matrices can be estimated from the volumetric measurementof the matrices and the amount and density of polymer, and any othersolids used to make the matrices.

The biocatalyst is characterized by having high internal surface areas,often in excess of at least about 1 and sometimes at least about 10,square meter per gram. In some instances, the volume of water that canbe held by a fully hydrated biocatalyst (excluding the volume of themicroorganisms) is in the range of 90 to 99 or more, percent. Preferablythe biocatalyst exhibits a Hydration Expansion Volume (HEV) of at leastabout 1000, frequently at least about 5000, preferably at least about20,000, and sometimes between 50,000 and 200,000, percent.

Usually the type of polymer selected and the void volume percent of thematrices are such that the matrices have adequate strength to enablehandling, storage and use in a bioconversion process.

The porous matrices may or may not have an exterior skin. Preferably thematrices have an exterior skin to assist in modulating the influx andefflux of components to and from the interior channels of the porousmatrix. Also, since the skin is highly hydrophilic, and additionalbenefit is obtained as contaminating or adventitious microorganisms havedifficulties in establishing a strong biofilm on the exterior of thebiocatalyst. These contaminating microorganisms are often subject toremoval under even low physical forces such as by the flow of fluidaround the biocatalysts. Thus, the fouling of the biocatalyst can besubstantially eliminated or mitigated by washing or by fluid flowsduring use.

Where present, the skin typically has pores of an average diameter ofbetween about 1 and 10, preferably 2 to 7, microns in average diameter.The pores may comprise about 1 to 30, say, 2 to 20, percent of theexternal surface area. The external skin, in addition to providing abarrier to entry of adventitious microorganisms into the interior of thebiocatalyst, is preferably relatively smooth to reduce the adhesion ofmicroorganisms to the external side of the skin through physical forcessuch as fluid flow and contact with other solid surfaces. Often, theskin is substantially devoid of anomalies, other than pores, greaterthan about 2 or 3 microns. Where a skin is present, its thickness isusually less than about 50, say, between about 1 and 25, microns. Itshould be understood that the thickness of the skin can be difficult todiscern where the porous matrix has an anisotropic structure with thedensest structure being at the exterior of the matrix.

The porous matrices provide a plurality of unique microenvironments andnano-environments within their interiors. These unique microenvironmentsand nano-environments result in enzymes or microorganisms located atdifferent regions within the biocatalyst being subjected to differentmetabolic conditions. The metabolic conditions may differ in one or moreof composition, oxidation or reduction potential and pH. For instance,the composition may vary based upon electron donor, other nutrients,contaminants, bioconversion products, and the like, and thus can affectthe metabolic processes within the microorganism in such environment.Hence, it is possible to have within the same matrix, aerobic andanaerobic metabolism and to have enhanced bioconversion of a lesspreferred substrate as the more preferred substrate is metabolized. Thisability to have plural, enhanced bioconversions can occur using a singlestrain of microorganism or using two or more different strains. In someinstances, different phenotypic changes may occur depending upon themicroenvironment in which the microorganisms are located.

A number of factors contribute to the existence of these uniquemicroenvironments. For instance, concentration gradients are a majordriving force for the ingress and egress of components in the aqueousphase in these channels. As the microorganisms in the biocatalystbioconvert components, concentration gradients occur, especially alongchannels extending from the major cavities. The changes in concentrationof components thus results in variations of component concentrationswithin the biocatalyst. In some situations, the microorganisms having areduced supply of electron donor or nutrients at one or more regionswithin the biocatalyst may be at or near starvation which can result inphenotypic changes leading to resistance to stress. The bioconversionand consequent gradient changes also affects the rate of ingress fromand egress to the exterior of the biocatalyst of components.

A high density of microorganisms can exist at steady-state operationwithin the biocatalysts. The combination of the flow channels and thehigh permeability of the polymeric structure defining the channelsenable viable microorganism population throughout the matrix, albeitwith a plurality of unique microenvironments and nano-environments. Insome instances, the cell density based upon the volume of thebiocatalyst is preferably at least about 100 grams per liter, preferablyat least about 200, and often between about 250 and 750, grams perliter.

Polysaccharide-Containing Biocatalysts

In one preferred aspect of the biocatalyst of this invention, it hasbeen found that through incorporating polysaccharide in the interior ofthe biocatalyst, the viability of the microorganism population can bemaintained. Typically polysaccharides are not usable by mostmicroorganisms. Often, the polysaccharide is provided in an amount of atleast about 0.1, say, at least about 0.2 to 100, gram per gram of cellsretained in the biocatalyst, and sometimes the biocatalyst containsbetween 25 and 500 grams of polysaccharide per liter of volume of fullyhydrated biocatalyst. The polysaccharide particles used in preparing thebiocatalysts preferably have a major dimension of less than about 50,preferably less than about 20, often between about 0.1 to 5, microns.The solid polysaccharide particles are preferably granular and oftenhave an aspect ratio of minimum cross-sectional dimension to maximumcross sectional dimension of between about 1:10 to 1:1, say 1:2 to 1:1.

Due to the ability of the polysaccharide to maintain the viability ofthe microorganisms in the biocatalyst, the storage, handling andprocesses for use of the biocatalyst can be facilitated. For instance,the biocatalysts can be used in bioconversion processes which areoperated in a carbon deficient manner. In metabolic processes wherecarbon source is added to maintain the microorganisms and not used inthe sought bioconversion of substrate to bioproduct, such as in thecatabolysis of nitrate, nitrite, and perchlorate anions and themetabolic reduction of metalates, the polysaccharide may serve as thesole source of carbon and thereby eliminate the necessity of addingcarbon source, or it may reduce the amount of carbon source added, i.e.,permit carbon deficient operation. An advantage is that the bioprocessescan be operated such that the effluent has essentially no COD. Thebiocatalysts also have enhanced abilities to tolerate disruptions insubstrate presence and be able to quickly regain bioconversion activity.Also, the biocatalysts can be remotely manufactured and shipped to thelocation of use without undue deleterious effect on the bioconversionactivity of the biocatalyst. The biocatalysts may be able enter a stateof essential stasis for extended durations of time in the absence ofsupplying substrate and other nutrients to the microbial composites evenwhere excursions in the desired storage conditions such as temperatureoccur. The bioactivity can be quickly regained in a bioreactor evenafter extended episodic occurrences of shutdown, feedstock disruption,or feedstock variability. The biocatalysts can be packaged and shippedin sealed barrels, tanks, and the like.

The polysaccharide may be from any suitable source including, but notlimited to, cellulosic polysaccharides or starches. Polysaccharides arecarbohydrates characterized by repeating units linked together byglycosidic bonds and are substantially insoluble in water.Polysaccharides may be homopolysaccharides or heteropolysaccharides andtypically have a degree of polymerization of between about 200 and15,000 or more, preferably between about 200 and 5000. The preferredpolysaccharides are those in which about 10, more preferably, at leastabout 20, percent of the repeating units are amylose (D-glucose units).Most preferably the polysaccharide has at least about 20, morepreferably, at least about 30, percent of the repeating units beingamylose. The polysaccharides may or may not be functionalized, e.g.,with acetate, sulfate, phosphate, pyruvyl cyclic acetal, and the like,but such functionalization should not render the polysaccharide watersoluble at temperatures below about 50° C. A preferred class ofpolysaccharides is starches.

Sources of polysaccharides include naturally occurring and synthetic(e.g., polydextrose) polysaccharides. Various plant based materialsproviding polysaccharides include but are not limited to woody plantmaterials providing cellulose and hemicellulose, and wheat, barley,potato, sweet potato, tapioca, corn, maize, cassava, milo, rye and branstypically providing starches.

Solid Sorbent-Containing Biocatalysts

In another preferred aspect of the biocatalysts of this invention, thebiocatalysts comprise a solid sorbent. The solid sorbent may be thehydrophilic polymer forming the structure or may be a particulate, i.e.,a distinct solid structure regardless of shape) contained in the solidstructure. The sorbent may be any suitable solid sorbent for thesubstrate or nutrients or other chemical influencing the soughtmetabolic activity such as, but not limited to, co-metabolites,inducers, and promoters or for components that may be adverse to themicroorganisms such as, and not in limitation, toxins, phages,bioproducts and by-products. The solid sorbent is typically an adsorbentwhere the sorption occurs on the surface of the sorbent. The particulatesolid sorbents are preferably nano materials having a major dimensionless than about 5 microns, preferably, between about 5 nanometers to 3microns. Where the solid sorbent is composed of polymer, the solidstructure may be essentially entirely composed of the polymer or may bea block copolymer or polymeric mixture constituting between about 5 and90 mass percent of the solid structure (excluding water). Where thesolid sorbent is a separate particulate in the biocatalyst, thebiocatalyst may comprise between about 5 to 90 mass percent of the massof the biocatalyst (excluding water and microorganisms but includingboth the hydrophilic polymer and the particulates). More than one solidsorbent may be used in a biocatalyst. Preferably the solid sorbent isrelatively uniformly dispersed throughout the interior of thebiocatalyst although the solid sorbent may have a varying distributionwithin the biocatalyst. Where the distribution varies, the regions withthe higher concentration of solid sorbent often are found toward thesurface of the biocatalyst.

Where a particulate sorbent is used, the sorbent comprises an organic orinorganic material having the sought sorptive capacity. Examples ofsolid sorbents include, without limitation, polymeric materials,especially with polar moieties, carbon (including but not limited toactivated carbon), silica (including but not limited to fumed silica),silicates, clays, molecular sieves, and the like. The molecular sievesinclude, but are not limited to zeolites and synthetic crystallinestructures containing oxides and phosphates of one or more of silicon,aluminum, titanium, copper, cobalt, vanadium, titanium, chromium, iron,nickel, and the like. The sorptive properties may comprise one or moreof physical or chemical or quasi-chemical sorption on the surface of thesolid sorbent. Thus, surface area and structure may influence thesorptive properties of some solid sorbents. Frequently the solidsorbents are porous and thus provide high surface area and physicalsorptive capabilities. Often the pores in the solid sorbents are in therange of about 0.3 to 2 nanometers in effective diameter.

The solid sorbent may be incorporated into the polymeric structure inany convenient manner, preferably during the preparation of thebiocatalyst.

Phosphorescent Biocatalysts

Another preferred aspect of the invention pertains to biocatalystscontaining phosphorescent material and photosynthetic microorganisms,i.e., microorganisms that uses light energy in a metabolic process.Preferably the microorganism is an algae, most preferably a microalgae,or cyanobacteria.

The bioactivity of photosynthetic microorganisms can be enhanced toproduce expressed bioproduct using broad-based light source such assunlight. In accordance with the invention, the photosyntheticmicroorganisms are irreversibly retained in biocatalysts in which theinterior of the biocatalyst contains phosphorescent material capable ofshifting UV light to light having a wavelength of between about 400 and800, preferably between about 450 and 650, nm and is capable ofexhibiting persistence, with the emission of the light often lasting forat least about 5 seconds. A phosphorescent material is a material thathas the ability to be excited by electromagnetic radiation into anexcited state, but the stored energy is released gradually. Emissionsfrom phosphorescent materials have persistence, that is, emissions fromsuch materials can last for seconds, minutes or even hours after theexcitation source is removed. A luminescent material is a materialcapable of emitting electromagnetic radiation after being excited intoan excited state. Persistence is the time it takes, after discontinuingirradiation, for photoluminescent emissions emanating from aphotoluminescent object to decrease to the threshold detectability.

The persistence of the radiation enables the microorganisms to be cycledin and out of a region of the culture liquid exposed to the light sourceand still be productive. With longer persistence durations, thephotosynthetic microorganisms can continue photo-bioconversion in theabsence of or reduction in light intensity. The ability of thebiocatalysts to maintain photosynthetic activity over extended periodsof time, often at least about 30 days, and in some instances for atleast one year, the cost of the phosphorescent materials is often offsetby the increased production, reduced footprint of the bioreactor, andfacilitated bioproduct recovery.

The biocatalyst, being highly hydrated is a significant distributor oflight radiation to photosynthetic microorganisms retained in theinterior of the biocatalyst and also serves to protect the microorganismfrom photorespiration. The solid debris in the culture liquid (anaqueous solution comprising nutrients for metabolic processes) can bematerially reduced, if not essentially eliminated, due to themicroorganisms being irreversibly retained in the biocatalyst. Thus theturbidity is reduced and a given light intensity can thus be found at agreater depth in the culture liquid. These advantages provided by thebiocatalysts of this invention can be realized in any photosyntheticprocess regardless of whether or not a phosphorescent material is used.

Examples of phosphorescent materials include, but are not limited to,phosphorescent materials are metal sulfide phosphors such asZnCdS:Cu:Al, ZnCdS:Ag:Al, ZnS:Ag:Al, ZnS:Cu:Al as described in U.S. Pat.No. 3,595,804 and metal sulfides that are co-activated with rare earthelements such as those describe in U.S. Pat. No. 3,957,678. Phosphorsthat are higher in luminous intensity and longer in luminous persistencethan the metal sulfide pigments include compositions comprising a hostmaterial that is generally an alkaline earth aluminate, or an alkalineearth silicate. The host materials generally comprise Europium as anactivator and often comprise one or more co-activators such as elementsof the Lanthanide series (e.g. lanthanum, cerium, praseodymium,neodymium, samarium, gadolinium, terbium, dysprosium, holmium, erbium,thulium, ytterbium, and lutetium), tin, manganese, yttrium, or bismuth.Examples of such phosphors are described in U.S. Pat. No. 5,424,006.

High emission intensity and persistence phosphorescent materials can bealkaline earth aluminate oxides having the formula MO_(m)Al₂O₃:Eu²⁺, R³⁺wherein m is a number ranging from 1.6 to about 2.2, M is an alkalineearth metal (strontium, calcium or barium), Eu²⁺ is an activator, and Ris one or more trivalent rare earth materials of the lanthanide series(e.g. lanthanum, cerium, praseodymium, neodymium, samarium, gadolinium,terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium),yttrium or bismuth co-activators. Examples of such phosphors aredescribed in U.S. Pat. No. 6,117,362. Phosphorescent materials alsoinclude alkaline earth aluminate oxides having the formula M_(k)Al₂O₄:2xEu²⁺, 2yR³⁺ wherein k=1−2x−2y, x is a number ranging from about0.0001 to about 0.05, y is a number ranging from about x to 3x, M is analkaline earth metal (strontium, calcium or barium), Eu²⁺ is anactivator, and R is one or more trivalent rare earth materials (e.g.lanthanum, cerium, praseodymium, neodymium, samarium, gadolinium,terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium),yttrium or bismuth co-activators. See U.S. Pat. No. 6,267,911B1.

Phosphorescent materials also include those in which a portion of theAl³⁺ in the host matrix is replaced with divalent ions such as Mg²⁺ orZn²⁺ and those in which the alkaline earth metal ion (M²⁺) is replacedwith a monovalent alkali metal ion such as Li⁺, Na⁺, K⁺, Cs⁺ or Rb⁺ suchas described in U.S. Pat. Nos. 6,117,362 and 6,267,911B1.

High intensity and high persistence silicates have been disclosed inU.S. Pat. No. 5,839,718, such as Sr.BaO.Mg.MO.SiGe:Eu:Ln wherein M isberyllium, zinc or cadmium and Ln is chosen from the group consisting ofthe rare earth materials, the group 3A elements, scandium, titanium,vanadium, chromium, manganese, yttrium, zirconium, niobium, molybdenum,hafnium, tantalum, tungsten, indium, thallium, phosphorous, arsenic,antimony, bismuth, tin, and lead. Particularly useful are dysprosium,neodymium, thulium, tin, indium, and bismuth. X in these compounds is atleast one halide atom.

Other phosphorescent materials include alkaline earth aluminates of theformula MO.Al₂O₃.B₂O₃:R wherein M is a combination of more than onealkaline earth metal (strontium, calcium or barium or combinationsthereof) and R is a combination of Eu²⁺ activator, and at least onetrivalent rare earth material co-activator, (e.g. lanthanum, cerium,praseodymium, neodymium, samarium, gadolinium, terbium, dysprosium,holmium, erbium, thulium, ytterbium, lutetium), bismuth or manganese.Examples of such phosphors can be found in U.S. Pat. No. 5,885,483.Alkaline earth aluminates of the type MAl₂O₄, which are described inU.S. Pat. No. 5,424,006, may also find application as may phosphorescentmaterials comprising a donor system and an acceptor system such asdescribed in U.S. Pat. No. 6,953,536 B2.

As can be appreciated, many other phosphors can find application. See,for instance, Yen and Weber, Inorganic Phosphors: Compositions,Preparation and Optical Properties, CRC Press, 2004.

The phosphorescent material may be a discrete particle or may be aparticle having a coating to facilitate incorporation and retention inthe polymer forming the matrix. The particles may be of any suitableshape. Generally the maximum dimension of the of the particles is lessthan about 1 millimeter, preferably less than about 0.1 millimeter. Theparticles may be nanoparticles.

The persistence time exhibited by the phosphorescent materials can rangefrom a short duration, e.g., about 5 to 10 seconds, to as much as 10 or20 hours or more and will be dependent upon the phosphorescent materialused. Preferred phosphorescent materials exhibit a persistence of atleast about one minute. The intensity of the emitted radiation will, inpart, depend upon the concentration of the phosphorescent material inthe biocatalyst and the nature of the phosphorescent material. Typicallythe phosphorescent material is provided in an amount of at least about0.1, say, between 0.2 and 5 or 10, mass percent of the polymer(non-hydrated) in the biocatalyst. One or more phosphorescent materialsmay be used in the biocatalyst. Where more than one phosphorescentmaterial are used, the combination may be selected to provide one ormore of wave shifting from different light wavelengths contained in theband width of the radiation source and providing differing persistencetimes. In preferred embodiments the phosphorescent materials are in theform of nanoparticles, e.g., having a major dimension of between about10 nm and 10 μm. In some instances, it may be desired to coat thephosphorescent materials with a compatibilizing agent to facilitateincorporation of the phosphorescent material within the polymer.Compatibilizing agents include, but are not limited to, molecules havingone or more of hydroxyl, thiol, silyl, carboxyl, or phosphoryl groups.

Enzyme-Containing Biocatalysts

In another aspect, the biocatalysts can contain, in addition to themicroorganisms, one or more isolated enzymes in the interior of thebiocatalyst to cause a catalytic change to a component which may besubstrate or other nutrients, or a bioproduct or by-product orco-product of the microorganisms, or may be a toxin, phage or the like.Typically extracellular enzymes bond or adhere to solid surfaces, suchas the hydrophilic polymer, solid additives, cell walls andextracellular polymeric substance. It is understood that isolatedenzymes may also be located within the cell of a microorganism. Hence,the enzymes can be substantially irreversibly retained in the interiorof the biocatalyst. Due to the structure of the biocatalysts of thisinvention, the microorganisms and the enzymes can be in close proximityand thus effective, cooperative bioconversions can be obtained. Theassociation of the enzymes with the interior surfaces of the biocatalysttypically increases the resistance of the enzyme or enzymes todenaturation due to changes in temperature, pH, or other factors relatedto thermal or operational stability of the enzymes. Also, by beingretained in the biocatalyst, the use of the enzyme in a bioreactor isfacilitated and undesirable post-reactions can be mitigated.

Examples of enzymes include, but are not limited to, one or more ofoxidorectases, transferases, hydrolases, lyases, isomerases, andligases. The enzymes may cause one or more metabolic conversions. Forinstance, an enzyme may metabolize a component in the feed to provide anintermediate for use by the microorganisms in the biocatalyst. An enzymemay be used to metabolize a metabolite of the microorganism to provide asought bioproduct. An enzyme may be used to metabolize a component inthe feed or a co-metabolite from the microorganism that may be adverseto the microorganism into a metabolite that is less adverse to themicroorganism. If desired, two or more different enzymes can be used toeffect a series of metabolic conversions on a component in the feed or ametabolite from the microorganism.

Representative enzymes include, without limitation: cellulase,cellobiohydrolase (e.g., CBHI, CBHII), alcohol dehydrogenase (A, B, andC), acetaldehyde dehydrogenase, amylase, alpha amylase, glucoamylase,beta glucanase, beta glucosidase, invertase, endoglucanase (e.g., EGI,EGII, EGIII), lactase, hemicellulase, pectinase, hydrogenase,pullulanase, phytase, a hydrolase, a lipase, polysaccharase, ligninase,Accellerase® 1000, Accellerase® 1500, Accellerase® DUET, Accellerase®TRIO, or Cellic CTec2 enzymes, phosphoglucose isomerase,inositol-1-phosphate synthase, inositol monophosphatase, myo-inositoldehydrogenase, myo-inosose-2-dehydratase, inositol 2-dehydrogenase,deoxy-D-gluconate isomerase, kinase, 5-dehydro-2-deoxygluconokinase,deoxyphophogluconate aldolase, 3-hydroxy acid dehydrogenase, isomerase,topoisomerase, dehydratase, monosaccharide dehydrogenase, aldolase,phosphatase, a protease, DNase, alginate lyase, laminarinase,endoglucanase, L-butanediol dehydrogenase, acetoin reductase,3-hydroxyacyl-CoA dehydrogenase, or cis-aconitate decarboxylase. Theenzymes include those described by Heinzelman et al. (2009) PNAS 106:5610-5615, herein incorporated by reference in its entirety.

The enzymes may be bound to the precursor for the hydrophilic polymer ofthe biocatalyst prior to the formation of the biocatalyst or may beintroduced during the preparation of the biocatalyst, e.g., by additionto the liquid medium for forming the biocatalyst. There are many methodsthat would be known to one of skill in the art for providing enzymes orfragments thereof, or nucleic acids, onto a solid support. Some examplesof such methods include, e.g., electrostatic droplet generation,electrochemical means, via adsorption, via covalent binding, viacross-linking, via a chemical reaction or process. Various methods aredescribed in Methods in Enzymology, Immobilized Enzymes and Cells, PartC. 1987. Academic Press. Edited by S. P. Colowick and N. O. Kaplan.Volume 136; Immobilization of Enzymes and Cells. 1997. Humana Press.Edited by G. F. Bickerstaff. Series: Methods in Biotechnology, Edited byJ. M. Walker; DiCosimo, R., McAuliffe, J., Poulose, A. J. Bohlmann, G.2012. Industrial use of immobilized enzymes. Chem. Soc. Rev.; andImmobilized Enzymes: Methods and Applications. Wilhelm Tischer and FrankWedekind, Topics in Current Chemistry, Vol. 200. Page 95-126.

C. Methods for Making Biocatalysts

The components, including microorganisms, used to make the biocatalystsand the process conditions used for the preparation of the biocatalystsare not critical to the broad aspects of this invention and may varywidely as is well understood in the art once understanding theprinciples of metabolically retaining microorganisms described above. Inany event, the components and process conditions for making thebiocatalysts with the irreversibly, metabolically retainedmicroorganisms should not unduly adversely affect the microorganisms.

The biocatalysts may be prepared from a liquid medium containing themicroorganism and solubilized precursor for the hydrophilic polymerwhich may be one or more of a polymerizable or solidifiable component ora solid that is fusible or bondable to form the matrix. Aqueous mediaare most often used due to the compatibility of most microorganisms andenzymes with water. However, with microorganisms that tolerate otherliquids, such liquids can be used to make all or a portion of the liquidmedium. Examples of such other liquids include, but are not limited toliquid hydrocarbons, peroxygenated liquids, liquid carboxy-containingcompounds, and the like. Mixed liquid media can also be used to preparethe biocatalyst. The mixed media may comprise miscible or immiscibleliquid phases. For instance, the microorganism may be suspended in adispersed, aqueous phase and the polymerizable or solidifiable componentmay be contained in a continuous solvent phase.

The liquid medium used to prepare the biocatalyst may contain more thanone type of microorganism, especially where the microorganisms do notsignificantly compete for the same substrate, and may contain one ormore isolated enzymes or functional additives such as polysaccharide,solid sorbent and phosphorescent materials, as described above.Preferably, the biocatalysts contain a single type of microorganism. Theconcentration of the microorganisms in the liquid medium used to makethe biocatalysts should at least be about 60 grams per liter. Asdiscussed above, the concentration of microorganisms should preferablyapproximate the sought density of microorganisms in the biocatalyst. Therelative amounts of microorganism and polymeric material in forming thebiocatalyst can vary widely. The growth of the population ofmicroorganisms post formation of the biocatalyst is contemplated as wellas the potential for damage to some of the population of microorganismsduring the biocatalyst-forming process. Nevertheless, highermicroorganism concentrations are generally preferred, e.g., at leastabout 100 grams per liter, preferably at least about 200, and oftenbetween about 250 and 750, grams per liter of the liquid medium used tomake the biocatalysts.

Any suitable process may be used to solidify or polymerize the polymericmaterial or to adhere or fuse particles to form the open, porouspolymeric matrix with microorganism irreversibly retained therein. Theconditions of suitable processes should not unduly adversely affect themicroorganisms. As microorganisms differ in tolerance to temperatures,pressures and the presence of other chemicals, some matrix-formingprocesses may be more advantageous for one type of microorganism thanfor another type of microorganism.

Preferably the polymeric matrix is formed from solidification of a highmolecular weight material, by polymerization or by cross-linking ofprepolymer in manner that a population of microorganisms is provided inthe interior of the biocatalyst as it is being formed. Exemplaryprocesses include solution polymerization, slurry polymerization(characterized by having two or more initial phases), and solidificationby cooling or removal of solvent.

The biocatalysts may be formed in situ in the liquid medium bysubjecting the medium to solidification conditions (such as cooling orevaporation) or adding a component to cause a polymerization orcross-linking or agglomeration of solids to occur to form a solidstructure such as a catalyst, cross-linking agent or coagulating agent.Alternatively, the liquid medium may be extruded into a solutioncontaining a solidification agent such as a catalyst, cross-linking orcoagulating agent or coated onto a substrate and then the compositesubjected to conditions to form the solid biocatalyst.

Polymeric materials used to make the biocatalysts may have an organic orinorganic backbone but have sufficient hydrophilic moieties to provide ahighly hydrophilic polymer which when incorporated into the matricesexhibits sufficient water sorption properties to provide the soughtHydration Expansion Volume of the biocatalyst. Polymeric materials arealso intended to include high molecular weight substances such as waxes(whether or not prepared by a polymerization process), oligomers and thelike so long as they form biocatalysts that remain solid under theconditions of the bioconversion process intended for their use and havesufficient hydrophilic properties that the Hydration Expansion Volumecan be achieved. As stated above, it is not essential that polymericmaterials become cross-linked or further polymerized in forming thepolymeric matrix.

Examples of polymeric materials include homopolymers and copolymerswhich may or may not be cross-linked and include condensation andaddition polymers that provide high hydrophilicity and enable theHydration Expansion Volumes to be obtained. The polymer may be ahomopolymer or a copolymer, say, of a hydrophilic moiety and a morehydrophobic moiety. The molecular weight and molecular weightdistribution are preferably selected to provide the combination ofhydrophilicity and strength as is known in the art. The polymers may befunctionalized with hydrophilic moieties to enhance hydrophilicity.Examples of hydrophilic moieties include, but are not limited tohydroxyl, alkoxyl, acyl, carboxyl, amido, and oxyanions of one or moreof titanium, molybdenum, phosphorus, sulfur and nitrogen such asphosphates, phosphonates, sulfates, sulfonates, and nitrates, and thehydrophilic moieties may be further substituted with hydrophilicmoieties such as hydroxyalkoxides, acetylacetonate, and the like.Typically the polymers contain carbonyl and hydroxyl groups, especiallyat some adjacent hydrophilic moieties such as glycol moieties. In someinstances, the backbone of the polymer contains ether oxygens to enhancehydrophilicity. In some instances, the atomic ratio of oxygen to carbonin the polymer is between about 0.3:1 to 5:1.

Polymers which may find use in forming the matrices includefunctionalized or non-functionalized polyacrylamides, polyvinylalcohols, polyetherketones, polyurethanes, polycarbonates, polysulfones,polysulfides, polysilicones, olefinic polymers such as polyethylene,polypropylene, polybutadiene, rubbers, and polystyrene, nylons,polythyloxazyoline, polyethylene glycol, polysaccharides such as sodiumalginate, carageenan, agar, hyaluronic acid, chondroitin sulfate,dextran, dextran sulfate, heparin, heparin sulfate, heparan sulfate,chitosan, gellan gum, xanthan gum, guar gum, water soluble cellulosederivatives and carrageenan, and proteins such as gelatin, collagen andalbumin, which may be polymers, prepolymers or oligomers, and polymersand copolymers from the following monomers, oligomers and prepolymers:monomethacrylates such as polyethylene glycol monomethacrylate,polypropylene glycol monomethacrylate, polypropylene glycolmonomethacrylate, methoxydiethylene glycol methacrylate,methoxypolyethylene glycol methacrylate, methacryloyloxyethyl hydrogenphthalate, methacryloyloxyethyl hydrogen succinate,3-chloro-2-hydroxypropyl methacrylate, stearyl methacrylate, 2-hydroxymethacrylate, and ethyl methacrylate; monoacrylates such as2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, isobutyl acrylate,t-butyl acrylate, isooctyl acrylate, lauryl acrylate, stearyl acrylate,isobornyl acrylate, cyclohexyl acrylate, methoxytriethylene glycolacrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate,phenoxyethyl acrylate, nonylphenoxypolyethylene glycol acrylate,nonylphenoxypolypropylene glycol acrylate, silicon-modified acrylate,polypropylene glycol monoacrylate, phenoxyethyl acrylate,phenoxydiethylene glycol acrylate, phenoxypolyethylene glycol acrylate,methoxypolyethylene glycol acrylate, acryloyloxyethyl hydrogensuccinate, and lauryl acrylate; dimethacrylates such as 1,3-butyleneglycol dimethacrylate, 1,4-butanediol dimethacrylate, ethylene glycoldimethacrylate, diethylene glycol dimethacrylate, triethylene glycoldimethacrylate, polyethylene glycol dimethacrylate, butylene glycoldimethacrylate, hexanediol dimethacrylate, neopentyl glycoldimethacrylate, polyprene glycol dimethacrylate,2-hydroxy-1,3-dimethacryloxypropane,2,2-bis-4-methacryloxyethoxyphenylpropane,3,2-bis-4-methacryloxydiethoxyphenylpropane, and2,2-bis-4-methacryloxypolyethoxyphenylpropane;

diacrylates such as ethoxylated neopentyl glycol diacrylate,polyethylene glycol diacrylate, 1,6-hexanediol diacrylate, neopentylglycol diacrylate, tripropylene glycol diacrylate, polypropylene glycoldiacrylate, 2,2-bis-4-acryloxyethoxyphenylpropane,2-hydroxy-1-acryloxy-3-methacryloxypropane; trimethacrylates such astrimethylolpropane trimethacrylate; triacrylates such astrimethylolpropane triacrylate, pentaerythritol triacrylate,trimethylolpropane EO-added triacrylate, glycerol PO-added triacrylate,and ethoxylated trimethylolpropane triacrylate; tetraacrylates such aspentaerythritol tetraacrylate, ethoxylated pentaerythritoltetraacrylate, propoxylated pentaerythritol tetraacrylate, andditrimethylolpropane tetraacrylate;urethane acrylates such as urethane acrylate, urethane dimethylacrylate, and urethane trimethyl acrylate;amino-containing moieties such as 2-aminoethyl acrylate, 2-aminoethylmethacrylate, aminoethyl methacrylate, dimethyl aminoethyl methacrylate,monomethyl aminoethyl methacrylate, t-butylaminoethylmethacrylate,p-aminostyrene, o-aminostyrene, 2-amino-4-vinyltoluene,dimethylaminoethyl acrylate, diethylaminoethyl acrylate, piperidinoethylethyl acrylate, piperidinoethyl methacrylate, morpholinoethyl acrylate,morpholinoethyl methacrylate, 2-vinyl pyridine, 3-vinyl pyridine,2-ethyl-5-vinyl pyridine, dimethylaminopropylethyl acrylate,dimethylaminopropylethyl methacrylate, 2-vinyl pyrrolidone, 3-vinylpyrrolidone, dimethylaminoethyl vinyl ether, dimethylaminoethyl vinylsulfide, diethylaminoethyl vinyl ether, 2-pyrrolidinoethyl acrylate,2-pyrrolidinoethyl methacrylate,and other monomers such as acrylamide, acrylic acid, anddimethylacrylamide.

Not all the above listed polymers will be useful by themselves, but maybe required to be functionalized or used to form a co-polymer with ahighly hydrophilic polymer.

Cross linking agents, accelerators, polymerization catalysts, and otherpolymerization additives may be employed such as triethanolamine,triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethylbenzylamine, dibenzyl amino, N-benzyl ethanolamine, N-isopropylbenzylamino, tetramethyl ethylenediamine, potassium persulfate,tetramethyl ethylenediamine, lysine, ornithine, histidine, arginine,N-vinyl pyrrolidinone, 2-vinyl pyridine, 1-vinyl imidazole, 9-vinylcarbazone, acrylic acid, and 2-allyl-2-methyl-1,3-cyclopentane dione.For polyvinyl alcohol polymers and copolymers, boric acid and phosphoricacid may be used in the preparation of polymeric matrices. As statedabove, the amount of cross-linking agent may need to be limited toassure that the matrices retain high hydrophilicity and the ability tohave a high Hydration Expansion Volume. The selection of the polymer andcross-linking agents and other additives to make porous matrices havingthe physical properties set forth above is within the level of theartisan in the art of water soluble and highly hydrophilic polymersynthesis.

The biocatalysts may be formed in the presence of other additives whichmay serve to enhance structural integrity or provide a beneficialactivity for the microorganism such as attracting or sequesteringcomponents, providing nutrients, and the like. Additives can also beused to provide, for instance, a suitable density to be suspended in theaqueous medium rather than tending to float or sink in the broth.Typical additives include, but are not limited to, starch, glycogen,cellulose, lignin, chitin, collagen, keratin, clay, alumina,aluminosilicates, silica, aluminum phosphate, diatomaceous earth,carbon, polymer, polysaccharide and the like. These additives can be inthe form of solids when the polymeric matrices are formed, and if so,are often in the range of about 0.01 to 100 microns in major dimension.

If desired, the microorganisms may be subjected to stress as is known inthe art. Stress may be one or more of starvation, chemical or physicalconditions. Chemical stresses include toxins, antimicrobial agents, andinhibitory concentrations of compounds. Physical stresses include lightintensity, UV light, temperature, mechanical agitation, pressure orcompression, and desiccation or osmotic pressure. The stress may produceregulated biological reactions that protect the microorganisms fromshock and the stress may allow the hardier microorganisms to survivewhile the weaker cells die.

Microorganisms

The microorganisms may be unicellular or may be multicellular thatbehaves as a single cell microorganism such as filamentous growthmicroorganisms and budding growth microorganisms. Often the cells ofmulticellular microorganisms have the capability to exist singularly.The microorganisms can be of any type, including, but not limited to,those microorganisms that are aerobes, anaerobes, facultative anaerobes,heterotrophs, autotrophs, photoautotrophs, photoheterotrophs,chemoautotrophs, and/or chemoheterotrophs. The cellular activity,including cell growth can be aerobic, microaerophilic, or anaerobic. Thecells can be in any phase of growth, including lag (or conduction),exponential, transition, stationary, death, dormant, vegetative,sporulating, etc. The one or more microorganisms be a psychrophile(optimal growth at −10° C. to 25° C.), a mesophile (optimal growth at20-50° C.), a thermophile (optimal growth 45° C. to 80° C.), or ahyperthermophile (optimal growth at 80° C. to 100° C.). The one or moremicroorganisms can be a gram-negative or gram-positive bacterium. Abacterium can be a cocci (spherical), bacilli (rod-like), or spirilla(spiral-shaped; e.g., vibrios or comma bacteria). The microorganisms canbe phenotypically and genotypically diverse.

The microorganisms can be a wild-type (naturally occurring)microorganism or a recombinant microorganism (including, but not limitedto genetically engineered microorganisms). A recombinant microorganismcan comprise one or more heterologous nucleic acid sequences (e.g.,genes). One or more genes can be introduced into a microorganism used inthe methods, compositions, or kits described herein, e.g., by homologousrecombination. One or more genes can be introduction into amicroorganism with, e.g., a vector. The one or more microorganisms cancomprise one or more vectors. A vector can be an autonomouslyreplicating vector, i.e., a vector that exists as an extra-chromosomalentity, the replication of which is independent of chromosomalreplication, e.g., a linear or closed circular plasmid, anextra-chromosomal element, a mini-chromosome, or an artificialchromosome. The vector can contain a means for self-replication. Thevector can, when introduced into a host cell, integrate into the genomeof the host cell and replicate together with the one or more chromosomesinto which it has been integrated. Such a vector can comprise specificsequences that can allow recombination into a particular, desired siteof the host chromosome. A vector system can comprise a single vector orplasmid, two or more vectors or plasmids, which together contain thetotal DNA to be introduced into the genome of the host cell, or atransposon. The choice of the vector will typically depend on thecompatibility of the vector with the host cell into which the vector isto be introduced. The vector can include a reporter gene, such as agreen fluorescent protein (GFP), which can be either fused in frame toone or more of the encoded polypeptides, or expressed separately. Thevector can also include a selection marker such as an antibioticresistance gene that can be used for selection of suitabletransformants. Means of genetically manipulating organisms aredescribed, e.g., Current Protocols in Molecular Biology, last updatedJul. 25, 2011, Wiley, Print ISSN: 1934-3639. In some embodiments, one ormore genes involved in byproduct formation are deleted in amicroorganism. In some embodiments, one or more genes involved inbyproduct formation are not deleted. Nucleic acid introduced into amicroorganism can be codon-optimized for the microorganism. A gene canbe modified (e.g., mutated) to increase the activity of the resultinggene product (e.g., enzyme). Sought properties in wild-type orgenetically modified microorganisms can often be enhanced through anatural modification process, or self-engineering process, involvingmultigenerational selective harvesting to obtain strain improvementssuch as microorganisms that exhibit enhanced properties such asrobustness in an environment or bioactivity. See, for instance,Ben-Jacob, et al., Self-engineering capabilities of bacteria, J. R. Soc.Interface 2006, 3, doi: 10.1098/rsif.2005.0089, 22 Feb. 2006.

The selected microorganism to be used in a biocatalyst can be targetedto the sought activity. The biocatalysts thus often containsubstantially pure strain types of microorganisms and, because of thetargeting, enable high bioactivity to be achieved and provide a stablepopulation of the microorganism in the biocatalyst.

Representative microorganisms for making biocatalysts of this inventioninclude, without limitation, those set forth in United States publishedpatent application nos. 2011/0072714, especially paragraph 0122;2010/0279354, especially paragraphs 0083 through 0089; 2011/0185017,especially paragraph 0046; 2009/0155873; especially paragraph 0093; and20060063217, especially paragraphs 0030 and 0031, and those set forth inAppendix A hereto.

Photosynthetic microorganisms include bacteria, algae, and molds havingbiocatalytic activity activated by light radiation. Examples ofphotosynthetic microorganisms for higher oxygenated organic compoundproduction include, but are not limited to alga such asBacillariophyceae strains, Chlorophyceae, Cyanophyceae, Xanthophyceaei,Chrysophyceae, Chlorella (e.g., Chlorella protothecoides),Crypthecodinium, Schizocytrium, Nannochloropsis, Ulkenia, Dunaliella,Cyclotella, Navicula, Nitzschia, Cyclotella, Phaeodactylum, andThaustochytrids; yeasts such as Rhodotorula, Saccharomyces, andApiotrichum strains; and fungi species such as the Mortierella strain.Genetically enhanced photoautotrophic cyanobacteria, algae, and otherphotoautotrophic organisms have been adapted to bioconvert carbohydratesinternal to the microorganism directly to ethanol, butanol, pentanol andother higher alcohols and other biofuels. For example, geneticallymodified cyanobacteria having constructs comprising DNA fragmentsencoding pyruvate decarboxylase (pdc) and alcohol dehydrogenase (adh)enzymes are described in U.S. Pat. No. 6,699,696. Cyanobacteria arephotosynthetic bacteria which use light, inorganic elements, water, anda carbon source, generally carbon dioxide, to metabolize and grow. Theproduction of ethanol using genetically engineered cyanobacteria hasalso been described in PCT Published Patent Application WO 2007/084477.

The following examples are provided in illustration of the biocatalystsand processes for making the biocatalysts and are not in limitation. Allparts and percentages of solids are by mass and of liquids and gases areby volume unless otherwise stated or is clear from the context.

In these examples, the following general procedure is used. Themicroorganisms for the biocatalyst are grown under suitable planktonicconditions in an aqueous medium for the microorganisms including thepresence of nutrients and micronutrients. This medium is referred toherein as the “Culture Medium”. The microorganisms used are as availableand thus may be either substantially pure strains or mixed cultures. Thecell density in the Culture Medium is determined by optical density. Ifthe cell density of the Culture Medium is below that sought to make thebiocatalyst, the Culture Medium is centrifuged or filtered to provide adenser, cell-containing fraction. A separately prepared aqueous solutionof solubilized precursor is made (referred to herein as the “PolymerSolution”). Any solid additive for the biocatalysts is added to thePolymer Solution in amounts that will provide the sought amount in thebiocatalyst. The Polymer Solution is mixed with a mechanical stirrer toassure uniform dispersion of the components in the aqueous medium. Wherenecessary to solubilize the precursor, the Polymer Solution can beheated as appropriate. In some instances, a micronutrient solution isalso added to the Polymer Solution.

Aliquots of each of the Culture Medium (or dense phase fromcentrifugation) and Polymer Solution are admixed under mechanicalstirring at about 30° C. to for a Precursor Solution. Where themicroorganism is anaerobic, the Culture Medium and the mixing of theCulture Medium and Polymer Solution and all subsequent steps aremaintained under anaerobic conditions by purging with nitrogen.

The Precursor Solution is then extruded through a perforated platehaving orifices of about 0.75 millimeter in diameter to form droplets ofabout 3 millimeters in diameter. The droplets fall into a gently stirredcoagulating bath of an aqueous boric acid solution having a pH of about5. The biocatalyst is recovered from the coagulating bath and washedwith distilled water. The biocatalyst, after washing, is placed in aliquid medium containing micronutrients and the substrate under suitablemetabolic conditions for the microorganisms.

Table I summarizes the examples. Table II sets forth the microorganismsused in the examples. Table III sets forth the hydrophilic polymer(s)that is used in the examples. Table IV sets forth the solid additivepackages used in the examples.

TABLE I Volume parts Volume parts Mass parts of Polymer Solu-Microorganism Solid Additive tion per 100 Microorganism culture per 100Solid package per Polymer parts of Pre- culture density parts of Pre-Additive liter of Pre- Example Solution cursor Solution Microorganismwet weight g/L cursor Solution Package cursor Solution 1 A 80 M-1 620 20S-1 1 2 Y 72 M-13 375 28 N/A N/A 3 DD 78 M-52 280 22 S-13 13 4 U 65 M-15300 35 S-25 0.2 5 BBB 73 M-27 440 27 N/A N/A 6 D 75 M-16 685 25 S-14 2.27 R 69 M-35 250 31 S-1 0.9 8 OOO 90 M-21 700 10 S-23 5.5 9 MM 45 M-1 8055 S-13 10 10 KKK 50 M-36 95 50 S-27 0.1 11 V 73 M-52 185 27 N/A N/A 12III 66 M-19 270 34 S-20 0.1 13 N 40 M-19 110 60 N/A N/A 14 A 80 M-38 40020 S-25 0.5 15 SSS 88 M-2 650 12 S-20 0.1 16 C 73 M-6 310 27 N/A N/A 17Z 60 M-40 250 40 S-6 1.2 18 XXX 73 M-35 400 27 S-7 0.5 19 CCC 65 M-38265 35 S-8 0.8 20 VVV 70 M-53 355 30 S-6 1.2 21 MMM 78 M-2 675 22 N/AN/A 22 NNN 74 M-53 305 26 S-6 0.5 23 C 75 M-38 365 25 S-8 0.8 24 EE 83M-19 650 17 N/A N/A 25 H 70 M-4 310 30 N/A N/A 26 YY 84 M-52 630 16 S-139.0 27 QQQ 90 M-20 715 10 N/A N/A 28 P 65 M-51 210 35 N/A N/A 29 JJJ 58M-26 205 42 S-13 3.5 30 KKK 48 M-35 180 52 S-24 0.3 31 V 70 M-38 460 30S-13 0.5 32 KK 66 M-18 380 34 S-19 2.2 33 Z 62 M-52 365 38 S-13 2.5 34 F62 M-22 355 38 S-3 0.4 35 CCC 66 M-6 455 34 S-6 0.55 36 H 68 M-6 410 32S-25 2.5 37 QQ 50 M-42 240 50 S-25 2.5 38 X 71 M-48 420 29 S-11 0.01 39M 72 M-53 415 28 S-21 1.0 40 RRR 85 M-1 670 15 S-23 1.0 41 T 76 M-19 33024 S-22 0.5 42 E 72 M-16 320 28 N/A N/A 43 KKK 50 M-48 100 50 N/A N/A 44M 74 M-17 400 26 S-23 1.0 45 FF 81 M-26 565 19 S-3 0.65 46 RRR 85 M-47595 15 S-3 0.92 47 YYY 55 M-13 115 45 S-26 1.0 48 QQ 40 M-41 65 60 S-130.7 49 SSS 88 M-35 660 12 S-26 0.1 50 C 76 M-36 540 24 N/A N/A 51 H 68M-42 460 32 S-20 0.1 52 TT 84 M-37 610 16 S-13 10.0 53 AAA 75 M-38 56525 S-1 1.5 54 W 50 M-20 260 50 S-14 2.5 55 TTT 74 M-18 440 26 S-20 0.256 NNN 78 M-13 645 22 N/A N/A 57 GG 58 M-19 200 42 S-14 2.5 58 J 81 M-47740 19 S-12 0.4 59 RR 72 M-53 575 28 S-25 1.7 60 PPP 72 M-28 570 28 S-141.0 61 G 66 M-6 320 34 N/A N/A 62 YY 83 M-28 730 17 S-14 1.0 63 O 68M-22 365 32 S-8 0.2 64 HHH 71 M-3 420 29 S-25 1.0 65 D 71 M-53 485 29N/A N/A 66 FF 76 M-25 580 24 N/A N/A 67 NN 58 M-15 280 42 S-9 1.0 68 JJJ65 M-8 420 35 S-1 1.0 69 Q 77 M-5 560 23 S-3 0.1 70 PP 70 M-12 425 30S-6 7.0 71 DDD 89 M-43 845 11 S-23 2.0 72 JJ 75 M-41 520 25 S-26 0.5 73MMM 85 M-25 730 15 N/A N/A 74 N 42 M-8 115 58 N/A N/A 75 XXX 75 M-26 50025 S-23 1.0 76 A 82 M-2 625 18 S-21 1.0 77 SSS 88 M-3 750 12 S-10 1.0 78A 79 M-1 555 21 S-4 0.17 79 M 72 M-38 510 28 S-13 7.5 80 RRR 75 M-43 56025 S-13 2.0 81 UUU 60 M-26 405 40 S-15 1.0 82 SS 85 M-49 770 15 S-13 0.283 VVV 66 M-9 390 34 S-17 1.4 84 YY 80 M-47 620 20 S-11 0.05 85 A 81M-55 600 19 S-24 0.17 86 NN 58 M-16 210 42 S-15 12.5 87 NN 58 M-46 20042 S-1 0.5 88 O 71 M-11 440 29 S-16 2.0 89 LLL 85 M-18 630 15 S-6 0.1790 C 72 M-2 595 28 S-12 1.0 91 B 68 M-5 480 32 S-7 2.0 92 RR 69 M-54 48531 N/A N/A 93 H 80 M-5 600 20 N/A N/A 94 ZZ 77 M-12 530 23 S-6 1.6 95 HH63 M-6 490 37 N/A N/A 96 TTT 75 M-19 570 25 N/A N/A 97 I 76 M-19 550 24S-25 0.1 98 Q 77 M-12 650 23 N/A N/A 99 GG 59 M-5 95 41 S-4 0.32 100 EE80 M-53 740 20 S-2 0.15 101 V 65 M-37 300 35 N/A N/A 102 LL 61 M-28 28039 S-23 2.5 103 S 40 M-20 70 60 S-19 0.1 104 B 69 M-2 540 31 S-2 1.1 105G 65 M-34 355 35 N/A N/A 106 X 72 M-38 520 28 S-13 6.2 107 M 65 M-15 44535 S-21 1.5 108 DDD 90 M-50 940 10 N/A N/A 109 A 81 M-50 725 19 N/A N/A110 Z 65 M-22 300 35 S-7 1.0 111 OOO 87 M-43 755 13 S-1 0.5 112 L 73M-26 585 27 S-14 1.5 113 RR 76 M-54 635 24 S-5 0.1 114 UU 79 M-34 765 21N/A N/A 115 E 72 M-5 360 28 S-25 0.1 116 TTT 71 M-19 355 29 S-6 0.14 117B 70 M-1 320 30 S-6 0.14 118 T 79 M-35 650 21 S-23 6.5 119 DD 76 M-39525 24 S-4 0.25 120 F 66 M-4 395 34 S-14 3.2 121 OO 68 M-24 445 32 S-21.2 122 W 51 M-54 175 49 S-15 14.0 123 LLL 80 M-5 745 20 S-6 0.8 124 AAA75 M-36 490 25 S-9 0.6 125 Y 73 M-12 480 27 S-13 5.0 126 QQ 44 M-19 20056 N/A N/A 127 C 72 M-11 410 28 N/A N/A 128 K 79 M-1 580 21 S-26 0.5 129MMM 75 M-12 460 25 N/A N/A 130 BB 44 M-34 125 56 S-6 1.1 131 M 69 M-23580 31 S-7 0.05 132 EEE 77 M-29 680 23 S-22 0.5 133 A 80 M-3 770 20 S-20.14 134 O 70 M-40 655 30 S-4 0.51 135 PPP 77 M-2 700 23 S-21 1.0 136 AA88 M-50 770 12 S-27 0.1 137 E 73 M-17 540 27 N/A N/A 138 MMM 72 M-44 60028 S-16 2.4 139 W 53 M-7 240 47 S-26 0.5 140 II 87 M-45 725 13 S-2 1.2141 B 67 M-1 410 33 S-24 0.1 142 UUU 57 M-35 320 43 S-11 0.012 143 D 72M-51 510 28 S-10 3.0 144 AAA 75 M-30 590 25 N/A N/A 145 WWW 75 M-51 65525 N/A N/A 146 OO 75 M-15 635 25 N/A N/A 147 I 80 M-4 810 20 N/A N/A 148FFF 72 M-40 470 28 S-13 6.2 149 AA 90 M-1 940 10 S-5 0.95 150 B 69 M-35455 31 N/A N/A 151 F 62 M-37 380 38 S-7 0.8 152 AAA 75 M-20 510 25 N/AN/A 153 J 78 M-13 665 22 S-23 1.2 154 N 43 M-33 175 57 S-14 8.5 155 K 78M-20 560 22 S-23 5.5 156 D 77 M-23 690 23 S-7 0.2 157 S 46 M-4 90 54 N/AN/A 158 OO 72 M-45 540 28 S-23 1.0 159 C 74 M-31 560 26 N/A N/A 160 A 82M-1 705 18 S-15 5 161 XXX 75 M-38 615 25 S-8 0.35 162 FFF 73 M-38 590 27S-5 2.0 163 HH 65 M-1 470 35 S-7 0.1 164 T 77 M-2 660 23 N/A N/A 165 G62 M-55 495 38 S-7 0.5 166 UUU 67 M-5 580 33 S-23 1.0 167 F 55 M-38 15045 S-8 0.1 168 GG 57 M-55 190 43 S-13 0.9 169 F 76 M-40 580 24 N/A N/A170 Y 70 M-51 450 30 S-9 0.1 171 K 77 M-14 575 23 S-27 1.0 172 E 72 M-39480 28 S-2 0.25 173 H 69 M-51 490 31 S-4 1.11 174 BB 45 M-37 120 55 S-110.5 175 R 70 M-24 430 30 S-2 0.2 176 O 72 M-35 450 28 S-8 0.25 177 I 78M-31 535 22 S-7 0.14 178 S 42 M-44 270 58 S-18 1.4 179 K 77 M-53 640 23S-23 2.2 180 FF 80 M-29 710 20 N/A N/A 181 PP 65 M-24 360 35 N/A N/A 182WWW 74 M-45 420 26 N/A N/A 183 B 68 M-51 390 32 N/A N/A 184 GGG 62 M-41330 38 S-14 7.5 185 S 44 M-6 250 56 S-3 0.84 186 CC 75 M-41 555 25 S-20.74 187 UUU 71 M-9 460 29 N/A N/A 188 P 64 M-33 310 36 S-5 2.0 189 BBB73 M-14 435 27 N/A N/A 190 XX 92 M-53 945 8 S-23 1.2 191 Z 60 M-7 420 40N/A N/A 192 AAA 75 M-12 510 25 N/A N/A 193 L 69 M-24 455 31 S-15 10.0194 H 68 M-32 505 32 S-24 1.11 195 D 77 M-15 630 23 N/A N/A 196 J 75M-45 595 25 S-16 4.0 197 BBB 74 M-55 550 26 S-12 0.58 198 WW 71 M-10 55029 S-16 4.5 199 HHH 70 M-4 555 30 S-5 0.29 200 QQ 52 M-7 250 48 N/A N/A201 VVV 64 M-12 425 36 S-19 1.0 202 L 70 M-24 530 30 S-15 1.0 203 SS 84M-13 735 16 S-2 0.1 204 MMM 71 M-12 500 29 N/A N/A

TABLE II Micro- organism Identifier Microorganism M-1 Saccharomycescerevisiae Sigma ® YSC2 ™ M-2 Zymomonas mobilis ZM4 ATCC ® 31821 ™ M-3Saccharomyces cerevisiae, Fermentis Ethanol Red ® M-4 Saccharomycescerevisiae ATCC ® 9763 ™ M-5 Clostridium acetobutylicum ATCC ® 824 ™ M-6Clostridium pasteurianum ATCC ® 6013 ™ M-7 Clostridium beijerinckiiATCC ® 10132 ™ M-8 Clostridium butyricum ATCC ® 19398 ™ M-9 Botryococcusbraunii UTEX 572 ™ M-10 Botryococcus braunii UTEX 2441 ™ M-11Botryococcus braunii var. Showa UC Herbarium UC147504 M-12 Nitrobacterwinogradskyi ATCC ® 25391 ™ M-13 Nitrosomonas europaea ATCC ® 19718 ™M-14 Nitrosomonas oceani ATCC ® 19707 ™ M-15 Lactobacillus delbrueckiiATCC ® 9649 ™ M-16 Lactobacillus casei ATCC ® 393 ™ M-17 Lactococcuslactis ssp. lactis ATCC ® 19435 ™ M-18 Lactobacillus amylovorus ATCC ®33620 ™ M-19 Enterobacter aerogenes ATCC ® 13048 ™ M-20 Enterobactercloacae ATCC ® 13047 ™ M-21 Rhodobacter sphaeroides ATCC ® 17029 ™ M-22Pseudonocardia dioxanivarans ATCC ® 55486 ™ M-23 Mycobacterium vaccaeATCC ® 15483 ™ M-24 Anaerobiospirillum succiniciproducens ATCC ® 29305 ™M-25 Actinobacillus succinogenes ATCC ® 55618 ™ M-26 Corynebacteriumglutamicum ATCC ® 13032 ™ M-27 Mannheimia succiniproducens ATCC ®29305 ™ M-28 Methanosarcina acetivorans ATCC ® 35395 ™ M-29Methanobrevibacter smithii ATCC ® 35061 ™ M-30 Methanothermobacterthermautotrophicus ATCC ® 29096 ™ M-31 Methanospirillum hungatei ATCC ®27890 ™ M-32 Methylosinus trichosporium ATCC ® 35070 ™ M-33Methylococcus capsulatus ATCC ® 19069 ™ M-34 Pseudomonas syringae ATCC ®19310 ™ M-35 Pseudomonas sp. ATCC ® 13867 ™ M-36 Achromobacterdenitrificans ATCC ® 15173 ™ M-37 Paracoccus denitrificans ATCC ®17741 ™ M-38 Dechloromonas agitata ATCC ® 700666 ™ M-39 Decholormonasaromatica ATCC ® BAA-1848 ™ M-40 Rhodococcus sp. ATCC ® 55309 ™ M-41Rhodococcus sp. ATCC ® 21504 ™ M-42 Desulfovibrio desulfuricans ATCC ®27774 ™ M-43 Cyanothece sp ATCC ® 51142 ™ M-44 Synechocystis sp. ATCC ®27184 ™ M-45 Chlamydomonas reinhardtii ATCC ® 30483 ™ M-46 Bacillusamyloliquefaciens ATCC ® 23350 ™ M-47 Citrobacter Freundii ATCC ® 8090 ™M-48 Klebsiella pneumonia ATCC ® 25955 ™ M-49 Bacillus selenitireducensATCC ® 700615 ™ M-50 Acidithiobacillus ferrooxidans ATCC ® 23270 ™ M-51Phanerochaete chrysosporium ATCC ® 24725 M-52 Escherichia Coli ATCC ®33456 ™ M-53 Acinetobacter calcoaceticus ATCC ® 23055 ™ M-54 Variovoraxparadoxus ATCC ® 17713 ™ M-55 Paracoccus denitrificans ATCC ® 19367 ™

TABLE III Polymer Solution Identifier Composition A 8.0 wt. percent ofpolyvinyl alcohol available as Elvanol ® 70-04 from Dupont, Inc. havinga degree of hydrolysis of 98.0-98.8 mol percent; 2.0 wt. percent ofsodium alginate available as Nalgin ™ MV-120 from Ingredient Solutions,Inc.; 0.5 wt. percent of medium molecular weight Poly(D-glucosamine)available as Sigma-Aldrich ® 448877 B 25 wt. percent ofPoly(acrylamide-co-acrylic acid) potassium salt-cross-linked availableas Sigma-Aldrich ® 432776; 0.2 wt. percent of Poly(2-hydroxyethylmethacrylate) available as Sigma-Aldrich ® P3932 C 14 wt. percent ofpoly(vinyl alcohol-co-ethylene) available as Sigma-Aldrich ® 414093having an ethylene composition of 32 mol percent; 2.0 wt. percent ofpolyethylene glycol with an average molecular weight of 200 available asSigma-Aldrich ® P3015 D 6.6 wt. percent of poly(N-isopropylacrylamide)available as Sigma-Aldrich ® 535311 having a molecular weight of19,000-30,000; 5.0 wt. percent of ethylene glycol dimethacrylateavailable as Sigma-Aldrich ® 335681 E 9.5 wt. percent of polyethyleneoxide available as POLYOX ™ WSR N-10 from Dow, Inc. having anapproximate molecular weight of 100,000; 0.5 wt. percent of polyethyleneglycol with an average molecular weight of 200 available asSigma-Aldrich ® P3015 F 23.0 wt. percent of polyvinyl alcohol availableas Elvanol ® 70-03 from Dupont ™ having a degree of hydrolysis of98-98.8 mol percent; 1.0% wt. percent of anhydrous calcium chlorideavailable as Sigma-Aldrich ® C1016; 0.9 wt. percent of sodium alginateavailable as Nalgin ™ MV-120 from Ingredient Solutions, Inc. G 22.5 wt.percent of polyvinyl alcohol available as Elvanol ® 70-20 from Dupont ™having a degree of hydrolysis of 98.5-99.2 mol percent; 2.0 wt. percentof xantham gum from Xanthamonas campestris available as Sigma-Aldrich ®G1253 H 15.0 wt. percent of polyvinyl alcohol available as Mowial ®28-99 from Kuraray Co., Ltd. ™ having a degree of hydrolysis of99.0-99.8 mol percent and a molecular weight of 145,000; 3.5 wt. percentof sodium alginate available as Nalgin ™ MV-120 from IngredientSolutions, Inc. I 21.7 wt. percent of polyethylene oxide available asPOLYOX ™ WSR N-80 from Dow, Inc. having an approximate molecular weightof 200,000; 1.0 wt. percent of medium molecular weightPoly(D-glucosamine) available as Sigma-Aldrich ® 448877; 0.5 wt. percentof sodium alginate available as Nalgin ™ MV-120 from IngredientSolutions, Inc. J 12.0 wt. percent of Poly(acrylamide-co-acrylic acid)potassium salt-cross-linked available as Sigma-Aldrich ® 432776; 2.0 wt.percent of sodium alginate available as Nalgin ™ MV-120 from IngredientSolutions, Inc. K 12.0 wt. percent of Poly(acrylamide-co-acrylic acid)potassium salt-cross-linked available as Sigma-Aldrich ® 432776; 0.2 wt.percent of ethylene glycol dimethacrylate available as Sigma-Aldrich ®335681 L 12.5 wt. percent of polyvinyl alcohol available as Poval ®PVA-202E from Kuraray Co., Ltd. ™ having a degree of hydrolysis of 87-89mol percent; 1.0 wt. percent polyaniline available as Sigma-Aldrich ®577073 M 12.5 wt. percent of poly(acrylic acid) available asSigma-Aldrich ® 192023 having an average molecular weight of 2000; 1.0wt. percent polyaniline available as Sigma-Aldrich ® 577073 N 55.0 wt.percent of poly(vinyl alcohol-co-ethylene) available as Sigma-Aldrich ®414093 having an ethylene composition of 32 mol percent; 1.0 wt. percentof poly(2-hydroxyethyl methacrylate) available as Sigma-Aldrich ® P3932;0.1 wt. percent of sodium alginate available as Sigma-Aldrich ® W201502O 21.0 wt. percent of poly(acrylic acid) available as Sigma-Aldrich ®192023 having an average molecular weight of 2000; 0.5 wt. percent ofpolyvinyl alcohol available as Elvanol ® 70-04 from Dupont, Inc. havinga degree of hydrolysis of 98.0-98.8 mol percent P 12.7 wt. percent ofpolyethylene oxide available as POLYOX ™ WSR N-80 from Dow, Inc. havingan approximate molecular weight of 200,000; 12.0 wt. percent ofpolyvinyl alcohol available as Elvanol ® 70-04 from Dupont, Inc. havinga degree of hydrolysis of 98.0-98.8 mol percent Q 13.0 wt. percent ofpolyethylene oxide available as POLYOX ™ WSR N-80 from Dow, Inc. havingan approximate molecular weight of 200,000; 2.1 wt. percent polyanilineavailable as Sigma-Aldrich ® 577073 R 18.0 wt. percent ofpoly(N-isopropylacrylamide) available as Sigma-Aldrich ® 535311 having amolecular weight of 19,000-30,000; 0.95 wt. percent of anhydrous calciumchloride available as Sigma-Aldrich ® C1016 S 50.0 wt. percent ofpolyvinyl alcohol available as Elvanol ® 70-03 from Dupont having adegree of hydrolysis of 98-98.8 mol percent; 0.2 wt. percent polyanilineavailable as Sigma-Aldrich ® 577073 T 10.0 wt. percent of poly(acrylicacid) available as Sigma-Aldrich ® 192023 having an average molecularweight of 2000; 1.0 wt. percent of polyethylene glycol with an averagemolecular weight of 200 available as Sigma-Aldrich ® P3015 U 20.0 wt.percent of polyvinyl alcohol available as Elvanol ® 70-06 from Dupont ™Inc. having a degree of hydrolysis of 98.5-99.2 mol percent; 1.0 wt.percent of Poly(2-hydroxyethyl methacrylate) available asSigma-Aldrich ® P3932 V 18.0 wt. percent of polyvinylalcohol-co-ethylene) available as Sigma-Aldrich ® 414093 having anethylene composition of 32 mol percent; 1.8 wt. percent of sodiumalginate available as Nalgin ™ MV-120 from Ingredient Solutions, Inc. W10.0 wt. percent of polyethylene oxide available as POLYOX ™ WSR N-80from Dow, Inc. having an approximate molecular weight of 200,000; 10.0wt. percent of polyethylene glycol with an average molecular weight of200 available as Sigma-Aldrich ® P3015; 10.0 wt. percent κ-Carrageenanavailable as Sigma-Alrdich ® 22048 X 11.5 wt. percent of polyvinylalcohol available as Elvanol ® 70-75 from Dupont ™ Inc. having a degreeof hydrolysis of 98.5-99.2 mol percent; 4.7 wt. percent of polyethyleneglycol with an average molecular weight of 200 available asSigma-Aldrich ® P3015 Y 12.5 wt. percent of polyvinyl alcohol availableas Elvanol ® 50-04 from Dupont ™ Inc. having a degree of hydrolysis of87.0-89.0 mol percent; 3.0 wt. percent of ethylene glycol dimethacrylateavailable as Sigma-Aldrich ® 335681; 1.0 wt. percent κ-Carrageenanavailable as Sigma-Alrdich ® 22048 Z 20.0 wt. percent of Elvanol ® 70-04polyvinyl alcohol from Dupont, Inc. having a degree of hydrolysis of98.0-98.8 mol percent; 1.90 wt. percent of sodium alginate available asNalgin ™ MV-120 from Ingredient Solutions, Inc.; 1.0 wt. percentκ-Carrageenan available as Sigma-Alrdich ® 22048 AA 3.7 wt. percent ofpolyethylene oxide available as POLYOX ™ WSR N-80 from Dow, Inc. havingan approximate molecular weight of 200,000; 0.5 wt. percent of anhydrouscalcium chloride available as Sigma-Aldrich ® C1016; 0.2 wt. percentκ-Carrageenan available as Sigma-Alrdich ® 22048 BB 35.0 wt. percent ofpolyvinyl alcohol available as Elvanol ® 70-27 from Dupont ™ Inc. havinga degree of hydrolysis of 95.5-96.5 mol percent; 6.0 wt. percent ofanhydrous calcium chloride available as Sigma-Aldrich ® C1016; 3.3 wt.percent of GRINDSTED ® Carrageenan CLFLX from Dupont, Inc. CC 25.0 wt.percent of polyethylene-alt-maleic anhydride available asSigma-Aldrich ® 188050 having an average molecular weight100,000-500,000; 2.2 wt. percent of polyethylene glycol with an averagemolecular weight of 200 available as Sigma-Aldrich ® P3015 DD 7.0 wt.percent of poly(vinyl alcohol-co-ethylene) available as Sigma-Aldrich ®414093 having an ethylene composition of 32 mol percent; 7.0 wt. percentof polyacrylic acid with an average molecular weight of 1800 availableas Sigma-Aldrich ® 323667 EE 8.0 wt. percent of polyvinyl alcoholavailable as Sigma-Aldrich ® 363065 having a degree of hydrolysis of 99+mol percent and a molecular weight of 146,000-186,000; 1.0 wt. percentκ-Carrageenan available as Sigma-Alrdich ® 22048; 1.0 wt. percent ofethylene glycol dimethacrylate available as Sigma-Aldrich ® 335681 FF8.0 wt. percent of polyethylene oxide available as POLYOX ™ WSR N-80from Dow, Inc. having an approximate molecular weight of 200,000; 1.0wt. percent of ethylene glycol dimethacrylate available asSigma-Aldrich ® 335681 GG 14.4 wt. percent of polyvinyl alcoholavailable as Elvanol ® 70-14 from Dupont ™ Inc. having a degree ofhydrolysis of 95.0-97.0 mol percent; 14.0 wt. percent of polyacrylicacid with an average molecular weight of 1800 available asSigma-Aldrich ® 323667 HH 18.1 wt. percent of poly(vinylalcohol-co-ethylene) available as Sigma-Aldrich ® 414093 having anethylene composition of 32 mol percent; 5.5 wt. percent ofPoly(2-hydroxyethyl methacrylate) available as Sigma-Aldrich ® P3932;1.0 wt. percent of anhydrous calcium chloride available asSigma-Aldrich ® C1016 II 4.0 wt. percent of polyethylene oxide availableas POLYOX ™ WSR N-10 from Dow, Inc. having an approximate molecularweight of 100,000; 3.8 wt. percent of polyacrylic acid with an averagemolecular weight of 1800 available as Sigma-Aldrich ® 323667 JJ 7.7 wt.percent of polyvinyl alcohol available as Poval ® PVA-202E from KurarayCo., Ltd. ™ having a degree of hydrolysis of 87-89 mol percent; 3.4 wt.percent of medium molecular weight Poly(D-glucosamine) available asSigma-Aldrich ® 448877 KK 13.5 wt. percent of Poly(2-hydroxyethylmethacrylate) available as Sigma-Aldrich ® P3932; 4.0 wt. percent ofpolyethylene-alt-maleic anhydride available as Sigma-Aldrich ® 188050having an average molecular weight 100,000-500,000 LL 19.0 wt. percentof polyvinyl alcohol available as Poval ® PVA-217E from Kuraray Co.,Ltd. ™ having a degree of hydrolysis of 87-89 mol percent; 1.2 wt.percent of Poly(2-hydroxyethyl methacrylate) available asSigma-Aldrich ® P3932 MM 33.0 wt. percent of polyethylene oxideavailable as POLYOX ™ WSR N-10 from Dow, Inc. having an approximatemolecular weight of 100,000; 1.0 wt. percent of medium molecular weightPoly(D-glucosamine) available as Sigma-Aldrich ® 448877 NN 23.0 wt.percent of polyethylene oxide available as POLYOX ™ WSR N-10 from Dow,Inc. having an approximate molecular weight of 100,000; 2.0 wt. percentof anhydrous calcium chloride available as Sigma-Aldrich ® C1016 OO 16.0wt. percent of poly(vinyl alcohol-co-ethylene) available asSigma-Aldrich ® 414093 having an ethylene composition of 32 mol percent;0.5 wt. percent of medium molecular weight Poly(D-glucosamine) availableas Sigma-Aldrich ® 448877 PP 14.0 wt. percent of polyvinyl alcoholavailable as Elvanol ® 70-04 from Dupont, Inc. having a degree ofhydrolysis of 98.0-98.8 mol percent; 0.55 wt. percent of sodium alginateavailable as Nalgin ™ MV-120 from Ingredient Solutions, Inc.; 0.27 wt.percent of polyethylene oxide available as POLYOX ™ WSR N-80 from Dow,Inc. having an approximate molecular weight of 200,000 QQ 40.0 wt.percent of polyvinyl alcohol available as Poval ® PVA-224E from KurarayCo., Ltd. ™ having a degree of hydrolysis of 80-83 mol percent; 0.7 wt.percent of medium molecular weight Poly(D-glucosamine) available asSigma-Aldrich ® 448877 RR 12.2 wt. percent of polyethylene oxideavailable as POLYOX ™ WSR N-80 from Dow, Inc. having an approximatemolecular weight of 200,000; 2.2 wt. percent of sodium alginateavailable as Nalgin ™ MV-120 from Ingredient Solutions, Inc. SS 5.6 wt.percent of ethylene vinyl alcohol copolymer available as Exceval ™HR-3010 from Kuraray Co., Ltd. ™ having a degree of hydrolysis of99-99.4 mol percent; 0.1 wt. percent of sodium carboxymethyl cellulosewith an average molecular weight of 250,000 available as Sigma-Aldrich ®419311 TT 6.9 wt. percent of polyethylene oxide available as POLYOX ™WSR N-80 from Dow, Inc. having an approximate molecular weight of200,000; 6.0 wt. percent of Poly(2-hydroxyethyl methacrylate) availableas Sigma-Aldrich ® P3932 UU 2.5 wt. percent of polyethylene-alt-maleicanhydride available as Sigma-Aldrich ® 188050 having an averagemolecular weight 100,000-500,000; 2.0 wt. percent of polyacrylic acidwith an average molecular weight of 1800 available as Sigma-Aldrich ®323667 VV 3.8 wt. percent of polyvinyl alcohol available as Poval ®PVA-224E from Kuraray Co., Ltd. ™ having a degree of hydrolysis of 80-83mol percent; 3.0 wt. percent of polyacrylic acid with an averagemolecular weight of 1800 available as Sigma-Aldrich ® 323667 WW 14.0 wt.percent of ethylene vinyl alcohol copolymer available as Exceval ™RS-1717 from Kuraray Co., Ltd. ™ having a degree of hydrolysis of 92-94mol percent; 2.0 wt. percent of xantham gum from Xanthamonas campestrisavailable as Sigma-Aldrich ® G1253 XX 1.0 wt. percent of polyvinylalcohol available as Elvanol ® 70-03 from Dupont ™ having a degree ofhydrolysis of 98-98.8 mol percent; 0.1 wt. percent of sodiumcarboxymethyl cellulose with an average molecular weight of 250,000available as Sigma-Aldrich ® 419311 YY 4.0 wt. percent of polyvinylalcohol available as Mowial ® 4-88 from Kuraray Co., Ltd. ™ having adegree of hydrolysis of 86.7-88.7 mol percent and a molecular weight of31,000; 0.05 wt. percent of anhydrous calcium chloride available asSigma-Aldrich ® C1016 ZZ 9.0 wt. percent of polyvinyl alcohol availableas Mowial ® 10-98 from Kuraray Co., Ltd. ™ having a degree of hydrolysisof 98.0-98.8 mol percent and a molecular weight of 61,000; 0.3 wt.percent of Poly(2-hydroxyethyl methacrylate) available asSigma-Aldrich ® P3932 AAA 5.0 wt. percent of polyvinyl alcohol availableas Mowial ® 56-98 from Kuraray Co., Ltd. ™ having a degree of hydrolysisof 98.0-98.8 mol percent and a molecular weight of 195,000; 5.0 wt.percent of polyethylene glycol with an average molecular weight of 200available as Sigma-Aldrich ® P3015 BBB 15.5 wt. percent of polyvinylalcohol available as Mowial ® 28-99 from Kuraray Co., Ltd. ™ having adegree of hydrolysis of 99.0-99.8 mol percent and a molecular weight of145,000; 1.5 wt. percent polyethylene glycol with an average molecularweight of 1450 available as Sigma-Aldrich ® P5402 CCC 17.0 wt. percentof polyvinyl alcohol available as Sigma-Aldrich ® 363138 having a degreeof hydrolysis of 98-99 mol percent and a molecular weight of31,000-50,000; 3.0 wt. percent of ethylene glycol dimethacrylateavailable as Sigma-Aldrich ® 335681 DDD 1.0 wt. percent of polyethyleneoxide available as POLYOX ™ WSR N-10 from Dow, Inc. having anapproximate molecular weight of 100,000; 1.0 wt. percent of mediummolecular weight Poly(D-glucosamine) available as Sigma-Aldrich ® 448877EEE 8.0 wt. percent of polyethylene oxide available as POLYOX ™ WSR N-80from Dow, Inc. having an approximate molecular weight of 200,000; 7.7wt. percent polyethylene glycol with an average molecular weight of 1450available as Sigma-Aldrich ® P5402 FFF 18.7 wt. percent of polyvinylalcohol available as Sigma-Aldrich ® 363065 having a degree ofhydrolysis of 99+ mol percent and a molecular weight of 146,000-186,000;0.8 wt. percent of polyacrylic acid with an average molecular weight of1800 available as Sigma-Aldrich ® 323667 GGG 25.9 wt. percent ofpolyvinyl alcohol available as Sigma-Aldrich ® 363065 having a degree ofhydrolysis of 99+ mol percent and a molecular weight of 146,000-186,000;2.9 wt. percent of sodium alginate available as Nalgin ™ MV-120 fromIngredient Solutions, Inc.; 2.7 wt. percent of polyacrylic acid with anaverage molecular weight of 1800 available as Sigma-Aldrich ® 323667 HHH19.0 wt. percent of polyethylene-alt-maleic anhydride available asSigma-Aldrich ® 188050 having an average molecular weight100,000-500,000; 0.05 wt. percent of medium molecular weightPoly(D-glucosamine) available as Sigma-Aldrich ® 448877; 0.03 wt.percent of xantham gum from Xanthamonas campestris available asSigma-Aldrich ® G1253 III 5.0 wt. percent of polyvidone available asKollidon ® 25 Sigma-Aldrich ® 02286 having a degree of hydrolysis of 99+mol percent and a molecular weight of 146,000-186,000; 4.0 wt. percentof polyacrylic acid with an average molecular weight of 1800 availableas Sigma-Aldrich ® 323667 JJJ 4.5 wt. percent of polyethylene-alt-maleicanhydride available as Sigma-Aldrich ® 188050 having an averagemolecular weight 100,000-500,000; 4.5 wt. percent of polyvinyl alcoholavailable as Poval ® PVA-224E from Kuraray Co., Ltd. ™ having a degreeof hydrolysis of 80-83 mol percent; KKK 20.0 wt. percent of poly(acrylicacid) available as Sigma-Aldrich ® 192023 having an average molecularweight of 2000; 8.0 wt. percent of Poly(2-hydroxyethyl methacrylate)available as Sigma-Aldrich ® P3932; 2.0 wt. percent of ethylene glycoldimethacrylate available as Sigma-Aldrich ® 335681 LLL 3.5 wt. percentof polyethylene-alt-maleic anhydride available as Sigma-Aldrich ® 188050having an average molecular weight 100,000-500,000; 1.0 wt. percent ofethylene glycol dimethacrylate available as Sigma-Aldrich ® 335681; 0.05wt. percent of anhydrous calcium chloride available as Sigma-Aldrich ®C1016 MMM 9.0 wt. percent of poly(N-isopropylacrylamide) available asSigma-Aldrich ® 535311 having a molecular weight of 19,000-30,000; 2.0wt. percent of sodium alginate available as Nalgin ™ MV-120 fromIngredient Solutions, Inc. NNN 8.8 wt. percent ofpolyethylene-alt-maleic anhydride available as Sigma-Aldrich ® 188050having an average molecular weight 100,000-500,000; 1.0 wt. percentpolyethylene glycol with an average molecular weight of 1450 availableas Sigma-Aldrich ® P5402 OOO 2.1 wt. percent of polyvinylalcohol-co-ethylene) available as Sigma-Aldrich ® 414093 having anethylene composition of 32 mol percent; 0.1 wt. percent of mediummolecular weight Poly(D-glucosamine) available as Sigma-Aldrich ® 448877PPP 4.3 wt. percent of Poly(acrylamide-co-acrylic acid) potassiumsalt-cross-linked available as Sigma-Aldrich ® 432776; 2.0 wt. percentof xantham gum from Xanthamonas campestris available as Sigma-Aldrich ®G1253 QQQ 1.3 wt. percent of polyethylene-alt-maleic anhydride availableas Sigma-Aldrich ® 188050 having an average molecular weight100,000-500,000; 0.5 wt. percent of Poly(2-hydroxyethyl methacrylate)available as Sigma-Aldrich ® P3932 RRR 9.4 wt. percent of polyvidoneavailable as Kollidon ® 25 Sigma-Aldrich ® 02286 having a degree ofhydrolysis of 99+ mol percent and a molecular weight of 146,000-186,000;2.0 wt. percent of xantham gum from Xanthamonas campestris available asSigma-Aldrich ® G1253 SSS 5.4 wt. percent of polyethylene oxideavailable as POLYOX ™ WSR N-10 from Dow, Inc. having an approximatemolecular weight of 100,000; 2.5 wt. percent polyethylene glycol with anaverage molecular weight of 1450 available as Sigma-Aldrich ® P5402 TTT7.9 wt. percent of polyethylene oxide available as POLYOX ™ WSR N-10from Dow, Inc. having an approximate molecular weight of 100,000; 1.1wt. percent of medium molecular weight Poly(D-glucosamine) available asSigma-Aldrich ® 448877 UUU 9.0 wt. percent ofpoly(N-isopropylacrylamide) available as Sigma-Aldrich ® 535311 having amolecular weight of 19,000-30,000; 1.1 wt. percent of sodium alginateavailable as Nalgin ™ MV-120 from Ingredient Solutions, Inc. VVV 10.5wt. percent of ethylene vinyl alcohol copolymer available as Exceval ™RS-1717 from Kuraray Co., Ltd. ™ having a degree of hydrolysis of 92-94mol percent; 2.2 wt. percent of Poly(2-hydroxyethyl methacrylate)available as Sigma-Aldrich ® P3932 WWW 10.0 wt. percent of polyvinylalcohol available as Mowial ® 28-99 from Kuraray Co., Ltd. ™ having adegree of hydrolysis of 99.0-99.8 mol percent and a molecular weight of145,000; 4.5 wt. percent of medium molecular weight Poly(D-glucosamine)available as Sigma-Aldrich ® 448877 XXX 10.0 wt. percent of poly(vinylalcohol-co-ethylene) available as Sigma-Aldrich ® 414093 having anethylene composition of 32 mol percent; 2.0 wt. percent of xantham gumfrom Xanthamonas campestris available as Sigma-Aldrich ® G1253

TABLE IV Solid Additive Package Identifier Composition S-1 Clayavailable as Nanomer ® I.28E from Sigma-Aldrich ® 682608 containing25-30 wt % trimethyl stearyl ammonium on Montmorillonite clay basematerial matrix S-2 Clay available as Nanomer ® PGV hydrophilicbentonite from Sigma-Aldrich ® 682659 S-3 Clay available as Nanomer ®I.44P from Sigma-Aldrich ® 682624 containing 35-45% wt. % dimethyldialkyl amine on Montmorillonite clay base material matrix S-4 Clayavailable as Nanomer ® I.34MN from Sigma-Aldrich ® 682640 containing25-30 wt. % methyl dihydroxyethyl hydrogenated tallow ammonium onMontmorillonite clay base material matrix S-5 Natural bentonite clay asCloisite ® Ca++ from Southern Clay Products/Rockwood Additives S-6Natural bentonite clay as Cloisite ® 116 from Southern ClayProducts/Rockwood Additives S-7 Granular activated carbon having aneffective size 0.7-0.9 mm available as HYDRODARCO ® 3000 from NoritAmericas S-8 Granular activated carbon having an effective size of 1 mmavailable as NORIT ® GAC 300 from Norit Americas S-9 Fumed silica havingan average particle size of 0.007 microns available as Sigma-Aldrich ® S5130 S-10 Sodium metasilicate as granular powder available asSigma-Aldrich ® 307815 S-11 Molecular sieves available asSigma-Aldrich ® 283592 having an average particle size of 2 microns S-12Sodium hydroxidecoated silica available as Ascarite ® II fromSigma-Aldrich 223913 S-13 Starch as available from Sigma-Aldrich ® S4251S-14 Starch as available from Spectrum ® M1372 S-15 Starch as availableas CHARGEMASTER ® L340 from Grain Processing Corporation S-16Trichromatic phosphors, pre-mixed available as Sigma-Aldrich ® 755966S-17 Yttrium oxide, europium doped phosphors with average particle size4-8 microns as available as Sigma-Aldrich ® 756490 S-18 Phosphors assodium yttrium fluoride, ytterbium and erbium doped with particle size1-5 microns available as Sigma-Alrich ® 756555 S-19 Sphagnum Peat MossAbsorbent available as CEP-PEAT2-P from Complete Environmental Products,Inc. S-20 Aluminum oxide nanowires with diameter of 2-6 nanometers andlength 200-400 nanometers as available as Sigma-Aldrich ® 551643 S-21Mesostructured silica with cell window size ~15 nanometers as availableas Sigma-Aldrich ® 560979 S-22 Hydroxyapatite nanopowder with particlesize <200 nanometers as available as Sigma-Aldrich ® 677418 S-23 Chitinas available as Sigma-Aldrich ® C7170 S-24 Iron oxide as available asSigma-Aldrich ® 310069 S-25 Fine ground silica available as MIN-U-SIL ®from U.S. Silica S-26 Polyethylene powder as MIPELON ™ from MitsuiChemicals America, Inc. S-27 Untreated wheat germ as available asSigma-Aldrich ® W0125

Each of the above biocatalysts exhibit phenotypic alterations and thebiocatalysts have a stable population of microorganisms and do notgenerate any appreciable debris from metabolic activity.

Bioconversions

A. Overview

As described above, the biocatalysts of this invention can be used for awide range of anabolic and catabolic bioconversion processes. Substratesmay be one or more of normally a gas, liquid or solid. The substratespreferably are capable of being dissolved in the aqueous medium forcontact with the biocatalyst although the biocatalysts of this inventioncan find advantageous application in processes where the substrate haslittle, if any, solubility in water, especially in gas-phase metabolicprocesses enabled by the biocatalysts of this invention. In the broadaspects the processes of this invention pertain to the bioconversion ofsubstrate to bioproduct, which processes comprise (a) contacting thesubstrate with biocatalyst of this invention, and (b) maintaining thebiocatalyst under metabolic conditions for a time sufficient tobioconvert at least a portion of the substrate to said bioproduct.Usually the bioproduct is recovered; however, in some aspects of thisinvention, the bioproduct may intentionally be a chemical that iscapable of being sequestered in the biocatalyst, e.g., where removingsoluble metal compounds from water.

Substrates can be natural or xenobiotic substances in an organism (plantor animal) or can be obtained from other sources. Hence, substratesinclude, but are not limited to, those that can be, or can be derivedfrom, plant, animal or fossil fuel sources, or can be produced by achemical or industrial process. The biocatalysts can also be applicableto water supply or waste water clean-up operations where the substrateis one or more contaminants. The biocatalysts generate metabolites as aresult of anabolic or catabolic activity and the metabolites may beprimary or secondary metabolites. The processes of this invention can beused to produce any type of anabolic metabolite.

Bioproducts may be degradation products especially where contaminantsare being removed from a fluid such as for water supply or waste watertreatment. Such degradation bioproducts include, but are not limited to,carbon dioxide, carbon monoxide, hydrogen, carbonyl sulfide, hydrogensulfide, water, and salts such as carbonate, bicarbonate, sulfide,sulfite, sulfate, phosphate, phosphite, chloride, bromide, iodide, andborate salts of ammonium, or group 1 to 16 (IUPAC) metals such assodium, potassium, manganese, magnesium, calcium, barium, iron, copper,cobalt, tin, selenium, radium, uranium, bismuth, cadmium, mercury,molybdenum and tungsten.

Bioproducts may be one or more of aliphatic compounds and aromaticcompounds including but not limited to hydrocarbons of up to 44 or 50carbons, and hydrocarbons substituted with one or more of hydroxyl,acyl, carboxyl, amine, amide, halo, nitro, sulfonyl, and phosphinomoieties, and hydrocarbons containing one or more hetero atoms includingbut not limited to, nitrogen, sulfur, oxygen, and phosphorus atoms.Examples of organic products as end products from metabolic processesare those listed in United States published patent application no.2010/0279354 A1, especially as set forth in paragraphs 0129 through0149. See also, United States published patent application no.2011/0165639 A1. Other bioproducts include p-toluate, terephthalate,terephthalic acid, aniline, putrescine, cyclohexanone, adipate,hexamethylenediamine (HMDA), 6-aminocaproic acid, malate, acrylate,apidipic acid, methacrylic acid, 3-hydroxypropionic acid (3HP),succinate, butadiene, propylene, caprolactam, fatty alcohols, fattyacids, glycerates, acrylic acid, acrylate esters, methacrylic acid,methacrylic acids, fucoidan, muconate, iodine, chlorophyll, carotenoid,calcium, magnesium, iron, sodium, potassium, and phosphate. Thebioproduct may be a chemical that provides a biological activity withrespect to a plant or animal or human. The biological activity can beone or more of a number of different activities such as antiviral,antibiotic, depressant, stimulant, growth promoters, hormone, insulin,reproductive, attractant, repellant, biocide, and the like. Examples ofantibiotics include, but are not limited to, aminoglycosides (e.g.,amikacin, gentamicin, kanamycin, neomycin, netilmicin, tobramycin,paromomycin); ansamycins (e.g., geldanamycin, herbimycin); carbacephem(loracarbef); carbapenems (e.g., ertapenem, doripenem,imipenem/cilastatin, meropenem); cephalosporins (first generation, e.g.,cefadroxil, cefazolin, cefalotin, cefalexin); cephalosporins (secondgeneration, e.g., cefaclor, cefamandole, cefoxitin, cefprozil,cefuroxime); cephalosporins (third generation, e.g., cefixime, cefdinir,cefditoren, cefoperazone, cefotaxime, cefpodoxime, ceftazidime,ceftibuten, ceftizoxime, ceftriaxone); cephalosporins (fourthgeneration, e.g., cefepime); cephalosporins (fifth generation, e.g.,ceftobiprole); glycopeptides (e.g., teicoplanin, vancomycin,telavancin); lincosamides (e.g., clindamycin, lincomycin); macrolides(e.g., azithromycin, clarithromycin, dirithromycin, erythromycin,roxithromycin, troleandomycin, telithromycin spectinomycin); monobactams(e.g., aztreonam); nitrofurans (e.g., furazolidone, nitrofurantoin);penicillins (e.g., amoxicillin, ampicillin, azlocillin, carbenicillin,cloxacillin, dicloxacillin, flucloxacillin, mezlocillin, methicillin,nafcillin, oxacillin, penicillin G, penicillin V, piperacillin,temocillin, ticarcillin); penicillin combinations (e.g.,amoxicillin/clavulanate, ampicillin/sulbactam, piperacillin/tazobactam,ticarcillin/clavulanate); polypeptides (e.g., bacitracin, colistin,polymyxin B); quinolones (e.g., ciprofloxacin, enoxacin, gatifloxacin,levofloxacin, lomefloxacin, moxifloxacin, nalidixic acid, norfloxacin,ofloxacin, trovafloxacin, grepafloxacin, sparfloxacin, temafloxacin);sulfonamides (e.g., mafenide; sulfonamidochrysoidine, sulfacetamide,sulfadiazine, silver sulfadiazine, sulfamethizole, sulfamethoxazole,sulfanilimide, sulfasalazine, sulfisoxazole, trimethoprim,trimethoprim-Sulfamethoxazole (Co-trimoxazole) (TMP-SMX); tetracyclines(e.g., demeclocycline, doxycycline, minocycline, oxytetracycline,tetracycline); drugs against mycobacteria (e.g., clofazimine, dapsone,capreomycin, cycloserine, ethambutol, ethionamide, isoniazid,pyrazinamide, rifampin, rifabutin, rifapentine, streptomycin) and others(e.g., arsphenamine, chloramphenicol, fosfomycin, fusidic acid,linezolid, metronidazole, mupirocin, platensimycin,luinupristin/dalfopristin, rifaximin, thiamphenicol, tinidazole).

Preferably an anabolic bioproduct is at least one of an oxygenatedorganic compound and hydrocarbon of up to about 100, often up to about50, carbon atoms. Most preferred oxygenated organic product includesmethanol, ethanol, acetic acid, n-propanol, propanol, propionic acid,n-butanol, i-butanol, butyric acid, acetone, and methyl ethyl ketone.

Examples of anabolic or catabolic processes suitable to be practiced bythe processes of this invention include, but are not limited to:

-   -   Syngas, i.e., gas containing carbon monoxide and optionally        hydrogen, for conversion to oxygenated organic product and        hydrocarbons. In typical prior art processes for the conversion        of syngas to oxygenated organic product, a limiting factor on        productivity is the mass transfer of carbon monoxide and        hydrogen from the gas phase into the liquid phase of the aqueous        medium. By using the biocatalysts of this invention for syngas        bioconversion, mass transfer can be enhanced.    -   Carbon dioxide-containing gases for conversion to oxygenated        organic product and hydrocarbons. The anabolic conversion may be        effected by algae, cyanobacteria, or other photo activated        microorganisms, e.g., to produce alcohols, biodiesel, and like.        Other bioconversion processes using carbon dioxide to produce        bioproducts include those to make organic acids and esters and        diacids and diesters such as succinic acid and lactic acid.    -   Combustion gases, e.g., from the disposal of solid wastes or        generation of energy, where the substrate comprises contaminants        sought to be removed from the gases such as oxygenated halides,        sulfoxy moieties, nitrogen oxides, heavy metal compounds and the        like.    -   Industrial process waste gases containing, for instance,        volatile organic compounds; solvents such as chlorine containing        solvents, ketones, aldehydes, peroxygenates, and the like;        ammonia or volatile amines; mercaptans and other sulfur        containing compounds; nitrogen oxides; and the like. The        industrial process waste gases may be air-based, such as exhaust        from painting operations, or maybe devoid of air such as purge        or waste gases. The ability to subject these substrates to        catabolic degradation can often eliminate the necessity for a        thermal oxidation unit operation resulting in both capital and        energy savings as often natural gas or other fuel is required to        maintain temperature for the thermal oxidation unit.    -   Natural gas (including, but not limited to, gas recovered by        underground fracturing processes, i.e., frac gas) wherein the        substrate for catabolic processing may be one or more of        oxygenates, such as nitrogen oxides, sulfur oxides;        perchlorates; sulfides, ammonia; mercaptans; and the like.    -   Nitrates, perchlorates, taste and odor compounds, organics,        chlorinated hydrocarbons, and the like removal from the water.        The source of the water may be from a water treatment facility,        ground sources, surface sources, municipal waste processing, and        industrial waste water. The water stream may be derived from        other bioconversion processes where substrate is not fully        consumed, such as in corn ethanol processes.    -   Carbohydrate, including, but not limited to cellulose,        hemicellulose, starches, and sugars for conversion to oxygenated        organic product and hydrocarbons.    -   Oxyanions, hydroxyls or soluble salts of sulfur, phosphorus,        selenium, tungsten, molybdenum, bismuth, strontium, cadmium,        chromium, titanium, nickel, iron, zinc, copper, arsenic,        vanadium, uranium, radium, manganese, germanium, indium,        antimony mercury, and rare earth metals for removal from water        by bioconversion and sequestration.

The metabolic processes using the biocatalysts may be conducted in anysuitable manner employing metabolic conditions sufficient for thebiocatalyst to convert the substrate to the sought bioproduct. Metabolicconditions include conditions of temperature, pressure, oxygenation, pH,and nutrients (including micronutrients) and additives required ordesired for the microorganisms in the biocatalyst. Due to themicroenvironments and phenotypic alterations associated with thebiocatalysts of this invention, often a broader range of metabolicconditions can be effectively used than those suitable for planktonicmicroorganisms. Any suitable bioreactor system may be used includingTypical Bioreactor Systems.

The metabolic processes using the biocatalysts of this invention providesufficient water to the biocatalyst to maintain the biocatalysthydrated. The bioconversion processes may involve direct contact withgas containing substrate or in contact with a liquid medium, often anaqueous medium. Water for this aqueous medium may be provided from anysuitable source including, but not limited to, tap water, demineralizedwater, distilled water, and process or waste water streams. The aqueousmedium can contain nutrients and additives such as co-metabolites,potentiators, enhancers, inducers growth promoters, buffers,antibiotics, vitamins, minerals, nitrogen sources, and sulfur sources asis known in the art. If desired, an antifoam agent may be used in theaqueous medium. In some instances, where additives are desired orrequired for the metabolic process, the biocatalysts of this inventionexhibit at least equivalent bioconversion activity at a lesserconcentration of such additives as compared to a planktonic,free-suspension system, all else being substantially the same.

The bioreactor may or may not be sterilized prior to introducing theaqueous medium. Due to the use of biocatalysts containing significantpopulations of microorganisms, bioreactors can have a rapid start-uptime.

The processes may be conducted with all carbon requirements beingprovided in the aqueous medium or on a carbon source deficient basis.Where operating in a carbon source deficiency, the aqueous medium oftenprovides at least about 50, frequently at least about 75, say, 80 toless than 100, mass percent on a carbon basis of the carbon nutrient. Insome instances polysaccharide is included in the biocatalyst wherecarbon source deficiency operations are anticipated. The carbon sourcedeficiency may occur intermittently or continuously during the metabolicprocess.

The bioconversion processes may be optimized to achieve one or moreobjectives. For instance, the processes may be designed to provide highconversions of substrate to bioproduct or may be designed to balancecapital and energy costs against conversion to bioproduct. As thebiocatalysts are highly hydrated, generally their density is close tothat of water. Accordingly, with fluidized bed reactor designs using anaqueous feed stream, energy consumption is lower than that where higherdensity supports are used. In some instances where the metabolicprocesses generate a gas, e.g., in the conversion of sugars to alkanolsor in the bioconversion of nitrate anion to nitrogen gas, gas canaccumulate in the biocatalyst to increase buoyancy. This accumulated gascan reduce the energy consumption for a fluid bed operation and canfacilitate the use of other bioreactor designs such as jet loopbioreactors.

The bioproduct may be recovered from the aqueous medium in any suitablemanner including the Typical Separation Techniques.

B. Metabolic Shift

In a preferred embodiment of the invention, a phenotypic alterationoccurs that results in a metabolic shift of the microorganisms in thebiocatalysts. The metabolic shift can occur in each of anabolic andcatabolic bioconversions. The metabolic shift results in less energybeing consumed by the microorganisms for growth. Accordingly, where asubstrate is used for both bioconversion to the bioproduct and forenergy by the microorganisms, the metabolic shift enhances thebioconversion efficiency to the bioproduct. An additional type ofmetabolic shift is termed a carbon flow shift. A carbon flow shiftoccurs when a microorganism can produce more than one bioproduct from asubstrate and the relative amounts of the bioproducts are altered. Forinstance, the fermentation of sugars by yeasts produce both ethanol andacetate anion. A carbon fow shift occurs when, e.g., the ratio ofethanol to acetate anion is increased. Similarly, in the production ofbutanol from sugars using Clostridia acetobutyricum, ethanol and acetoneare co-produced and a carbon flow shift increases the ratio of butanolproduced. A metabolic shift can be of significant economic benefit,especially in large bioconversion facilities and where the cost of thesubstrate is material such as where syngas or carbohydrate is thesubstrate. In metabolic systems where a carbon source needs to beprovided to maintain the microorganisms, the metabolic shiftbeneficially reduces the amount of the carbon source provided tomaintain a given rate of bioproduct production.

In more preferred embodiments pertaining to anabolic bioconversions of acarbon-containing substrate to bioproduct, at least about 95, preferablyat least about 98, percent of the theoretical maximum bioconversion ofthe substrate to the sought bioproduct is achieved. For example, in thebioconversion of glucose to ethanol, carbon dioxide and ethanol areproduced. The amount of ethanol produced as compared with thetheoretical amount that would be produced if all the sugar werebioconverted to ethanol and carbon dioxide produced in the ethanolproduction pathway. Similarly, in the bioconversion of carbon monoxide,the theoretical maximum conversion to ethanol is that 6 moles of carbonmonoxide produce 1 mole of ethanol and 4 moles of carbon dioxide (carbondioxide, of course, can be bioconverted to ethanol in the presence ofhydrogen).

In addition to a metabolic shift, the biocatalysts of this inventionundertake a cryptic growth which is believed to be enabled by phenotypicalterations and communication among the microorganisms. The crypticgrowth aids in providing a biocatalyst that does not generate soliddebris. Nevertheless, the ability of the biocatalysts of this inventionto maintain a stable population of microorganisms over extended periodsof time evidences that a phenotypic metabolic shift occurs in thepopulation of microorganisms.

C. Enhanced Bioconversion

In another preferred aspect of the invention, the biocatalysts exhibitan enhanced rate of bioconversion as compared to that of planktonicmicroorganisms having the same cell density per unit volume ofbioreactor, all else being substantially the same. This aspect of theinvention provides for improved anabolic and catabolic bioconversionprocesses due to the greater bioactivity. In some instances, themicroorganisms may undergo a phenotypic alteration such that abioconversion is observed that does not occur in planktonic growth.

Moreover, since often higher cell densities can be provided by thebiocatalysts of this invention than with planktonic growth in freesuspension or supported biocatalysts, even greater increases inbioconversion activity can be obtained per unit volume of bioreactor orper given unit of hydraulic retention time. Hence, reduced residencetimes for either batch or continuous processing can be achieved per unitof bioconversion.

The use of the biocatalysts of this invention also enables substrate infeed streams to be reduced to very low concentrations and also enablesvery low concentrations of substrate to be metabolically bioconverted.In some applications it is desired for a bioconversion process to reducea substrate to very low concentrations, e.g., for efficient use of thesubstrate or such that the bioconversion effluent need not be furthertreated to remove the substrate. Examples of the latter are municipalwastewater where the effluent should contain little, if any,biodegradable carbon compounds, and reducing toxic materials such as1,4-dioxane, N-nitrosodimethylamine (NDMA) and perchlorate anion andendocrine disrupters contained in water to concentrations of parts perbillion or less. Other examples are components that affect taste andodor in drinking water affected by algal blooms such as methylisoboreal(MIB) and geosmin that may only be present in micro-concentrations.Thus, one embodiment of processes of this invention pertains to reducingthe concentration of ultra-low contaminants (contaminants in aconcentration less than about 50 micrograms per liter) in a water streamcomprising:

-   a. continuously passing, said water stream to a bioreactor, said    bioreactor being maintained at metabolic conditions including the    presence of biocatalyst of this invention containing microorganisms    capable of bioconversion of said ultra-low contaminants irreversibly    retaining therein;-   b. contacting said water stream with said biocatalyst for a time    sufficient to reduce the concentration of said ultra-low    contaminants; and-   c. withdrawing from said bioreactor a treated water stream having a    reduced concentration of said ultra-low contaminants.

Preferably, each of the ultra-low contaminants is present in aconcentration in the water stream the passed to the bioreactor in anamount of at least about 10, say at least about 50, nanograms per liter(ng/L) and less than about 50, often less than about 20, micrograms perliter (mcg/L). Preferably at least about 50, and sometimes at leastabout 80 or 90, percent of the contaminant in the water stream isbioconverted.

The interior microenvironments and phenotypic changes in thebiocatalysts of this invention, in another preferred aspect of thisinvention, also provide for enhanced, simultaneous bioconversion of twoor more substrates by a single microorganism species. Usuallymicroorganisms prefer or metabolize one substrate over another in aphenomenon known as diauxie. In accordance with this aspect of theinvention, the bioconversion rate of the less preferred substrate isless depressed at the same mole ratio of more preferred to lesspreferred substrate than that in a planktonic process using the samemicroorganism and cell density and substantially the same processconditions. One example of diauxie is the treatment of water containingnitrate and perchlorate anions where the nitrate anions are thepreferred substrate.

The biocatalysts of this invention contain microenvironments that canpossess different conditions than those external to the biocatalyst.Thus, microenvironments in the interior of the biocatalysts enable bothaerobic and anaerobic bioconversion processes to occur, even using thesame microorganism. Thus, for instance, ammonium cation can be oxidizedand the resulting nitrate anion reduces to nitrogen in an aerobicaqueous medium. The metabolic conditions in a given microenvironment maybe affected by other metabolic activity within the biocatalysts. Forinstance, metabolizing an electron donor such as a carbon source, mayconsume oxygen and thus provide a reducing environment.

The biocatalysts can serve to provide a self-modulation and enablemetabolic activity that would not be possible in a planktonic growth ina free suspension. This phenomenon is readily appreciated for redox typebioconversions. Consequently, metabolic processes that are reductions ofsubstrates may proceed in the presence of oxygen or oxidizing componentsin an aqueous medium surrounding the biocatalyst. By way of example, andnot in limitation, the biocatalysts can be used for catabolysis ofhydrocarbons, such as aliphatic and aromatic hydrocarbons of 1 to 50 ormore carbons, including alkanes, alkenes, and alkynes, and aromaticssuch as benzene, toluene and xylene; ethers, ketones, aldehydes,alcohols, carboxylic acids and esters of 1 to 50 or more carbons;halogenated hydrocarbons such as brominated and chlorinated hydrocarbonsincluding perchloroethylene, dichloroethylene, vinyl chloride,trichloroethane, trichloroethylene, methylene chloride, chloroform,carbon tetrachloride and polychlorinated biphenyls (PCB's), and solublemetal and semi-metal compounds including nitrates, nitrites, sulfates,sulfites, phosphates, phosphites, and other metalates.

D. Enhanced Toxin Tolerance

Surprisingly, the biocatalysts of this invention exhibit an increasedtolerance to toxins. While not wishing to be limited to theory, it isbelieved that some potential reasons for this increased tolerance, inaddition to providing an environment where the microorganisms aremetabolically retained and physically protected, could reside in thefact that the biocatalyst provides an environment where themicroorganisms have time to react to the presence of the toxins todevelop an internal resistance; the ability of the microorganisms tohave increased cell wall stability and cell geometric stability; and thecommunication among the population of microorganisms to enhance theability of the community to react and develop resistance mechanisms tothe toxins. The exhibited tolerance is greater than that exhibited byplanktonic microorganisms and sometimes is greater than that exhibitedby conventional immobilized biofilms. Hence, a phenotypic shift by themicroorganisms and their community may also contribute to the enhancedtolerance to toxins.

In some processes, especially anabolic processes, the bioconversionproduct (bioproduct) itself is toxic to the microorganisms or aco-product or by-product is produced that is toxic to themicroorganisms. For example, the bioconversion of sugars to ethanol withyeast in a free cell, batch fermentation bioreactor is typically limitedto a concentration of ethanol of about 15 percent. With thebioproduction of isobutanol or n-butanol from sugars, the maximumfermentation broth concentration is generally about 2.5 percent. Thus,the titer of bioproduct in the fermentation broth has to be limited toavoid deleterious concentrations of bioproduct, and the energy requiredfor separation of the bioproduct increases. Moreover, with batchprocesses, the limitation on titer results in shorter cycle times.Hence, increased costs per unit volume of bioproduct are incurredincluding those associated with downtime of the bioreactor, cleaning ofthe bioreactor and replacement of the population of microorganisms. Theincreased resistance of the microorganisms to toxicity in accordancewith the processes of this invention enables higher concentrations ofbioproduct to be produced and, for batch fermentation processes, reducesthe frequency of shutdowns.

In other processes, toxins may be included as contaminants in thefeedstocks providing the substrate to the microorganisms. Althoughpretreating feedstocks to reduce the concentration of these toxins totolerable levels can be done, such pretreatment results in added capitaland operating costs. One particularly attractive application for thebiocatalysts of this invention is in treating brackish or saline wateror brine to metabolize other components in the water. The water may befrom surface, ground or industrial sources. Examples of components thatmay require degradation in such waters include, but are not limited tonitrates, nitrites, chlorates, perchlorates, halogenated organicsincluding but not limited to chlorinated solvents and PCB's,hydrocarbons including but not limited to aliphatic and aromatichydrocarbons and oxygenated hydrocarbons such as 1,4-dioxane, carboxylicacids, ethers, ketones and aldehydes.

In some instances, the substrate itself may have an adverse effect onthe microorganisms when present in too high of a concentration. Reducingthe concentration of the substrate, e.g., by dilution, adds to thecapital and operating costs of the metabolic process. Examples ofsubstrates that can be toxic include carbon monoxide, hydrogen cyanide,hydrogen sulfide, permanganate, and oxygenated organic compounds whereused to make other bioproducts.

Another toxin affecting microorganisms includes viruses, or phage.Treatment of aqueous media suffering from phage is problematic. Thebioreactor can be emptied, sterilized, and then repopulated which incurssignificant downtime as well as operating expense. In some instances,additives can be provided to the aqueous media as antiviral agents. Thisagain increases the costs of the metabolic process.

In the broad aspects, the processes for bioconverting a substratecontained in an aqueous medium to bioproduct under bioconversionconditions including the presence of microorganisms for saidbioconversion, wherein the aqueous medium contains at least one toxin inan amount sufficient to have a deleterious effect if said microorganismswere freely suspended in said aqueous medium under said bioconversionconditions, comprise attenuating the effect of the toxin by using abiocatalyst of this invention in the bioconversion process.

In some instances, the rate of bioconversion of the substrate tobioproduct is not significantly reduced, all other parameters remainingthe same, when the concentration of bioproduct in the fermentation brothis about 20, frequently about 30, say about 50, or more percent greaterthan that achievable using a free cell suspension of the microorganism.Where used to bioconvert sugar to ethanol, ethanol concentrations in thefermentation broth of 20 mass percent or more can often be achieved. Forthe bioconversion of sugar to isobutanol or n-butanol, bioproductconcentration in the fermentation broth of at least about 3, andsometimes between about 3.5 and 5 or more mass percent, can be achieved.

In many instances, the microorganisms are able to withstandconcentrations of the toxins at least about 20, and preferably at leastabout 30, percent greater than said microorganisms in free suspension insaid aqueous medium. In many instances, the increased tolerance of theprocesses to the presence of toxins can be observed using a Batch ToxinTolerance Test (BTT Test) defined above. The processes of this thisinvention exhibit in a BTT Test a bioconversion of at least about 20percent, preferably at least about 30 or 50 percent, greater than thatusing the free suspension. In some instances the microorganisms are ableto withstand concentrations of the toxins at least about 10, andpreferably at least about 20, percent greater than said microorganismsin the form of a biofilm on a bone char support, all other conditionsbeing the same.

In many instances, even when the concentrations of the chemicals reacheslevels where the bioconversion rate exhibited by the biocatalyst ismaterially affected, the processes of this invention tend to provideprotection to at least a portion of the microorganisms metabolicallyretained in the biocatalyst. Thus, upon the termination of the excursioninto regimes where the microorganisms are adversely affected,bioconversion activity recommences evidencing survival of at least aportion of the population of the microorganisms providing the soughtmetabolism. Where a portion of the population is adversely affectedduring the excursion, the population of the microorganisms in thebiocatalyst can increase after the termination of the excursion to asteady-state level.

In examples 205 to 207 a continuous stirred tank bioreactor having aworking volume of 7 liters is used for batch experiments. The bioreactoris provided with controls to maintain temperature. The pH of thefermentation broth is controlled, typically to a pH of about 5. Thefermentations are conducted in a batch mode. A 1000 milliliter solutionof 223 grams of sugar in the form of honey per liter is charged to thebatch bioreactor. The honey has a composition of about 38 mass percentfructose, 31 mass percent glucose, 7.31 mass percent maltose, 1.3 masspercent sucrose, 1.5 mass percent higher sugars and about 17 percentwater with the balance being non-sugar components. The fermentations areconducted at about 30° to 35° C. In all examples, the same strain ofSaccharomyces cerevisiae is used. The biocatalyst used is substantiallythat prepared in accordance with Example 25 has a Hydration ExpansionVolume of about 70,000. The biocatalyst is contacted with dilute aqueousethanol (varying between about 5 and 10 mass percent) for about two daysprior to use.

Example 205

In this example, the batch bioreactor is used, and industrial gradeethanol is added to the fermentation broth to provide a 20 mass percentconcentration of ethanol. A run uses a free suspension of S. cerevisiaeto provide about 150 grams of yeast per liter, and another run usessufficient biocatalyst to provide about 150 grams of yeast per liter.After 72 hours under fermentation conditions, the fermentation brothcontaining the free suspension yields no ethanol whereas the biocatalystproduces about 75 percent of the amount of ethanol theoreticallypossible. In the absence of the added ethanol, the free suspensionprovides after 72 hours a production of ethanol that is about 78 percentof the amount of ethanol theoretically possible. The biocatalystproduces an amount of ethanol between about 96 and 98 percent of thattheoretically possible. The high conversion evidences that a metabolicshift occurs.

Example 206

In this example, for a period of about 24 hours, the biocatalyst isexposed to a 20 percent by mass aqueous ethanol solution. Thebiocatalyst is then washed and then used in the batch bioreactor toprovide a theoretical yeast content of about 150 grams per liter. After72 hours, the free cell batch reaction does not generate any ethanol.The batch reaction using the biocatalyst yields about 98 percent of theethanol theoretically possible.

Example 207

In this example the amount of honey added to the fermentation broth isincreased to provide about 288 grams per liter of sugar. Several batchreactions are conducted using about 150 grams per liter of S. cerevisiaecontained in biocatalyst. After 72 hours, the batch reactions using thebiocatalyst yields between about 96 and 99 percent of the ethanoltheoretically possible.

Example 208

This example demonstrates the resistance of Rhodococcus to variousconcentrations of ethanol where the microorganism is in a biocatalyst ofthis invention. Approximately 20 grams of biocatalyst substantially asprepared in example 169 are placed in a serum bottle for each batchtest. A total of 7 serum bottles are prepared. About 80 milliliters ofsolution containing ethanol are placed in each serum bottle. Thesolution for each bottle is at a different ethanol concentration. Eachsolution is prepared using absolute ethanol and the various solutionscontain 0, 10, 20, 35, 50, 80 and 100 volume percent ethanol. Thecontact between the solution and the biocatalyst is at room temperature(about 22° C.) for 24 hours. After which time, the biocatalyst in eachserum bottle is washed. The biocatalyst from each serum bottle isevaluated for oxygen up-take, thereby indicating the viability of themicroorganisms. This evaluation is conducted by placing the biocatalystin a 100 milliliter flask and pouring about 80 milliliters of distilledwater that has been aerated to saturation into the flask. Oxygen probemeasurements are taken each 15 minutes. All biocatalysts survived theimmersion in ethanol and in comparison to the control with no ethanol,all substantially recovered their bioactivities as evidenced by oxygenup-take. In a control experiment, no microorganisms survive the additionof 5 volume percent ethanol to a free suspension containing themicroorganisms.

E. In-Situ Sterilization

It may be desired to add toxins to the medium containing themicroorganisms to control the population of undesired microorganismsthat may compete for nutrients or may provide undesired metabolites. Insome processes, such as the conversion of corn sugar to ethanol, thepresence of adventitious or undesirable microorganisms is addressed bysterilization of batch reactors at the conclusion of each run.Continuous bioconversion processes, however, are not so amenable tofrequent sterilization. Hence, continuous processes are typicallymonitored for undesired metabolites, or are monitored for theproductivity of the sought bioproduct, and shut down for sterilizationwhen required.

Removal of the adventitious microorganisms from water or other feedstockfor catabolic or anabolic processes can be done, however, with increasedcapital and operating costs. The alternative is to periodically replaceand replenish the sought microorganisms in the bioreactor used for thecontinuous processes. Another alternative is disclosed by Sumner, etal., in United States Published Patent Application 20090087897, where astabilized chlorine dioxide is added preventatively in an amounteffective to prevent growth of bacteria to a fermentation processes formaking ethanol.

The biocatalysts of this invention enable controlling the presence ofcontaminating microorganisms due to the enhanced toxin resistanceexhibited by the biocatalysts. These processes pertain to bioconvertinga substrate contained in an aqueous medium to bioproduct under metabolicconditions including the presence of microorganisms for saidbioconversion, wherein a toxin is provided to the aqueous medium in anamount sufficient to control contaminating microorganisms, wherein themicroorganisms are retained in a biocatalyst of this invention.

The toxin used to control the contaminating microorganisms may be abacteriostatic agent, a bactericidal agent or a bacteriolytic agent.Preferably the toxin is a disinfecting agent, and most preferably is anoxidizing agent. These preferred disinfecting agents are relativelyinexpensive and include hydrogen peroxide, peracetic acid, aldehydes(especially glutaraldehyde and o-phthalaldehyde), ozone, andhypochlorite. The introduction of the toxin into the aqueous medium mayoccur in response to an undesired buildup of the population ofcontaminating microorganisms, or may be on a periodic schedule orcontinuously to control the build-up of contaminating microorganisms.The concentration of disinfecting agent added to the aqueous mediumshould be sufficient to either reduce or maintain the population of thecontaminating microorganisms at a desired level.

Where hydrogen peroxide is the sterilizing agent, is usually introducedsuch that it is present in the aqueous medium in a concentration ofbetween about 0.1 to about 5, preferably 0.5 to 3, mass percent. Whereperacetic acid is used is the sterilizing agent, the amount introducedinto the aqueous medium is generally sufficient to provide aconcentration between about 0.1 to about 3, preferably 0.2 to 2, masspercent. Glutaraldehyde and o-phthalaldehyde are often used to provide aconcentration in the aqueous medium of between about 0.01 to about 0.5mass percent. Ozone can be bubbled through the aqueous medium in orderto effect the reduction in the population of contaminatingmicroorganisms. Hypochlorite anion is typically available as an aqueoussolution of sodium hypochlorite. Typically the concentration ofhypochlorite anion in the aqueous medium is between about 0.1 to 3, say,between about 0.2 to 2, mass percent.

The duration of the presence of the sterilizing agent in the aqueousmedium should be sufficient in order to effect the desired reduction ofthe population of the contaminating microorganisms. In one embodiment aconcentration of the sterilizing agent may be maintained by continuousbasis in the aqueous medium and thus act as a preventative to thebuild-up of a population of contaminating microorganisms. In otherpreferred embodiments, the sterilizing agent is added intermittentlywhen needed to control the population of the contaminatingmicroorganisms. In the latter case, the duration of the maintenance ofmicroorganism-killing concentrations of the sterilizing agent istypically less than about 20, and is often in the range of, 0.1 to 10,hours.

The control of the population of the contaminating microorganisms ismost advantageously conducted under the same conditions that themetabolic process would be conducted. If desired, it is possible to useconditions different than those that would normally be used for themetabolic process provided that the conditions are not undulydeleterious to the microorganisms contained in the biocatalyst.Conditions typically include temperatures in the range of between about5° to 60° C., and a pH the range of between about 5.0 and 8.5, say, 6 to8. Preferably, the presence of nutrients and other adjuvants remain aconcentration in the aqueous medium that substantially same as used forthe bioconversion process.

Example 209

In this example water containing about 50 parts per million mass ofnitrate anion per liter is continuously passed to a bioreactorcontaining biocatalyst having Paracoccus denitrificans ATCC® 17741retained in the interior. The biocatalyst is prepared substantially asset forth in Example 101 and has a Hydration Expansion Volume of about70,000. The biocatalyst provides about 150 grams of microorganism perliter in the bioreactor. The hydraulic residence time is about 600minutes and the reactor is operated at about 25° C. The effluent watercontains less than about 1 part per million mass of nitrate anion perliter. Sodium hypochlorite is added to the water to provide aconcentration of 0.5 gram per liter, and sodium acetate is added at anamount approximately equivalent to 1.1 times the theoretical demand. Thebioreactor is operated for 2 hours with this composition. The effluentwater continues to contain less than about 5 parts per million mass ofnitrate anion per liter. In additional runs, the biocatalyst is immersedfor 24 hours at about 25° C. in an aqueous solution containing sodiumhypochlorite at concentrations of 1.0 and 2.0 grams per liter beforebeing used in the apparatus. These concentrations of sodium hypochloriteare considered lethal to planktonic microorganisms in free suspension asshown by a control experiment.

After immersion in the 1.0% concentration solution, the performance ofthe microorganisms is not affected and the water effluent continues tocontain less than about 1 parts per million mass of nitrate anion perliter. Biocatalyst is removed and again immersed in the 1.0% solutionfor 24 hours. After the second immersion in the 1.0% concentrationsolution, the performance of the microorganisms is not affected and thewater effluent continues to contain less than about 1 parts per millionmass of nitrate anion per liter.

After immersion in the 2.0% concentration solution, the performance ofthe microorganisms is reduced to about 62 percent and the water effluentcontains less than about 20 parts per million mass of nitrate anion perliter. Biocatalyst is removed and again immersed in the 2.0% solutionfor 24 hours. After the second immersion in the 2.0% concentrationsolution, the performance of the microorganisms is improved, and thewater effluent contains less than about 4 parts per million mass ofnitrate anion per liter.

F. Strain Stability

In preferred embodiments, the biocatalysts of this invention essentiallycontain in their interiors a single strain of microorganisms, i.e., areaxenic. This provides for consistency in bioconversion performance,including bioconversion rate and selectivity, and thereby enhances theviability of commercial-scale processes. In addition, having a singlestrain of microorganism frequently enhances sociobiological behaviorsuch as horizontal gene transfer, production of public goods, altruisticbehaviors, taking up DNA of lysed same-strain cells, and the like, allof which can be beneficial to the biocatalyst and its performance.

Whether a metabolic process uses a wild state or modified wild state orgenetically modified microorganism, several concerns exist includingthat automutation of the strain of microorganisms could lead to anadverse change in the population of microorganisms. Althoughautomutation may occur inherently, the sociobiological behavior of themicroorganisms, which behavior is enhanced in the biocatalysts of thisinvention, can mitigate or prevent untoward genotypic changes to thepopulation. Additionally, in that the phenotypic changes of themicroorganisms in the biocatalysts of this invention usually result in ametabolic shift, the rate of reproduction is reduced. Hence adverseautomutation is more readily modulated by the population ofmicroorganisms. Further, the biocatalysts tend to mitigate externalinputs that may induce undesired automutations.

The biocatalysts of this invention are made with a high concentration ofmicroorganisms, often substantially at the steady-state density of themicroorganisms in the biocatalyst. Numerous advantages follow from thismethod. First, the essentially fully active biocatalysts can be madeunder conditions that assure strain purity. Second, scale-up issimplified as a plurality of batches can be made and then accumulated ina volume required for a commercial-scale bioreactor. Quality checks canbe made with each batch. Third, the population of microorganisms in thebiocatalyst can be sufficiently concentrated that sociobiologicalbehaviors that prevent untoward automutation exist. Fourth, as themicroorganisms are substantially irreversibly retained in the interiorof the biocatalyst, any contaminating microorganisms would beconstrained to a biocatalyst and not adversely affect the microorganismsin the other biocatalysts. Fifth, within a single biocatalyst structure,any contaminating microorganism will tend to be metabolically retainedin a region with a constrained population, and the community of theintended strain of microorganisms is believed to communicate or interactto enhance competitive strength against invading microorganisms(territorial competitiveness) and to maintain strain uniformity. Sixth,the exo-network of the microorganisms in the biocatalysts facilitateshorizontal gene transfer. And seventh, the biocatalysts provide amicroenvironment that tends to assure stable microbial constituency.

In some embodiments the sought microorganism is less robust, and indeed,some, such as syntrophic microorganisms, may only be able to thrive inrelationship with another microorganism and are typically difficult toobtain and maintain a pure culture even though the syntrophicmicroorganism may have the ability to effect the sought bioconversion tobioproduct. In some instances, the microorganisms in the biocatalyst mayundergo adaptation and potential genetic alteration during use in ametabolic process. The communication and potential horizontal genetransfer provided by the biocatalysts of this invention and theexo-network facilitates uniformity of the microorganism strain withinthe biocatalysts.

G. Stasis Capability

The biocatalysts of this invention provide an internal environment thatpermits the microorganisms metabolically retained therein to effectivelycommunicate. The communication also serves to assure that the communityof microorganisms survives during periods where little or no nutrientsare supplied to the biocatalysts, that is, the biocatalyst can enterinto an essential state of stasis. The essential state of stasis asdescribed in this section is with respect to the biocatalyst itself. Itshould be understood that with the high populations of microorganisms ina biocatalyst, microenvironments can exist where the microorganisms fromtime-to-time do not obtain nutrients. Hence, even while the biocatalystis exhibit bioconversion activity, zones within the biocatalyst can bein essential stasis and regain bioactivity upon an increase in thesupply of nutrients and substrates to the biocatalyst.

Heretofore, stasis of microorganisms has been obtained by storage atcool temperatures with reduced supply of nutrients or freezing.Maintaining such cool or freezing conditions can be expensive,especially for large volumes of microorganisms, and is subject to lossof power or mechanical breakdown, and can be deleterious to thepopulation of the microorganisms.

The biocatalysts of this aspect of the invention can pass into a stateof stasis not requiring the supply of nutrients and without costlystorage conditions yet still with the microorganisms having an abilityto rapidly achieve the desired biological activity upon start-up in abioreactor. By maintaining the microorganisms in an essential state ofstasis for extended periods of time, not only can the time intervalbetween manufacture and start-up be tolerated, but also the microbialcomposites can be placed in simple containers for shipping such assealed barrels, tanks, and the like without the addition of nutrientsduring the period of storage. Planned and unplanned shutdowns of abioconversion process using the biocatalysts of this invention can beaccommodated without loss of bioactivity. Because the microorganismsthemselves modulate the stasis, no equipment or control system isrequired to protect the population of microorganisms or restartmetabolic activity. In yet a further preferred aspect of the invention,the biocatalyst contains solid polysaccharide in its interior to evenfurther enhance the ability of the biocatalyst to remain in a state ofstasis for longer durations.

The conditions required for entry into stasis fall within a broad range.The temperature may be substantially that used for the metabolicprocess. The biocatalyst should have some degree of hydration duringstorage although it is not essential that the biocatalyst be immersed inan aqueous medium. Often the temperature ranges between about −10° C. to50° C. or more, and most preferably between about 5° C. or 10° C. to 30°C. for purposes of energy savings and convenience. Although lowertemperatures are generally preferred, higher temperatures still providesignificant durations of stasis of the microorganisms in thebiocatalysts of this invention. Where the microorganism is sensitive tooxygen, it is preferred, but sometimes not essential, that oxygen beexcluded during storage.

Typically the biocatalyst can remain in a state of stasis for extendedperiods of time, e.g., at least about 1, often at least about 20, andsometimes greater than about 50 or 100, weeks. The bioactivity of thebiocatalysts is regained upon subjecting the biocatalysts to metabolicconditions. Often essentially complete bioactivity is regained in lessthan 5, and sometimes less than 3, days.

Examples 210 to 215

In the following examples, various biocatalysts according to theinvention are subjected to storage for the periods set forth in thebelow table and are then used for the intended metabolic process. Priorto being stored, the biocatalysts are used for the metabolic reactionfor at least 2 days. The results are summarized in Table V.

TABLE V Biocatalyst Duration of Days to of Metabolic Storage, recoverExample Example Process days bioactivity 210 9 Glucose to 30 1 ethanol211 52 Nitrate to 350 3 nitrogen 212 110 1,4-Dioxane 365 7 degradation213 116 Perchlorate 700 3 to chloride 214 92 Municipal 90 1 wastewatertreatment 215 146 Glucose to 300 5 Lactic Acid

H. Photosynthetic Processes

The biocatalysts of this invention can be used in photosyntheticprocesses. The biocatalyst contains one or more suitable photosyntheticmicroorganisms including bacteria, algae, yeasts and molds havingbiocatalytic activity activated by light radiation. Preferably themicroorganism is an algae, most preferably a microalgae, orcyanobacteria. In some instances Botryococcus is desired due to organiccompound productivity. The biocatalyst may contain luminescentcomponents as described above, but such components are not critical tothe use of a biocatalyst in a photosynthetic process.

Photo-bioconversion conditions are maintained for conversion of at leastone substrate to the sought bioproduct including conditions oftemperature, pressure, oxygenation, pH, and nutrients and additives. Thebioconversion may be on a continuous, semi-continuous or batch mode ofoperation. Reactor designs include, but are not limited to, TypicalBioreactor Systems provided that access is provided to provide lightenergy to the biocatalyst. The biocatalyst is freely mobile in the inthe culture liquid. More than one reactor vessel may be used. Forinstance, reactor vessels may be in parallel or in sequential flowseries. The processes and apparatus of this invention may use land-basedreactors, or the reactors may be adapted to float on a body of watersuch as a reservoir, river, lake, or ocean. The floating reactors can beadapted to take advantage of the natural temperature moderation of thebody of water, and, in some instances, natural movements of the body ofwater may assist in the agitation.

The bioreactor may be open, e.g., as a pond or raceway, or closed. Thelight source may be any suitable light source but preferably sunlightprovides at least a major portion of the light radiation of step (c),often at least about 75, say, at least about 90, percent, and sometimesessentially all, of the light radiation is from sunlight. Since thebiocatalysts provide at least some UV protection to the microorganisms,lenses, mirrors, moving arrays that follow the sun and the like may beused to enhance the intensity of the light ° radiation contacting theculture liquid. Moreover, the biocatalyst may provide protection tomicroorganisms that are susceptible to bleaching or death in thepresence of high intensity light.

The photo-bioconversion conditions, rate of substrate supply and thedensity of the microorganisms in the culture liquid can influencebioconversion. Accordingly, for a given system of biocatalysts,substrates and bioproducts, productivities can vary widely. In someinstances, the biocatalysts used in the processes of this invention canfacilitate maintaining desired microorganism densities in the cultureliquid and thus facilitate high productivities per surface area exposedto light radiation. In some instances, it may be desired to provideperiods of darkness to the photosynthetic microorganisms where suchperiods enhance the productivity of the microorganisms.

The culture liquid in the bioreactor may be substantially stagnant, butpreferably is subjected to forces to provide movement to the cultureliquid. Most preferably the movement of the culture liquid is sufficientto cause movement of the biocatalyst to and from the region receivingthe light radiation (“direct contact area”) of the culture liquid.

Examples of substrates include, but are not limited to, carbon dioxide,carbon monoxide, hydrogen, methane, ethane, propane, hydrogen sulfide,carbonyl sulfide, mercaptans, ammonia, lower alkylamines, phosphines,and mixtures thereof. Syngas (synthesis gas) is an often proposedgaseous substrate for anaerobic bioconversions. Carbohydrates, includingsugars and polysaccharides, may find application as substrates. Lipidsmay also find utility as substrates. Other substrates include, but arenot limited to, aliphatic and aromatic molecules. Aliphatic (includingcycloaliphatic) and aromatic substrates include, but are not limited tohydrocarbons of from, e.g., about 1 to about 44 or 50 carbon atoms whichmay contain hetero atoms, e.g., oxygen, sulfur, phosphorus, andnitrogen, and which may be substituted, e.g., with acyl, halogen,hydroxyl, amine, amide, thiol, nitro, or phosphine groups.

The photo-bioconversion conditions, rate of substrate supply and thedensity of the biocatalysts in the fermentation broth can influence theproductivity of the culture liquid to produce bioproducts. Accordingly,for a given system of biocatalysts, substrates and bioproducts,productivities can vary widely. In some instances, the irreversiblyretained biocatalysts used in the processes of this invention canfacilitate maintaining desired biocatalyst densities in the cultureliquid and thus facilitate high productivities per surface area exposedto light radiation. In some instances, it may be desired to provideperiods of darkness to the photosynthetic microorganisms where suchperiods enhance the productivity of the microorganisms.

The recovery of the bioproduct from the culture liquid may be effectedby any suitable unit operation or unit operations including TypicalSeparation Techniques. The culture liquid may be removed from thereactor for bioproduct recovery or the bioproduct recovery may beeffected in the reactor. In the latter case, separation may be byevaporation, e.g., with lower vapor pressure organic compounds such asethanol, or phase separation as with, e.g., higher molecular weightorganic compounds such as aromatic or aliphatic hydrocarbons, alcohols,ethers, and esters (for instance, glycerides) of 6 or more carbons.Where the culture liquid is removed from the reactor for bioproductrecovery or purge, any suitable unit operation may be used to retain thebiocatalyst in the reactor such as, but not limited to, decanting (wherethe density of the biocatalyst is greater or less than that of theculture liquid), filtration, centrifugation, and the like. If desired,especially where the biocatalytic activity of the biocatalyst isobserved to be decreasing, a portion of the biocatalyst may be removedand replaced to provide for a continuously operating facility.

For purposes of facilitating the understanding of the processes andapparatus of this invention and not in limitation thereof, reference ismade to FIG. 3 which depicts a cross section of a portion of a reactor300. Reactor 300 comprises reactor vessel 302 has a clear polymericcover at its top represented by the dotted line and contains cultureliquid 304. A plurality of biocatalyst particles 306 containingcyanobacteria and phosphorescent material are dispersed within cultureliquid 304. Carbon dioxide is used as the substrate to make ethanol inreactor 300.

As depicted, culture liquid and off gas are recycled. Screen filter 308is provided to prevent removal of biocatalyst and permit off-gas andculture liquid to be drawn from reactor vessel 302. The fluid passesthrough line 310 for recycle via line 312 and distributor 314 for returnto reactor vessel 304. Distributor 314 is adapted to provide formovement of biocatalyst 306 to the surface of culture liquid 304 toreceive radiation 316 from a radiation source. While an externalradiation source is depicted, alternatively or in addition, internalradiation sources could be used. A draw stream of recycling cultureliquid is taken via line 318 for product recovery. Make up cultureliquid is provided via line 320. The make-up culture liquid containsdissolved carbon dioxide. If desired, ammonium carbonate may be used tosupply both carbon and nitrogen to the microorganisms.

I. Representative Metabolic Process Discussions

The biocatalysts due to the microenvironments in the biocatalyst,communication among the microorganisms and the phenotypic alterationsundergone by the microorganisms provide a number of process-relatedadvantages including, but not limited to,

-   -   no solid debris being generated,    -   the potential for high densities of microorganisms in a        bioreactor,    -   stable population of microorganisms and bioactivity over        extended periods of time,    -   metabolic shift towards production rather than growth and carbon        flow shift,    -   ability to undergo essential stasis for extended durations,    -   ability to quickly respond to changes in substrate rate of        supply and concentration,    -   attenuation of diauxie,    -   enhanced control and modulation of pH and redox balances in the        microenvironment of the biocatalyst,    -   greater tolerance to substrate, bioproduct and contaminants,    -   ability to bioconvert substrate at ultralow concentrations,    -   ability to use slower growing and less robust microorganisms and        increased resistance to competitiveness,    -   enhanced strain purity capabilities,    -   ability to be subjected to in situ antimicrobial treatment,    -   ability to quickly start a bioreactor since the population of        microorganisms required at full operation is contained in the        biocatalyst,    -   ability to contact biocatalyst with gas phase substrate, and    -   ease of separation of bioproduct from biocatalyst thereby        facilitating continuous operations.

In the following discussions pertaining to certain of the many uses ofthe biocatalysts of this invention, some or all these process-relatedadvantages provide significant improvements over existing processes. Arecitation of these process-related advantages as they pertain to eachof the below described processes is not repeated for each and is to beimputed for each of the processes.

Additionally, it is to be understood that biocatalyst options such asthe incorporation of sorbents, polysaccharide, and phosphorescentmaterials (for photosynthetic processes) can be used with any of thebelow described processes. Further, process steps such as in situsterilization, gas phase bioconversion and photosynthetic reactorconfiguration (for photosynthetic processes) can be used with any of thebelow described processes. It is to be understood for the belowdiscussions that the cell concentrations in a bioreactor will dependupon the concentration of the biocatalyst in the bioreactor as well asthe concentration of cells within the biocatalyst.

The unique properties of the biocatalysts of this invention enable manymetabolic processes. Below are described some of the processes providingadvantageous bioconversions. Figures used to describe the processes arenot in limitation and omit minor equipment such as pumps, compressors,valves, instruments and other devices the placement of which andoperation thereof are well known to those practiced in chemicalengineering and omit ancillary unit operations.

i. Municipal Wastewater

Municipal wastewater typically contains dissolved organics (BOD and(COD), solids (Total Suspended Solids, TSS), and various ions includingammonium cation and phosphorus-containing anions. Release of municipalwastewater into the environment results in numerous adverse effects.Nitrogen and phosphorus are the predominant contributors toeutrophication of surface waters. These nutrients can also lead to algalblooms. The algal blooms can cause taste and odor problems when thewater is to be used for drinking purposes. Other biochemical activitiesthat may be stimulated by overenrichment of surface waters include thestimulation of microbes that can pose risks to human health.

Municipal wastewater treatment systems generally have a plurality ofoperations including three treatment stages of processing. The primarytreatment separates solids from liquids. Where the wastewater containsimmiscible, low density liquids such as fats and oils, these liquids areskimmed off, and the remaining liquid is passed to a secondary treatmentwhich usually uses microorganisms to substantially degrade under aerobicconditions biodegradable soluble organic contaminants. At the completionof the secondary treatment, solids from these microorganisms areseparated by settling, and the liquid is passed to the tertiarytreatment prior to discharge. Not all municipal wastewater treatmentfacilities employ tertiary treatment. Accordingly, the effluent cancontain significant amounts of nitrogen compounds.

Tertiary treatment can include the removal of nitrogen. Ammonium cationmay be first subjected to a nitrification to produce nitrite and thennitrate, e.g., in the presence of Nitrosomonas spp. and then Nitrobacterspp. Denitrification requires anoxic conditions and electron donor.Hence, some facilities add a donor such as methanol or even raw sewage.Often over 4 kilograms of oxygen are consumed per kilogram of ammoniumnitrogen removed, and the nitrification and denitrification processesand increase power consumption for a typical facility by 30 percent ormore. Solids are generated by the microorganisms and are removed at thecompletion of the tertiary treatment before discharge of the treatedwater.

Typical municipal wastewater treatment facilities must treat 4 or 5million liters of raw sewerage per day, and some facilities treatupwards of 1 billion liters of municipal waste water per day. Due tothese large volumes and the time required to effect the soughtbiodegradation, a plurality of parallel treatment units are required tohandle these substantial flow of municipal wastewater. The secondary andtertiary treatments require an aerobic environment. Efforts to reducethe residence time for treatment for these aerobic include bubbling airthrough the wastewater. The use of oxygen-enriched air or oxygen providefurther reductions in the cycle time, i.e., the duration required toachieve the sought reduction in organic carbon and ammonium cation. Evenso, the hydraulic retention time of the water being treated in asecondary or tertiary treatment operation is often in excess of at least16 hours, say, between about 18 and 30, hours with a sludge retentiontime that can be from 10 to 30 days. This significant hydraulicretention time necessitates the use of large reactors. Generally, thereactors are operated in a batch mode. Accordingly, multiple reactorsare required in order to sequence patches such that the municipalwastewater treatment facility can handle a continuous incoming stream ofwastewater. A plurality of settling ponds is required to effectseparation of the solids (sludge) from secondary and tertiarytreatments. And the sludge must be disposed in an environmentallyappropriate manner.

An additional challenge facing tertiary treatments is that themicroorganisms are sometimes not stable, whether due to the presence ofadventitious competitive microorganisms or changes in conditions or thecomposition of the wastewater.

Hiatt in U.S. Pat. No. 6,025,152 discloses a mixture of bacteria thatare reported to be able to oxidize ammonia and nitrites, organic aminesand organonitriles and aerobically reduce nitrates to molecularnitrogen. The anammox process has been proposed for removal of ammoniaunder anaerobic conditions. In this process anammox bacteria oxidizeammonium under anoxic conditions with nitrite as the electron acceptor.Typically the anammox process is conducted with a low ratio of carbonsource to nitrogen so as to retard the population growth ofheterotrophic denitrifying bacteria. The anammox bacteria are verysensitive to the presence of oxygen, thus posing another challenge foruse in municipal wastewater treatment.

Processes are provided in this aspect of the invention for the treatmentof municipal wastewater wherein the water from the primary treatment iscontinuously passed to a bioreactor that effectively catabolizes organiccarbon to carbon dioxide and ammonium cation to nitrate anion. Thebioreactor generates essentially no solids that pass to the treatedwater, thus eliminating the need for any additional sludge separationoperations and sludge disposal from such operations. Moreover, thesought bioconversion of organic carbon and ammonium cation can often becompleted with a relatively short hydraulic retention time, often, lessthan about 12, and in preferred aspects, less than about 6, hours. Theshort hydraulic retention times enable a small footprint bioreactor tobe used, and since the processes continuous, a plurality of largebioreactors otherwise required to operate in a batch mode is notrequired. These relatively short hydraulic residence times can beobtained without the need to use oxygen-enriched air or oxygen.Preferably the dissolved oxygen concentration in the wastewater streamduring contact with the biocatalyst is at least about 1 milligram perliter and preferably between about 2 to 3, milligrams per liter to saveon aeration costs. Further, the concentration of oxygen in thewastewater need not be high to achieve the short hydraulic retentiontimes, and the short hydraulic retention times reduce the amount ofenergy required to aerate the wastewater for a given reduction inammonia and organic carbon.

In the broad aspects of this aspect of the invention, processes forcatabolizing dissolved organic carbon and ammonium cation in awastewater stream comprise:

a. continuously passing said wastewater stream to a bioreactorcontaining biocatalyst of this invention having substantiallyirreversibly retained therein microorganisms capable of catabolizingdissolved organic carbon to carbon dioxide and ammonium cation tonitrate anion, preferably an ammonia-oxidizing microorganism;b. contacting in said bioreactor said wastewater stream with saidbiocatalyst in the presence of oxygen for a time sufficient to providean oxidized effluent containing less than about 5, preferably less thanabout 1 ppm, by mass of ammonium cation and having a reduced biochemicaloxygen demand (BOD), preferably less than about 10, preferably less thanabout 4, milligrams per liter,wherein substantially no solids pass from the biocatalyst to theoxidized effluent.

If desired, the oxidized effluent is subjected to subsequent unitoperations, e.g., for the bioconversion of nitrate to nitrogen and forthe removal of phosphorus. Preferably the denitrification is conductedusing biocatalyst of this invention having substantially irreversiblyretained therein microorganisms capable of denitrifying nitrate anion,preferably a heterotrophic denitrifying microorganism. By substantiallyirreversibly retaining denitrifying microorganisms in the biocatalyst ofthis invention, the wastewater being treated need not be deaerated toobtain high denitrifying bioactivity.

One advantage of a sequential nitrifying and denitrifying unitoperations in accordance with this aspect of the invention is thatcarbon source for the denitrification can be controlled to meet thestoichiometric requirement for the denitrification without resulting inan increase of COD in the effluent. The organic carbon from thenitrification operation may vary depending upon the composition and rateof introduction of the wastewater to the nitrification operation and theoperation of the nitrification operation to achieve the sought reductionin ammonium cation concentration. Consequently, the COD in the waterfrom the nitrification operation may be over about 5, preferably lessthan about 20, milligrams per liter. This organic carbon thus offsetsany required carbon source for the denitrification.

In another preferred embodiment of this aspect of the invention at leasta portion of the solids contained in the waste water being processed,e.g., debris from indigenous microorganisms, is hydrolyzed and degradedto further reduce BOD and TSS in the effluent. Typically these solidstend not to adhere to the biocatalyst, especially biocatalysts having askin, due to the currents of water passing through the bed ofbiocatalyst. By reducing the velocity of the water being treated, e.g.,as would happen as the water emerges from the biocatalyst bed or byproviding an expanded section, at least some of the solids aredisentrained from the water an can be subjected to hydrolysis forextended periods of time. The carbon values from the hydrolysis of thedebris become dissolved in the treated water and are passed to asubsequent bioreactor for degradation of carbon values. The retention ofsolids may occur at numerous points in the processes of this invention.For instance, the nitrification operation may contain two or morebioreactors in series and the hydrolysis occurs between the beds ofbiocatalyst in these bioreactors. Similarly, the retention of solids forhydrolysis may occur between nitrification and denitrificationoperations.

Since the processes of this invention use biocatalyst in which themicroorganisms are retained and have an ability to retard or exclude theentry of indigenous microorganisms, the selected microorganism can betargeted to the sought activity, and the biocatalyst often contains asubstantially pure strain of the microorganisms, thereby enabling higherbioactivity to be achieved than that which can be obtained usingindigenous microorganisms or activated sludge.

The raw wastewater may be from any source although the processes of thisinvention are particularly useful for treating municipal wastewater. Theraw wastewater typically has a BOD of between about 50 or 100 and 600 ormore milligrams of oxygen per liter. The COD of the wastewater isgreater than the BOD and is often substantially greater, e.g., even upto 5000 or more milligrams per liter. The ammonium cation content of theraw wastewater can also vary over a wide range and is often betweenabout 10 and 700, more frequently between about 25 and 200, milligramsper liter. The raw wastewater may contain other components including,but not limited to, sulfur compounds, phosphorus compounds, inorganicsalts and solubilized metals.

Preferably, the wastewater to be treated contains less than about 200,and often less than about 100, grams per liter of solids having a majordimension greater than about 10 microns. If desired, the wastewater canbe subjected to ultrafiltration to remove substantially all competitivemicroorganisms prior to being passed to the aerobic bioreactor.

Wastewater is passed to at least one aerobic bioreactor containingbiocatalyst for the bioconversion of organic carbon to carbon dioxideand ammonium cation to nitrate anion. The water in the aerobicbioreactor contains dissolved oxygen. Preferably the dissolved oxygenconcentration in the wastewater stream during contact with thebiocatalyst is at least about 2, say, at least about 3 or more,milligrams per liter. Conveniently, the oxygen is supplied by air oroxygen-enriched air. The oxygen may be supplied by any convenient meansincluding by bubbling or sparging oxygen containing gas through thewater or agitating or otherwise mechanically treating the water such asby spraying to facilitate water-gas contact. Oxidizing componentsinclude, but are not limited to, peroxide and percarbonate. Theenvironment provided by the biocatalyst can serve to protect themicroorganisms retained therein from the effects of peroxide,percarbonate, and other oxidizing components. Where such oxidizingcomponents are used, the concentration of active oxygen is preferably inthe range of between about 1 and 10, more preferably, between about 1and 5, milligrams per liter. In general, Typical Mesophilic Conditionsare used. For most municipal wastewater facilities, the other conditionsof the aerobic treatment are typically those defined by ambientconditions.

The aerobic bioreactor may be in any suitable configuration includingTypical Bioreactor Systems, preferably suitable for continuousoperation. Often the cell density is at least about 100, preferably atleast about 200, and sometimes between about 400 and 800, grams perliter.

The duration of the contact between the wastewater and the biocatalystduring the aerobic treatment in the bioreactor is sufficient to providethe desired reduction of metabolizable organic carbon and ammoniumcation. The duration will thus depend upon the concentration of theorganic carbon and ammonium cation in the wastewater, the desiredreduction, and the density of microorganisms in the bioreactor as wellas the conditions employed. Relatively low average hydraulic retentiontimes can be realized. The average hydraulic retention time in someinstances is less than about 6, and most preferably less than about 4,hours. Thus the bioreactor can be relatively compact, i.e., provide lowfootprint, yet handle high volumes of wastewater to be treated.

If desired, the oxidized effluent may be filtered. The oxidized effluentmay be discharged from the wastewater treatment system, but since itcontains nitrate anion, it is usually subjected to a process to reducenitrate anion to nitrogen. Any suitable denitrification unit operationmay be used. A particularly advantageous denitrification unit operationuses biocatalyst of this invention having substantially irreversiblyretained therein denitrifying microorganisms such that no sludge isgenerated that needs to be removed from the process.

As stated above, the denitrification may be conducted in the samebioreactor in which nitrification is occurring or in a separatebioreactor. The denitrification unit operation may be incorporated intothe aerobic treatment to catabolize organic carbon and ammonium cation.One such process uses biocatalyst of this invention containingmicroorganism capable of both nitrification and denitrificationdiscussed elsewhere herein. Alternatively, biocatalyst of this inventioncontaining denitrification microorganisms can be intermixed with thebiocatalyst for the oxidation. It is believed that the microenvironmentsprovided by the biocatalyst generate anaerobic conditions then enablethe denitrification to occur. Most often, the removal of nitrate anionis conducted in a separate unit operation. Where the concentration ofnitrate anion is low, the use of ion exchange resins may be feasible.Chemical reduction processes have also been proposed, e.g., using sulfurdioxide or other reducing agent. However, most municipal wastewaterfacilities that remove nitrate anion use metabolic processes underanoxic or anaerobic conditions and activated sludge. The denitrifiedeffluent typically contains less than about 1, preferably less thanabout 0.01, milligrams of nitrate anion per liter.

Typical denitrifying microorganisms include species of Pseudomonas,Achromobacter, Bacillus and Micrococcus such as Paracoccusdenitrificans, Thiobacillus denitrificans, and Micrococcusdenitrificans. Denitrifying microorganisms require the presence ofmetabolizable organic carbon as well as anoxic conditions. Typicallydenitrifying microorganisms are less sensitive to toxic chemicals thanare nitrifying microorganisms, and recover from toxic shock more rapidlythan nitrifying microorganisms, especially autotrophic microorganisms.Typical bioreactors include those having a free suspension ofmicroorganisms and those having supported microorganisms which may be ina fixed or trickle bed or fluidized bed.

In these processes, Typical Mesophilic Conditions can be used. The pH ofthe water to be treated will depend upon its source. In general, the pHis maintained between about 4 and 8.5, for instance, between 6.0 and8.0. Buffers, if desired, may be used to maintain the water at a givenpH value during the process. In some instances, it may be possible touse metabolizable organic carbon remaining from the aerobic treatment.Generally the metabolizable organic carbon is separately added in acontrolled manner in order to assure that the denitrified effluent has alow BOD. Any suitable metabolizable organic carbon can be used such asmethanol, acetate anion, and the like.

A general understanding of this process may be facilitated by referenceto FIGS. 4 and 5.

Apparatus 400 is a schematic depiction of a municipal wastewatertreatment facility using the processes of this invention. Municipalwastewater enters apparatus 400 via line 402. For purposes of ease ofunderstanding, and not in limitation of the invention, the wastewatercontains about 50 parts per million by mass of ammonium cation and has aBOD of about 150 milligrams per liter. The wastewater is passed tocentrifuge 404 for separation of solids. It is to be understood thatinstead of centrifuge 404, a filter or settling ponds may be used. Athick slurry containing solids is withdrawn from centrifuge 404 via line406. A supernatant liquid is passed from centrifuge 404 via line 408 tobioreactor 410.

Bioreactor 410 contains biocatalyst of this invention suitable for thecatabolic conversion of organic carbon to carbon dioxide and ammoniumcation to nitrate anion. For the purposes of this discussion, thebiocatalyst is substantially that of Example 148 containing Rhodococcussp. Air enters bioreactor 410 via line 412, and gaseous effluent iswithdrawn via line 414. The average hydraulic residence time inbioreactor 410 is sufficient to provide an oxidized effluent having anammonium cation concentration of less than 5 parts per million by massand a BOD of less than 20 milligrams per liter. Bioreactor 410 is adownflow bed reactor for purposes of this illustration. Becausesubstantially no solids are generated, no solids separation unitoperation is required. However, if desired, the oxidized effluent may bepassed through a filter to remove at least a portion of any solidspresent.

A preferred bioreactor is illustrated in FIG. 5 in which like componentsbear the same identification numeral as those in FIG. 4. The supernatantliquor is passed via line 408 to bioreactor 410 at the top of a bed ofbiocatalyst 502. Air is introduced into bioreactor 410 via line 412 anddistributor 504 at a bottom portion of reactor 410. The air flowsupwardly through the bed of biocatalyst. Gaseous effluent is withdrawnvia line 414 at the top of bioreactor 410, and oxidized effluent iswithdrawn via line 416 from the bottom of bioreactor 410 via line 416.Bioreactor 410 is depicted as having retention zone 506 below the bed ofbiocatalyst. This retention zone serves to retain at least a portion ofthe solids, at least some of which are hydrolyzed to organics that canbe further oxidized to carbon dioxide during subsequent processing ofthe effluent. The metabolic oxidation of the organics can be effected bythe microorganisms used in the biocatalyst, e.g., for the nitrification,denitrification or phosphate removal. Sometimes the indigenousmicroorganisms in the nitrification bioreactor and any subsequentreactor using the biocatalyst of this invention, contribute less thanabout 5, often between about 1 and 3 or 4, percent of the observedbioactivity.

The oxidized effluent is passed from bioreactor 410 via line 416 toanaerobic bioreactor 420. Anaerobic bioreactor 420 serves to reduce thenitrate anion to nitrogen and operates under anaerobic conditions.Advantageously, anaerobic bioreactor 420 contains biocatalystsubstantially as set forth in Example 168 which contains Paracoccusdenitrificans microorganisms. The presence of some oxygen, e.g., up toabout 2 or 4 parts per million by mass, can be tolerated in the oxidizedeffluent being treated in anaerobic bioreactor 420. Since the organiccarbon is substantially reduced in bioreactor 410, additional organiccarbon such as acetate anion is added via line 418 to either theoxidized effluent in line 416 or anaerobic bioreactor 420. Anaerobicbioreactor 420 may be any suitable type of reactor. For purposes ofdiscussion, it is a downflow, fixed bed bioreactor. The averagehydraulic residence time is often less than about 1 hour.

Nitrogen and other gases exit anaerobic bioreactor 420 via line 422. Afurther advantage of using the biocatalyst is that relatively little ofthe sulfur compounds contained in the oxidized effluent are reduced tohydrogen sulfide or other sulfhydryl compounds. Anaerobic bioreactor 420provides a denitrified effluent withdrawn via line 424. The effluentusually containing less than about 1 part per million by mass of nitrateanion.

Example 216

An apparatus containing a nitrifying bioreactor and a denitrifyingbioreactor similar to that described in connection with FIG. 4 is usedfor this example. The example is conducted with wastewater temperatureswithin the range of about 20° C. to 25° C.

The effluent from a primary treatment at the municipal wastewater plantat Union City, Calif., is used as the feed to the apparatus. Freshsamples of effluent are obtained usually on a daily basis both to assurethat fresh raw wastewater is being used and to observe the effect, ifany, of variations in the composition of raw water being fed to amunicipal wastewater facility. Changes in usage, rain runoff, andoperation of the primary treatment can all have an effect. The primaryeffluent is maintained in a holding tank that is aerated to controlodor. The COD of the primary treatment effluent varies from about 80 to440 milligrams per liter and the BOD varies from about 50 to over 160milligrams per liter. The ammonium cation concentration varies betweenabout 25 and 55 milligrams per liter.

The primary effluent is fed to the aerobic nitrification bioreactorcontaining biocatalyst substantially as set forth in Example 148. Duringthe first 17 days of operation, the primary effluent is fed to thebioreactor without filtration. Thereafter the effluent is filtered. Theaerobic nitrification reactor is a downflow bioreactor with air beingfed at the bottom which causes a suspension of the biocatalyst. Aperforated plate is used to retain the bed of biocatalyst and distributethe air in the bioreactor. The bioreactor influent has a dissolvedoxygen concentration of about 5 to 8 milligrams per liter. Severalhydraulic retention times are used varying from about 3 hours to about 5hours. The aerobic nitrification bioreactor has a volume at the bottomwhere solids are observed to settle. The effluent is then passed to afluidized bed anoxic bioreactor containing the biocatalyst substantiallyas set forth in Example 101. No unit operation is used to remove oxygenfrom the effluent from the nitrification reactor prior to itsintroduction into the denitrification bioreactor. The effluent from thedenitrification bioreactor contains about 2 to 5 milligrams of oxygenper liter. The hydraulic residence time in the denitrificationbioreactor is about 20 minutes.

After 3 days of operation, the analysis of effluent from thedenitrification bioreactor commences and is continued for about 8 weeks.After 3 days, the BOD is less than 20 milligrams per liter and theammonia is about 1 milligram per liter at a hydraulic retention time inthe nitrification bioreactor of about 5 hours. After about 14 days, theBOD remained under about 10 milligrams per liter regardless of whetherthe hydraulic retention time in the nitrification bioreactor is 3, 4 or5 hours. The ammonium cation concentration of the effluent also remainedrelatively constant at 1 or below milligram per liter except for a fewdays, but always below about 10 milligrams per liter. The total nitrateand nitrite in the effluent from the denitrifying bioreactor istypically below 10, and most days below about 5, milligrams per literalthough occasional excursion up to about 15 milligrams per liter areobserved.

Example 217

Substantially the same apparatus described in Example 216 is used forthis example. The wastewater is obtained from the municipal wastewaterplant at Union City, Calif., and has a COD of about 350 to 400milligrams per liter and BOD of about 130 to over 160 milligrams perliter. The ammonium cation concentration varies between about 40 to 55milligrams per liter.

The aerobic bioreactor contains biocatalyst substantially as describedin example 134 and is operated substantially as set forth in theprevious example. The average hydraulic residence time is about 3 hoursin the aerobic bioreactor. The effluent from the aerobic bioreactorcontains both nitrate and nitrite anion. The effluent is then passes tothe anaerobic bioreactor containing biocatalyst substantially asdescribed in example 52. The dissolved oxygen concentration in theeffluent from the aerobic bioreactor is about 4 milligrams per liter.The average hydraulic residence time in the second bioreactor is about24 minutes, and the effluent contains a total nitrogen below about 10milligrams per liter.

ii. Phosphate Removal

As stated above, phosphorus can lead to eutrophication. Thus, in someinstances, governmental regulations have required phosphate removal fromwastewater streams, often to below about 1 part per million by mass(ppm-m). Despite the presence of phosphorus in surface waters,ironically phosphorus is a limited resource. Many of the commercialfertilizers that contain phosphorus derive that phosphorus from themining of phosphorus rock, and the reserves of phosphorus rock arebecoming depleted.

Numerous processes for the treatment of water to reduce phosphateconcentration have been proposed such as chemical precipitation andbiological treatment. One process disclosed for both removing phosphatefrom water and providing a phosphorus-containing fertilizer is disclosedby Britton in United States Patent Application Publication 2012/0031849.In the disclosed process struvite is produced by the addition ofmagnesium to phosphate containing water. The struvite is precipitated aspellets which can be used as fertilizer or for other applications. In2007, the United States Environmental Protection Agency issued a report“Biological Nutrient Removal Processes and Costs” (EPA Report). Thisstudy considered both the chemical precipitation and biologicaltreatment routes to remove soluble phosphates including the cost forinstallation and operation of selected commercial units.

By this invention biological processes are provided for the removal ofsoluble phosphate from water using biocatalysts of this invention. Theseprocesses for the biological reduction of soluble phosphate in watercomprise:

-   a. contacting said water in a bioreactor with biocatalyst of this    invention having substantially irreversibly retained therein    phosphate accumulating microorganisms (PAOs) under phosphate    accumulating conditions for a time sufficient to reduce the    concentration of phosphate in said water and provide a biocatalyst    containing phosphate laden microorganism wherein said phosphate    accumulating conditions comprise the presence of    polyhydroxyalkanoate (PHAs), especially poly-β-hydroxybutyrate,    within said microorganisms and the presence of aerobic or anoxic    conditions in the water:-   b. subjecting said biocatalyst containing phosphate laden    microorganism to anaerobic conditions in an aqueous medium    sufficient to release phosphate from said microorganisms into said    aqueous medium to provide a phosphate-rich aqueous medium; and-   c. separating said biocatalyst from the phosphate-rich aqueous    medium for use and step (a).

Examples of phosphate accumulating microorganisms include, but are notlimited to, Acintobacter spp., Actinobacteria, CandiidatusAccumulibacter phosphatates, α-Proteobacteria, β-Proteobacteria, andγ-Proteobacteria.

The processes of this invention treat water to remove soluble phosphate(soluble phosphate as used herein is intended to include monobasicphosphate, dibasic phosphate, tribasic phosphate, and pyrophosphateanions). The water to be treated (herein referred to as “raw waterstream”) may be derived from any suitable source including, but notlimited to, surface and groundwater, municipal wastewater, industrialwastewater, and water generated by mining operations. Due to therobustness provided by the biocatalyst, the water to be treated maycontain a number of components, including the presence of componentsthat would, if the microorganisms were in a free suspension, adverselyaffect phosphate removal. The raw water feed may be subject to unitoperations to remove one or more components prior to being subjected tophosphate removal or may be directly fed to the phosphate removalprocess.

The raw water feed often contains at least about 2, say at least about4, milligrams of phosphate (calculated as PO₄ ⁺³) per liter. Municipalwastewater frequently contains between about 4 and 20 milligrams ofphosphate per liter; however, the processes of this invention can beused to treat raw water streams containing high concentrations ofphosphate, e.g., 500 or more milligrams per liter.

The processes of this invention serve to reduce the soluble phosphateconcentration in the raw water feed to provide treated water. Thereduction in the concentration of soluble phosphates is often at leastabout 50, preferably at least about 70, percent. In the preferredaspects of this invention, the treated water contains less than about 1,and often less than about 0.1, milligram of phosphate per liter.Advantageously, the low concentrations of phosphate in the treated watercan be obtained without the necessity of using a chemical precipitant.The treated water may be suitable for discharge, recycling, or furtherprocessing. Since essentially no sludge from microbial debris isgenerated, the treated water need not be subjected to post treatmentoperations such as settling ponds.

The phosphate removal is effected under oxidizing conditions. Oxidizingconditions can be provided by supplying oxygen or oxidizing component.Conveniently, the oxygen is supplied by air or enriched air. Generally,the dissolved oxygen content of the raw water feed during phosphateremoval is at least about 1, preferably at least about 2, say, betweenabout 2 and 20, milligrams per liter the oxygen may be supplied by anyconvenient means including by bubbling or sparging oxygen containing gasthrough the water or agitating or otherwise mechanically treating thewater to facilitate water-gas contact. Oxidizing components include, butare not limited to, nitrate, peroxide, and percarbonate. Where suchoxidizing components are used, the concentration of active oxygen ispreferably in the range of between about 1 and 10, more preferably,between about 1 and 5, milligrams per liter.

As most phosphate accumulating microorganisms are mesophiles, TypicalMesophile Conditions can be used. The pH of the raw water stream beingtreated is preferably more basic than about 6, and is often in the rangeof between about 6 or 6.5 and 9.

The duration of the contact between the raw water stream and thebiocatalyst during the phosphate removal step is sufficient to providethe desired reduction of soluble phosphate in the water. The durationwill thus depend upon the concentration of the soluble phosphate in theraw water stream, the desired reduction of phosphate concentration, andthe density of phosphate accumulating microorganisms in the bioreactoras well as the conditions employed for the phosphate removal. Due to thehigh concentration of phosphate accumulate microorganisms that can beprovided by using the biocatalyst, relatively low batch cycle orhydraulic retention times can be realized.

The phosphate accumulating microorganisms retain the phosphorus inexcess of the amount required for biological processes in the form ofpolyphosphate within the cell. In some embodiments, the concentrated,phosphate-containing water has a phosphate concentration at least 10times greater than that of the raw water feed. In some instances, thisconcentrated water will have at least about 100, preferably at leastabout, 500, milligrams of phosphate per liter. Usually higherconcentrations of phosphate in concentrated water result in less energybeing required to obtain a solid phosphate-containing product.

A transition between the aerobic and anaerobic stages is required andcan be effected in any suitable manner. For instance, the supply ofoxygen or other oxidizing compound to the raw water being processed inthe bioreactor may be terminated. The residual oxygen may be consumed inthe accumulation of additional amounts of phosphate, and then the waterbeing treated can be displaced with the separate aqueous medium intendedto accumulate the released phosphate.

In the processes of this invention, the release of the phosphate is intoa separate aqueous medium than the treated water. In preferredoperations, the release of the phosphate enables a concentrated,phosphate-containing water to be obtained that is relatively free fromthe presence of other contaminants that may be contained in the rawwater stream. Thus, the concentrated water has enhanced utility inproviding phosphate suitable for industrial or agricultural use. Ifdesired, phosphate can be recovered from the concentrated,phosphate-containing water. Any suitable process may find application toeffect such recovery. Unit operations for providing even furtherconcentrated water include chemical precipitation, evaporation, andreverse osmosis.

The phosphorus can be released by maintaining the microorganisms underanaerobic conditions. Often, the dissolved oxygen concentration in thewater (or oxidizing value of an oxidizing compound is used instead ofoxygen) is less than about 0.5, preferably less than about 0.2,milligrams per liter. It is to be understood that some microenvironmentswithin the biocatalyst may have higher or lower concentrations ofoxygen. Indeed, in a continuous operation is possible to sequencebetween the aerobic phosphate removal stage and the anaerobic phosphaterelease stage such that only a portion of the microorganisms retained inthe biocatalyst are being used to remove and release phosphorus. Theremaining of microorganisms are believed not only to be available foraccommodating changes in the volume flow rate of the raw water streamand its phosphate concentration but also serve to shuttle oxygen andphosphate within the biocatalyst.

As the conditions of temperature, pressure and pH for the release ofphosphate can be the same as those for the recovery of phosphate fromthe raw water, often there is no need to purposely induce a change.Typically it is not necessary to add nutrients, includingmicronutrients, to the separate aqueous medium.

For some microorganisms, the kinetic rate of release of phosphate fromthe microorganisms is faster than that for the accumulation ofphosphate. Preferably the phosphate release stage is operated to providea high concentration of phosphorus in the concentratedphosphate-containing product. If desired, the phosphate release stagecan be operated in two or more steps, the first being to provide themaximum concentration of phosphate in the aqueous medium, and the lattersteps to provide for the reduction of the phosphate contained in themicroorganisms, albeit providing a concentrated phosphate-containingproduct that has a lower concentration of phosphate than that of thephosphate removal stage.

During accumulation of the phosphate, it is believed that the PHA andoxygen or oxidizing compounds are bioconverted to carbon dioxide andwater. In general, between about 2 and 20, preferably between about 4and 10, carbon atoms of PHA are bioconverted per phosphorus atom ofsoluble phosphate accumulated in the microorganism. PHA is formed by thephosphate accumulating microorganisms under anaerobic conditions in thepresence of carbon-containing substrate. Volatile fatty acids of 2 to 5carbon atoms have generally been preferred as the carbon-containingsubstrate. However, with the use of biocatalysts of this invention morecomplex carbon sources such as sugars and acetic acid can be used togenerate the PHA.

The processes of this aspect of the invention, by retaining thephosphate accumulating microorganisms in the biocatalyst, providesignificant flexibility as to when the PHA production occurs. Forinstance, the carbon-containing substrate may be provided during atleast a portion of the duration of the release of phosphate, or aseparate, anaerobic stage may be employed specifically for theproduction of PHA. In the latter case, the microenvironments within thebiocatalyst and the metabolic state of the microorganisms permit themicroorganisms to remain viable during the duration of the release ofthe phosphate stage. This latter case is beneficial where theconcentrated phosphate-containing product is desired to have anessential absence of added organic compounds.

The kinetic rate for the formation of PHA depends, in part, upon thecarbon-containing substrate used and the concentration of the substrate.In most instances, the biological reaction rate to PHA is more rapidthan that for the accumulation of phosphate. Further, the biocatalystcan enable the retention of carbon-containing substrate beyond theduration of the PHA-generating stage, and the more occludedmicroorganisms in the biocatalyst may have a sufficient absence ofoxygen and a sufficient presence of carbon-containing substrate togenerate additional PHA.

The processes may be conducted on a batch, semi-continuous andcontinuous basis, and are preferably conducted on a continuous basis.The bioreactor may be in any suitable configuration including TypicalBioreactor Systems. One bioreactor can be employed and batch cycledthrough the phosphate removal and release stages. For most commercialoperations, operation on a continuous basis is preferred. Thebiocatalyst may be moved from one bioreactor to another, with each ofthe bioreactors the adapted to perform a different function, e.g., abioreactor for phosphate removal from the raw water; a bioreactor forphosphate release; and, optionally, a separate bioreactor for PHAgeneration. In this manner, countercurrent flows of biocatalyst andwater can occur in each bioreactor to facilitate removal of solublephosphate from the raw water stream and maximize the phosphateconcentration in the phosphate-containing product. Another approach isto cycle each bioreactor containing biocatalyst from, e.g., a phosphateremoval stage to a phosphate release stage to a PHA generation stage.Combinations of these two approaches can be used. For instance, abioreactor may be used to remove phosphate from the raw water stream,and the phosphate removing stage is then stopped with the biocatalystthen being provided to a countercurrent flow bioreactor operating underanaerobic conditions to provide a highly concentratedphosphate-containing product. The biocatalyst is then provided toanother bioreactor which first operates under PHA forming conditions andthen is transitioned to conditions for phosphate removal.

A general understanding of the invention and its application may befacilitated by reference to FIGS. 6, 7 and 8.

FIG. 6 is a schematic depiction of one type of apparatus generallydesignated as 600 suitable for practicing the processes of thisinvention. As depicted, the apparatus comprises 5 bioreactor assembliesA, B, C, D, and E. Each of the assemblies will be described in furtherdetail with respect to FIG. 7.

For purposes of discussion, the bioreactors are fluidized bed reactors,although it can be readily appreciated that other types of bioreactors,such as packed bed and trickle bed, can be used. As shown, the apparatusis a number of fluid transport headers which can comprise one or morefluid conduit lines. Water flow header assembly is indicated by element602 and provides for the transport of raw water to the bioreactorassemblies as well as water between the bioreactor assemblies and waterbeing recycled within a bioreactor assembly. Line 604 is adapted toprovide carbon source, if necessary, to header assembly 602. Air header606 is adapted to supply air, or other oxygen containing gas, to each ofthe bioreactor assemblies. Drain header 608 is adapted to transporttrain water from one bioreactor assembly to another. Header assembly 610is adapted to provide for fluid communication within a bioreactorassembly, from one bioreactor assembly to another bioreactor assembly,and for the removal of a concentrated phosphate-containing stream.Header assembly 612 is adapted to withdraw treated water from theapparatus. Header assembly 614 is adapted to exhaust gases from theapparatus. In FIG. 6, the circular elements generally indicate valvingassemblies. The valving assemblies and operation will be discussedfurther in connection with FIG. 7.

FIG. 7 is a more detailed depiction of the bioreactor assemblies of FIG.6. As shown, the bioreactor assemblies comprise bioreactor 702.Bioreactor 702 contains biocatalyst comprising Candidatus Accumulibacterphosphatis. Line 704 is adapted to direct aqueous streams to bioreactor702. As will be discussed later, the aqueous stream may be a raw waterstream, a stream from another bioreactor, or a recycle stream. Line 706provides oxygen-containing gas, usually air, to the bioreactor. Valve708 controls the flow there, and distributor 710 serves to distributethe oxygen-containing gas into bioreactor 702. Line 712 is provided atthe bottom of bioreactor 702 for purposes of purging or drainingbioreactor 702. Valve 714 controls the flow of water through line 712.

At the top of bioreactor 702 is provided line 720 for purposes ofwithdrawing gases such as the residual from the oxygen-containing gassupplied via line 706 and carbon dioxide resulting from the metabolicactivity. Valve 722 is provided online 720 and is adapted to control theflow of gases through line 720. These withdrawing gases are typicallydischarged to the atmosphere; however, they may be subjected totreatment to insert or remove components such as methane. As shown, atan upper portion of bioreactor 702 line 716 is provided to withdrawtreated water from the bioreactor. As will be discussed later, thistreated water line is used to remove water from a bioreactor operatingin the polishing mode, or if no bioreactor is operating in the polishingmode, then from a bioreactor operating in the primary phosphate removalmode. Valve 718 controls the flow of water through line 716. Also, line724 is provided at an upper portion of bioreactor 702 for the removal ofwater for recycle or transport to another bioreactor. Both lines 716 and724 are provided with screens, or other devices, to prevent biocatalystcontained in bioreactor 702 from passing into these lines. Line 724 isprovided with valve 726 which is adapted to control the flow of waterfrom bioreactor 702 into line 724. Line 724 is also provided withdirecting valve 728 which is adapted to direct the water into line 730which carries a concentrated phosphate-containing aqueous stream forremoval and/or to line 732. Line 732 contains valve 734 which is adaptedto recycle water via line 738 and line 704 to bioreactor 702 or passwater into line 736 for passage to another bioreactor.

As shown, line 704 can also receive other aqueous streams. These streamscan include raw water provided via line 740 and water from anotherbioreactor via line 744. Valve 742 is provided to control the relativevolumes an amount of these streams as will be discussed later. Line 746is adapted to provide carbon source, if necessary, to bioreactor 702.Valve 748 controls the flow of the carbon source to bioreactor 702.

For purposes of illustration only, and not in limitation of theinvention, the 5 bioreactor assemblies depicted in FIG. 6 are adapted tobe sequenced through various modes of operation. One skilled in the artcan readily appreciate that fewer or a greater number of bioreactorassemblies can be used and the sequencing altered.

The following summarizes the five modes of operation used for purposesof this illustration:

Anaerobic PHA Generation Mode—in this mode, the bioreactor is operatedunder anaerobic conditions including the presence of carbon source,which may be added carbon source or that contained in the raw water tobe treated;Primary Aerobic PO₄ Removal Mode—in this mode, oxygen containing gas ispassed through the bioreactor to effect removal of phosphate from thewater;Polishing Aerobic PO₄ Removal Mode—in this mode, water treated byanother bioreactor that is operating in the Primary Aerobic PO₄ RemovalMode is further subject to contact with biocatalyst in the bioreactorfor removal of additional phosphate from the water;Purge Mode—in this mode, the bioreactor transitions from an aerobic orand anoxic environment to an anaerobic environment for release ofphosphate from the biocatalyst; andAnaerobic PO₄ Release Mode—in this mode, the bioreactor is operatedunder an anaerobic environment for release of phosphate from thebiocatalyst to provide a phosphate-rich effluent stream.

The following discussion describes the operation of the apparatus ofFIGS. 6 and 7 using the sequencing outlined in FIG. 8. As can be seen inFIG. 8, each of the bioreactor assemblies, A, B, C, D, and E sequencethrough the same modes. This discussion will therefore reference theoperation of a single bioreactor assembly with the understanding thatthe discussion will be equally applicable to each of the otherbioreactor assemblies. Each of the modes of operation is of the sameduration of time for purposes of this illustration.

The discussion commences with the operation of a bioreactor in theAnaerobic PHA Generation Mode, which is a reactor that has in theimmediately preceding period of time been used in the Anaerobic PO₄Release Mode. Thus, at the start of the cycle, the bioreactor containsan aqueous medium that, although anaerobic, is rich in phosphate. At theinitiation of this cycle, valve 742 and valve 714 are closed. First,valve 714 is opened to prevent the aqueous medium in bioreactor 702 topass through line 712 and then be directed to phosphate recovery. Duringdraining, raw water feed to the apparatus may be terminated, or the rawwater feed may be directed to a bioreactor operating in the PrimaryAerobic PO₄ Removal Mode. Alternatively, the apparatus may be providedwith surge tanks. Any suitable fluid may be used to replace the volumeof bioreactor 702 that occurs from the draining. Often, air is suitableeven though it is desired that the bioreactor be operated andaerobically in this mode. Alternatively, the displacement of thephosphate-rich medium in bioreactor 702 at start of this mode can beeffected by passing raw water via line 704 into bioreactor 702 whilewithdrawing the phosphate-rich aqueous medium from the top of thebioreactor via line 724.

Once bioreactor 702 is drained, valve 714 is closed and valve 742 ispositioned to permit a raw water feed stream that contains a solublephosphate to be passed from line 740 into line 704 for introduction intobioreactor 702. The raw water feed stream refluidizes the biocatalyst.Valve 722 and valve 718 remain closed. Bioreactor 702 is operated undermetabolic conditions, including anaerobic or anoxic, conditions suchthat the biocatalyst bioconverts the carbon source in the raw water feedto PHA. The carbon source may be contained in the raw water feed stream.If necessary, carbon source can be provided during this mode via line746 to the desired concentration by regulation of valve 748. The rawwater feed stream, after passing through the fluidized bed ofbiocatalyst in bioreactor 702 exits via line 724 and is passed via valve728 to line 732. Valve 734 directs the water via line 736 to abioreactor operating in the Primary Aerobic PO₄ Removal Mode. Ifnecessary, a portion of this water may be directed by valve 734 via line738 back to bioreactor 702 in order to maintain a desired degree offluidization of the biocatalyst.

Near the completion of the Anaerobic PHA Generation Mode, bioreactor 702the transition to the Polishing Aerobic PO₄ Removal Mode is commenced.This transition comprises initiating the flow of oxygen-containing gasinto bioreactor 702 via line 706 by opening valve 708. At this time,valve 722 is opened to permit gases to exit bioreactor 702 via line 720.The flow of the water from bioreactor 702 remains unchanged during thistransition and is passed to a bioreactor operating in the PrimaryAerobic PO₄ Removal Mode. This transitioning allows the bioreactor toserve as the bioreactor operating in the Polishing Aerobic PO₄ RemovalMode during the next period.

At the conclusion of Period 1 valve 742 terminates the flow of raw feedwater and commences flow of effluent from the bioreactor operating inthe Primary Aerobic PO₄ Removal Mode from line 744. Also, valve 726 isclosed and valve 718 is open to permit phosphate-reduced water to passfrom the apparatus via line 716. However, if a recycle stream is desiredto provide sufficient flow to fluidize the biocatalyst in bioreactor702, valve 726, valve 728 and valve 734 can be set to provide the soughtflow rate of water back to bioreactor 702. Since the prior transitioningplaced bioreactor 702 in an aerobic environment, the microorganisms havean enhanced PHA content and reduced phosphorus content and thus caneffectively remove soluble phosphate in the water being treated todesirably low concentrations. In addition, the use of a bioreactor inthe Polishing Aerobic PO₄ Removal Mode enables fluctuations in thesoluble phosphate concentration in, as well as fluctuations in the flowrate of, the raw water feed to be accommodated while still providing thesought flow phosphate concentration in the treated water.

In general, no transitioning is required to cycle a bioreactor fromoperation in the Polishing Aerobic PO₄ Removal Mode to the PrimaryAerobic PO₄ Removal Mode. Bioreactor 702, at the conclusion of Period 2,begins operation in the Primary Aerobic PO₄ Removal Mode by switchingthe source of the water and line 744 from another bioreactor operatingin the Primary Aerobic PO₄ Removal Mode to the effluent from abioreactor operating in the Anaerobic PHA Generation Mode. Valve 718 isclosed and valve 726 is opened permitting the aqueous medium to thedirected via line 724 to valve 728 and to line 732. Valve 734 directsthe effluent via line 736 to a bioreactor operating in the PolishingAerobic PO₄ Removal Mode. A portion of the effluent may be directed byvalve 734 to line 738 for recycle to bioreactor 702 in order to providethe desired fluidization of the biocatalyst.

Either before the end of Period 3 in which bioreactor 702 is operatingin the Primary Aerobic PO₄ Removal Mode or at the beginning of Period 4in which bioreactor 702 will be operating in the Purge Mode, valve 708is closed to cease the flow of oxygen-containing gas into bioreactor702. Sufficient residual oxygen remains in the aqueous medium inbioreactor 702 and in the biocatalyst to permit additional dissolvedphosphate uptake. The effluent from bioreactor 702 can continue to bedirected to a bioreactor operating in the Polishing Aerobic PO₄ RemovalMode or a bioreactor operating in the Primary Aerobic PO₄ Removal Mode(line 736 would thus be in fluid communication with line 744 of anotherbioreactor which is operating in the Primary Aerobic PO₄ Removal Mode).Usually in the Purge Mode, the aqueous medium in bioreactor 702 iscontinually recycled through positioning of valves 726, 728, and 734. Ifdesired, all or a portion of the aqueous medium contained in bioreactor702, which medium contains dissolved oxygen, can be drained via line712. The drained aqueous medium can be passed to another bioreactoroperating in either the Primary Aerobic PO₄ Removal Mode or thePolishing Aerobic PO₄ Removal Mode. In the Purge Mode the process torelease phosphorus retained by the microorganisms begins. The Purge Modealso facilitates dissipating oxygen concentration gradients within thebiocatalyst.

In Period 5, bioreactor 702 is operated in the Anaerobic PO₄ ReleaseMode. In this mode, the phosphate-laden water in bioreactor 702 isrecycled by means of lines 724, 732, 738, and 704, with a portion of thewater being directed by valve 728 to line 730. The combination of theuse of a Purge Mode with the Anaerobic PO₄ Release Mode tends to providethe highest feasible concentration of phosphate in the water streamwithdrawn via line 730. In an alternative embodiment, thephosphate-laden water in bioreactor 702 may be drained through line 712.The phosphate-laden water may be disposed or subjected to furtherchemical or processed treatment to recover phosphate. For instance,struvite may be formed and phase separated with return of the water tothe apparatus. Alternatively, the phosphate-laden water may be subjectto evaporation, distillation, or reverse osmosis to provide a moreconcentrated phosphate-containing stream which may find industrial oragricultural use.

Although the illustration has depicted the Purge Mode and Anaerobic PO₄Release Mode to occur in separate periods, the modes may be combined ina single period.

iii. Mitigation of Biofouling from Aquatic Microorganisms

Water obtained from sources containing aquatic organisms, especiallymacroorganisms such as barnacles (such as acorn barnacles and goosebarnacles); marine mussels; freshwater mussels; zebra mussels;bryozoans; tube worms; polychaetes, seasquirts, sponges; and seaanemones, is used for a number of purposes. For example, the water maybe sought to be used as potable water, a source of water fordesalination, cooling water such as for power plants and manufacturingfacilities, for sanitary facilities, and ballast for ships. Watersources contain the macroorganisms can cause biofouling of surfaces suchas pipes, tanks and process equipment such as pumps, valves, heatexchangers, filtration devices, reactors and the like. Periodicmaintenance is required to remove the deposits or replace fouledequipment. Removing the deposits from these macroorganisms can beproblematic due to the strength of adherence of these organisms to thesurface and the hardness of the shell bodies.

In accordance with this aspect of the invention, the water that containsor may contact aquatic macroorganisms is first contacted withbiocatalysts of this invention containing microorganisms that arecapable of catabolic conversion of dissolved, metabolizable organiccarbon (organocarbon) in the water. The microorganism selected should betolerant of the other components of the raw water including, but notlimited to, salinity, other anions and cations, any organics orpollutants present, and pH. Examples of microorganisms capable ofconverting organocarbon to carbon dioxide include, but are not limitedto, Acinetobacter Johnsonii, Alcanivorax dieselolie, Azoarcus sp,Bacillus globiformis, Bacillus mojavensis, Bacillus subtilis,Escherichia coli, Eubacterium biforme, Lactosphaera pasteurii.Microthirx parvicella, Moraxella cuniculi, Nocardia asteroids,Pseudomonas pseudoalcaligenes, Rhococccus rhodnii, Rhodcoccuscoprophilus, Rhodoferax fermentans, Rhodococcus jostii, Saccharophagusdegradans, Skermania piniformis, Sphingomonas capsulate, Variovoraxparadoxus, and Zoogloea sp

The contact is for a time sufficient to reduce the concentration ofmetabolizable organocarbon to a level where survival of macroorganismsis inhibited. A water feed may be continuously contacted withbiocatalyst; however, intermittent or periodic treatment of the watermay be sufficient to disrupt macroorganism growth downstream of thebiocatalyst.

Accordingly, biofouling by aquatic macroorganisms can be accomplishedwithout the addition of chemicals. Moreover, the biocatalysts do notthemselves generate food sources for the macroorganisms, do not increasethe mass of solids to be removed by any downstream filtration. Inpreferred aspects of the invention, the concentration of organocarbondownstream from the contact with the biocatalyst is insufficient tomaintain the viability of suspended microorganisms.

The water is often, but not necessarily always, obtained from surfacesources and maybe salt, brackish or fresh water. The water contains foodand nutrients for supporting the aquatic macroorganisms, and usuallycontains microorganisms.

The conditions for the contacting of the water and biocatalyst may varyover a wide range and is usually under Typical Mesophile Conditions.Usually, the temperature of the contacting is substantially the ambienttemperature of the water. In some instances, the dissolved oxygen in thewater is sufficient for the metabolic bioconversion of the organocarbonto carbon dioxide; however, aeration of the water may be desired in someinstances. Generally, the dissolved oxygen content in the water to becontacted with the biocatalysts is in the range of about 1 to 50 ormore, say, 1 to 10, parts per million by mass. Typically no nutrientsneed be added to the water.

The bioreactor may be in any suitable configuration including TypicalBioreactor Systems. With the high cell densities and bioactivitiesachievable using with the biocatalysts of this invention, the averagehydraulic residence time of the water in the bioreactors is typicallyless than about 24, more frequently less than about 6 or 10, hours, andin some instances may be in the range of about 0.5 to 4, hours.

Since the biocatalyst provides environments in which the microorganismscan survive for extended periods of time without the addition ofadditional food sources, the biocatalyst can be cycled betweenenvironments containing organocarbon (“metabolizing cycle”) andenvironments containing essentially no organocarbon (“cleaning cycle”).This cycling often retards any growth of organisms on the surface of thebiocatalyst. In general, the duration of the cleaning cycle, if used, isat least about 2, say, between about 6 and 48, hours.

With reference to FIG. 9, apparatus 900 is an assembly for thedesalination of seawater using reverse osmosis membranes. Seawater ispassed to plenum 902. The arrows indicate the flow of the seawater intoplenum 902. Plenum 902 as a plurality of screens, two of which areillustrated, screen 904 a and screen 904 b. Movable flap 905 is providedin plenum 902 and is adapted to stop flow of water to screen 904 a andthen move as indicated by the dotted line to stop flow of water toscreen 904 b. It is to be understood that movable flap 905 may bepositioned such that water can flow to both screens 904 a and 906 b.

Each screen has a dedicated header which for screen 904 a is header 906a, and for screen 904 b is header 906 b. Each header has lines going toeach bioreactor. For purposes of this illustration, two bioreactors areshown, bioreactor 912 and bioreactor 914. Line 908 a provides fluidcommunication between header 906 a and bioreactor 912, and line 908 bprovides fluid communication between header 906 b and bioreactor 912.Line 910 a provides fluid communication between header 906 a andbioreactor 914, and line 910 b provides fluid communication betweenheader 906 b and bioreactor 914.

Each bioreactor 912 and 914 are depicted as fluid bed bioreactorscontaining biocatalyst, which for purposes of discussion is thebiocatalyst of example 113. Bioreactor 912 is shown as having effluentlines 916 and 912, and bioreactor 914 is shown as having effluent lines918 and 924. Effluent lines 916 and 918 are in fluid communication withrecycle header 920. Effluent lines 922 and 924 are in fluidcommunication with treated water header 926. Treated water header 926directs treated water to ultrafiltration membrane unit 928. The filtratefrom ultrafiltration membrane unit 928 is passed via line 930 to reverseosmosis unit 932. Desalinated water exits via line 934, and a rejectedstream exits via line 936 from reverse osmosis unit 932.

Returning to recycle header 920, water is passed to surge tank 938.Water from surge tank 938 can be directed via line 942 plenum 902. Thewater from line 942 enters plenum 902 in the region occluded by movableflap 905 and upstream of the occluded screen.

There are several modes of operation of the apparatus, all within thebroad aspects of this invention. In one mode, bioreactors 912 and 914operate independently, and in another mode, bioreactors 912 and 914operate in water flow sequence.

By way of example, in a first mode of operation raw water enters plenum902 and is directed through screen 904 b to header 906 b. Line 908 b isvalved off, and the water in header 906 b passes through line 910 b tobioreactor 914. In bioreactor 914, organocarbon is converted to carbondioxide to provide a treated water stream containing essentially noorganocarbon. This treated water stream exits via line 924 and passes totreated water header 926 where it ultimately passes through the reverseosmosis unit to provide a desalinated water. At this point in time, line918 is valved off.

Surge tank 938, which had previously been filled with treated watercontaining essentially no organocarbon, supplies water via line 940 intothe occluded region of plenum 902 defined by movable flap 905 and screen904 a. The water is then passed through screen 904 a into header 906 a.Line 910 a is valved off so that water does not enter bioreactor 914,but line 908 a is valved open such that the treated water passes throughthe bioreactor 912. The water then exits bioreactor 912 via line 916 tobe returned by recycle header 920 to surge tank 938. At this point intime, line 922 is valved off. As can be seen, the cycling of treatedwater through screen 904 a, header and line 906 a and 908 a andbioreactor 912 serve to provide a cleaning cycle. The use of movableflap 905 enables the treated water to contact the flap to similarlyattenuate the growth of macroorganisms on the flap.

Upon the completion of the cleaning cycle for screen 904 a, header 906 aand bioreactor 912, movable flap 905 is moved to permit flow of rawwater through screen 904 a and occlude the flow of raw water to screen904 b. The same valving positions are maintained for headers 906 a and906 b which results in bioreactor 912 treating the raw water. Effluentline 916 is valved off and effluent line 922 is valved open to pass thetreated water to treated water header 926. Bioreactor 914 is subjectedto a cleaning cycle as is screen 904 b, header 906 b and line 910 b.Effluent line 924 from bioreactor 914 is valved off, and effluent line918 is valved open and passes the water to recycle header 920. Waterfrom surge tank 938 is passed via line 940 to the occluded regiondefined by movable flap 905 and screen 904 b in the plenum. The side ofthe plenum that had been exposed to raw water during the prior cycle isnow exposed to the water having an essential absence of organocarbon.Thus, the apparatus facilitates maintaining both sides of movable flap905 relatively free of macroorganisms.

In the next cycle, line 908 a is valved off, line 908 b is valved openand bioreactor 912 is subjected to a cleaning cycle. At the same time,line 910 a is valved open, line 910 b is valved off and bioreactor 914serves to treat raw water to remove organocarbon. In this cycle,effluent line 918 is valved off and effluent line 924 is valved open andpasses treated water to treated water header 926. Also, effluent line922 from bioreactor 912 is valved off, and the water is passed via line916 to recycle header 920.

In the last of the four cycles, movable flap 905 is moved to occludeflow of raw water to screen 904 a and permit flow of raw water to screen904 b. Thus, bioreactor 914 treats raw water, and effluent line 918 isvalved closed and effluent line 924 is valved open to direct the treatedwater to treated water header 926. Bioreactor 912 is subjected to acleaning cycle with effluent line 916 valved opened and effluent line922 valved closed. Line 940 directs the water from surge tank 938 to theoccluded region defined by movable flap 905 and screen 904 a.

The apparatus depicted in FIG. 9 can also be used in a sequential bedmode. In a first cycle movable flap 905 provides an occluded regionupstream from screen 904 a in plenum 902. Raw water entering plenum 902passes through screen 904 b and into header 906 b. Line 908 b is valvedclosed, and the water passes through line 910 b into bioreactor 914 fortreatment to remove organocarbon. The treated water is passed via line918 to recycle header line 920. Line 924 is valved closed. Thus surgetank 938 receives a treated water which is then passed via line 940 theoccluded region in advance of screen 904 a. Since the treated water hassubstantially no organocarbon, the water is useful for a cleaning cycle.This water enters header 906 a and is passed to bioreactor 912 via line908 a which is valved open. Line 910 a is valved closed. Any residual oradditional organocarbon is us subjected to biocatalyst in bioreactor 912for additional bioconversion to carbon dioxide. The water frombioreactor 912 is passed via line 918 to treated water header 926.Effluent line 916 is valved closed.

In a manner consistent with the description of the first mode ofoperation of the apparatus, the movable flap positioning and valving toeach of the bioreactors can be cycled such that all lines and reactorsare passed through a cleaning cycle.

iv. Aerobic Catabolysis of Ammonium Ion to Nitrogen

As discussed above biological processes for removal of ammonium cationfrom aqueous streams oxidize ammonium cation typically conducted in anaerobic environment. The oxidation effluent contains nitrate anions andpossibly nitrite anions, especially where the oxidation is not complete.Often over 4 kilograms of oxygen are consumed per kilogram of ammoniumnitrogen removed and the nitrification and denitrification processes andincrease power consumption for a typical facility by 30 percent or more.

The resulting nitrate and nitrite ions are also contaminants and arepreferably removed from the water prior to discharge to the environment.Bioconversion processes for denitrification are also well known.Typically the reduction of these oxyanions to nitrogen requires ananoxic or anaerobic environment and electron donor. Hence, somefacilities add a donor such as methanol or even raw sewage. The need forfundamentally different conditions for ammonium oxidation and nitratereduction contributes to the capital and operating expense of adopting asystem to bioconvert ammonium to nitrogen. The anaerobic conditions forthe nitrate reduction can also lead to the production of hydrogensulfide and other sulfhydryl compounds.

Also discussed above is the anammox process.

By this aspect of the invention, the biocatalysts of this inventionenable ammonium cation to be bioconverted in an aerobic environment tonitrogen using microorganisms contained in activated sludge (hereinreferred to as an “N/D microorganism”. Since the biocatalyst of thisinvention is used, no solids are generated by the microorganisms in thebiocatalyst. In the broad aspects, the contacting between watercontaining ammonium cation and the biocatalyst is under metabolicconditions for a time sufficient to provide a treated water having aconcentration of ammonium less than about 50, preferably less than about90, percent of that in wherein the nitrate concentration of the feedwater and a concentration of nitrate ion less than about 1 milligram perliter. Further, this reduction of nitrate and nitrite anions in thetreated water can occur even in the presence significant amounts ofoxygen, e.g., greater than 5 or 8 milligrams of oxygen per liter, in thewater. In preferred embodiments of this aspect of the invention, thetreated water contains sufficient water that it need not be aerated fordischarge to the environment, e.g., contains at least about 0.5,preferably at least about 1, milligram of oxygen per liter. Moreover, nohydrogen sulfide or other sulfhydryl compounds are generated by theprocess.

The water may be from any source including municipal wastewater, groundwater and surface water. The ammonium cation content of the water to betreated can also vary over a wide range and is often between about 5 or10 and 250, more frequently between about 25 and 200, milligrams perliter. The water to be treated may contain other components including,but not limited to, sulfur compounds, phosphorus compounds, inorganicsalts and solubilized metals. Often, the oxygen concentration in thewater to be treated is in the range of from about 0.5 to 10 or moremilligrams per liter.

The biocatalyst of this invention used in these processes contain N/Dmicroorganisms Suitable N/D microorganisms may or may not exhibit bothnitrification and denitrification metabolic activities when in a freesuspension in an aqueous medium. While not wishing to be limited totheory, it is believed that a phenotypic alteration occurs in someinstances that contributes to the performance of N/D microorganisms. TheN/D microorganisms can be obtained from activated sludge. Preferably,the activated sludge is acclimated under aerobic conditions underTypical Mesophile Conditions and fed with bicarbonate anion. In someinstances the pH is maintained at between about 6 and 8.

The ammonium biodegradation processes may be conducted in any suitablemanner. The processes may be on a continuous, semi-continuous or batchmode of operation and use Typical Bioreactor Systems.

Any suitable metabolic conditions can be used including TypicalMesophile Conditions. In general, the pH is maintained between about 4and 8.5, for instance, between 6.0 and 8.0. Buffers, if desired, may beused to maintain the water at a given pH value during the process.Carbon source nutrient may be required and may be any convenient carbonsource such as a low molecular weight hydrocarbon or oxygenatedhydrocarbon such as ethanol, acetate, and sugars.

The duration of the contact of the water and biocatalyst is for a timesufficient to obtain the sought reduction in ammonium. The duration canvary over a wide range depending upon the type of reactor, thebiocatalyst and the concentration of the microorganism population in thebioreactor. In many instances, the duration of the contact may be lessthan 12, preferably less than 8, hours to achieve a reduction inammonium concentration to less than about 1 milligram per liter, andsometimes, the contact is less than one hour. A significant advantage ofthe processes of this invention is that not only is ammonium convertedto nitrogen, the treated water contains little, if any, nitrate ornitrite anion.

Example 218

A continuously stirred, aerated tank bioreactor is filled to about 70percent of its height with a biocatalyst substantially as described inexample 92 but using microorganisms derived from activated sludgeacclimatized as set forth above and at a wet cell density of about 350to 400 grams per liter. The biocatalyst is in the form of spheres havingdiameters of about 4 millimeters. The effluent from a primary treatmentat the municipal wastewater plant at Union City, Calif., is used as thefeed to the bioreactor. A series of batch runs are conducted in thebioreactor, each using the effluent with different ammonium cationconcentrations: 100, 200 and 1000 milligrams of ammonium cation perliter. The ammonium cation concentrations are adjusted by the additionof ammonium hydroxide. The pH is adjusted to about 7 at the beginning ofeach run. Each run is conducted until the ammonium cation concentrationis below about 0.1 milligram per liter. At the conclusion of each run,the wastewater is analyzed for nitrite and nitrate anion. The totalnitrogen in the wastewater is below about 1 milligram per liter.

v. Nitrate and Perchlorate Removal from Water

The biocatalysts of this invention can be used to remove nitrate andremove perchlorate anion, and both when present together, from water.Nitrates are a contaminant in water, and the United States EnvironmentalProtection Agency has set a limit of 10 milligrams of nitrate (based onthe mass of nitrogen) in potable water. Perchlorate anion contaminationof a number of sources of ground water and surface water has occurred.The concentration of perchlorate anion in these contaminated waters canvary widely. One health concern that arises due to the presence ofperchlorate is its interference with the thyroid gland's ability toproduce hormones which in turn can cause metabolism, growth anddevelopment problems. Due to concerns about the adverse effects ofperchlorate, reduction of perchlorate levels to concentrations in thevery low micrograms per liter are sought to be achieved. Often, waterthat is contaminated with perchlorate anion contains nitrate anion. Thepresence of nitrate in water contaminated with perchlorate poseschallenges to a metabolic process in that not only is nitratepreferentially reduced, but also the concentration of perchlorate has tobe reduced to very low levels.

In the broad aspects, the processes for reducing the concentration ofnitrate anion or perchlorate anion or both when present in watercomprises contacting the water with a biocatalyst of this inventioncontaining a strain of microorganism capable of reducing said anionsunder metabolic conditions and for a time sufficient to bioconvert suchanion. Nitrate and perchlorate-reducing microorganisms, especiallybacteria, are readily obtainable from the environment and some priorworkers have described self-inoculation systems for the biodegradationof these anions. See, for instance, U.S. Published Patent ApplicationNo. 2010/0089825. Representative of species of bacteria that areavailable in nature, especially creek and waste water, include Vibriodechloraticans, Cuznesove B-1168, Wolinella succinogenes, Acinetobacterthermotoleranticus, Ideonella dechloratas, Ralstonia eutrophia, andGR-1, a strain identified to belong to the β subgroup of Proteobacteria.See, for instance, Coates, et al, Nature Rev. Microbiol., 2, pages569-80 (2004), and Applied Environmental Microbiol., 65, pages 5234-41(1999); and Wu, et al, Bioremediation Journal, 5, pages 119-30 (2001)for discussions of microorganisms capable of perchlorate respiration. Itis understood that microorganisms used may be wild strains or may begenetically-modified recombinant microorganisms.

The concentration of nitrate in the water can vary widely depending uponsource, and is often in the range of about 0.5, say, 1, to 100 or moremilligrams per liter. In mining operations and aquaculture, wastewatercan often contain 500 or more milligrams of nitrate per liter, andreduction of such high concentrations of nitrate anion to suitablelevels for discharge has heretofore been problematic. The concentrationof perchlorate in the water can vary widely depending upon source. Insome reported instances, perchlorate concentrations greater than 10milligrams per liter have been observed. However, in view of theconcerns raised by perchlorate contamination, it may be desired to treatwater that contains very low concentrations of perchlorate, e.g., as lowas about 10 micrograms per liter. The water to be treated may containother components including, but not limited to, sulfur compounds,phosphorus compounds, inorganic salts and solubilized metals. Often, theoxygen concentration in the water to be treated is in the range of fromabout 0.5 to 10 or more milligrams per liter.

The biocatalyst may contain any suitable microorganism. Thebiodegradation processes may be conducted in any suitable manner. Theprocesses may be on a continuous, semi-continuous or batch mode ofoperation using suitable bioreactors including Typical BioreactorSystems.

Suitable metabolic conditions are maintained such as Typical MesophilicConditions. The pH of the water to be treated will depend upon itssource. In general, the pH is maintained between about 4 and 8.5, forinstance, between 4 and 8.0. Lower pH tends to enhance the degradationof perchlorate anion.

If needed, electron donors can be added to the water to be treated.Electron donors include, but are not limited to, hydrogen,carbohydrates, hydrocarbons, alkanols, aldehydes, carboxylic acids,ketones, aldehydes, glycerides and the like. See, for instance,paragraph 0055 of U.S. Published Patent Application No. 2006/0263869. Ifelectron donors are required, they may be added in any suitable manner.The addition of electron donors is typically based upon achieving thesought reduction in perchlorate rather than total electron acceptor inthe water to be treated. Accordingly, where electron donor has to beprovided, the processes of this invention require less electron donorthan those where oxygen is preferentially consumed prior to anysignificant biodegradation of perchlorate anion.

The duration of the contact of the water and polymeric matrices is for atime sufficient to obtain the sought reduction in nitrate andperchlorate anion. The duration can vary over a wide range. As statedabove, even though the concentration of perchlorate anion may be verylow, e.g., less than 100 micrograms per liter, and oxygen is present,the duration of the contact may be relatively brief, even to achieve atreated water containing less than 5 micrograms of perchlorate perliter. In many instances, the duration of the contact may be less thanseveral hours to achieve a reduction in perchlorate anion concentrationof less than about 5 micrograms per liter, and sometimes, the contact isless than one hour, and often less than about 30, even less than about5, minutes.

The treated water can contain oxygen as the use of the biocatalyst doesnot necessitate that oxygen be consumed prior to the biodegradation ofperchlorate anion. In most instances, the oxygen concentration of thetreated water is at least about 0.1, preferably at least about 0.5, andmost preferably at least about 10 or even 50, milligrams per liter.Whether or not the dissolved oxygen concentration in the treated wateris sufficiently high to be discharged without aeration will in partdepend upon the oxygen concentration in the water to be treated.Filtration may be desired to remove any solids from, e.g., exogenousmicroorganisms that may be introduced with the water to be treated.

Example 219

An aqueous solution is prepared that contains perchlorate anion in anamount of 500 micrograms and nitrate anion (calculated as nitrogen) inan amount of 10 milligrams per liter of distilled water. Oxygen isremoved to below 0.5 milligram per liter by sparging the aqueoussolution with nitrogen. The volume of the aqueous solution is reduced byabout 20 volume percent and contains 410 micrograms of perchlorate anionand 15 milligrams of nitrate anion per liter of aqueous solution. Sodiumacetate is then added in an amount of 0.6 parts by mass of sodiumacetate per part by mass of total perchlorate and nitrate anion in theaqueous solution. The pH of the aqueous solution is adjusted to about 7.

The aqueous solution is then added to a glass flask containingbiocatalysts of Example 31 in an amount sufficient to immerse thebiocatalyst. The aqueous solution and biocatalyst is maintained at roomtemperature, about 25° C. After 24 hours, the perchlorate concentrationof is about 80 micrograms per liter of solution and the nitrateconcentration is about 790 micrograms per liter of solution.

Example 220

An aqueous solution containing 128 milligrams of nitrate anion, 12milligrams of nitrite anion, and about 9 milligrams of molecular oxygenper liter of water is continuously fed to an up-flow bioreactor at arate that provides a hydraulic residence time of 25 minutes. The up-flowreactor contains the biocatalyst as substantially set forth in Example52. The treated water from the bioreactor contains less than about 1.3milligrams of nitrate anion and less than 0.01 milligrams of nitriteanion per liter of water.

Example 221

An aqueous solution containing about 12 to 15 milligrams of nitrateanion and about 0.4 milligrams of perchlorate anion and about 4milligrams of molecular oxygen per liter of water is continuously fed toan up-flow bioreactor at a rate that provides a hydraulic residence timeof 25 minutes. The up-flow bioreactor contains about 70 percent of itvolume with biocatalyst substantially as described in Example 52. Thebiocatalyst contains Paracoccus denitrificans. The pH of the water beingpassed to the bioreactor is adjusted to about 7, and sodium acetate isadded to the water as carbon source. The nitrate concentration of theeffluent from the bioreactor is less than about 1 milligram per literand perchlorate anion less than about 4 micrograms per liter.

Example 222

An aqueous solution containing between about 600 and 800 milligrams ofnitrate anion per liter is continuously fed to two up-flow bioreactorsin series. Each up-flow reactor is the same size, and each contains thebiocatalyst as substantially set forth in Example 52. The hydraulicresidence time is varied between 25 minutes and 30 minutes based uponthe volume of both bioreactors. The treated water from the secondbioreactor contains less than 10 parts per million nitrate anion andless than 1 part per million nitrite anion.

vi. Metals Removal

Soluble metal and semi-metal compounds can be found as contaminants invarious water sources. These contaminants may be naturally occurring orcan be the result of human activities such as manufacturing, mining,metal-refining, waste disposal, and the like. Some of these compoundspose health hazards and can adversely affect the environment.

The biocatalysts of this invention are beneficially useful for treatingwater containing at least one soluble compound of metal or semi-metalsince the interior of the biocatalyst provides microenvironments thatfavor redox conditions for effecting the reduction of the metal orsemi-metal to form a solid. These processes comprise:

-   (a) continuously introducing said water into a reaction zone    containing biocatalyst of this invention;-   (b) contacting the water with said biocatalyst which contains    microorganism capable of reducing said soluble compound for a time    sufficient to reduce the concentration of said at least one soluble    compound in the water;-   (c) maintaining said biocatalyst under metabolic conditions    sufficient to metabolically reduce the oxidation state of the metal    or semi-metal to form elemental metal or semi-metal or precipitated    compound thereof; and-   (d) withdrawing water having a reduced concentration of said at    least one soluble compound from the bioreaction zone.

Frequently, the metal or semi-metal of the soluble compound comprises atleast one of sulfur, phosphorus, selenium, tungsten, molybdenum,bismuth, strontium, cadmium, chromium, titanium, nickel, iron, zinc,copper, arsenic, vanadium, uranium, radium, manganese, germanium,indium, antimony mercury, and rare earth metals. The soluble compoundwill depend upon the particular metal or semi-metal, and may be anhydroxide, carbonate, nitrate, carboxylate (e.g., formate, acetate, orpropionate); or an oxyanion of the metal or semi-metal that is solublein water.

The metabolic conditions include the presence of a carbon source whichis metabolized by the microorganisms in the biocatalyst. The metabolismof carbon source is believed to provide a gradient within the interiorof the biocatalyst to enhance the activity of a portion of themicroorganisms for the metabolic reduction of metals and semi-metals.Hence, the metabolic reduction can occur even where the water beingtreated contains oxygen. The metabolic reduction may provide anelemental material or a precipitated compound. The precipitated compoundhas the metal or semi-metal in a reduced oxidation state, and theprecipitated compound may be one or more of oxides, carbonates, sulfidesand hydroxides. The specific nature of the precipitated compound willdepend upon the metal or semi-metal of which it is composed to providethe insolubility properties.

In some instances, the metabolic reduction of the metal or semi-metalmay lag the accumulation of the soluble compound by the porous matricesand the microorganisms. In such situations, the bioreaction zone may besized to permit a steady-state operation, or porous matrices may becycled between a bioreaction zone to which the water to be treated ispassed and bioreaction zone that is maintained under metabolicconditions where additional metabolic reduction occurs.

The metabolic processes may be conducted in any suitable mannerincluding Typical Mesophilic Conditions and using Typical BioreactorSystems. Carbon source nutrient may be required and may be anyconvenient carbon source such as a low molecular weight hydrocarbon oroxygenated hydrocarbon such as ethanol, acetate, and sugars.

The interior of the biocatalyst provides a plethora of microenvironmentsfor microorganisms, and these microenvironments can vary within thebiocatalyst. Thus, some microenvironments may change the composition ofthe water such that other microenvironments may be under conditions morefavorable for the metabolic reduction. For instance, where the watercontains oxygen, the microorganisms may metabolize the oxygen andprovide an oxygen-depleted water that passes to other microenvironmentswhere conditions favor metabolic reduction. Hence, the biocatalystserves to provide a self-modulation of the metabolic reduction. In someembodiments of this invention, external modulation of the metabolicreduction conditions can be effected by the rate of supply of electrondonor. In general, the more electron donor, the more acidic the pHwithin the biocatalyst. Since the modulation is within the interior ofeach biocatalyst structure, the biocatalytic activities of thebiocatalysts in a reaction zone can be relatively uniform.

Often at least a portion of the solid metabolic product remains in thecell or otherwise in the biocatalyst. In other instances, the metabolicproduct is removable from the biocatalyst. If desired, the water fromthe bioreactor may be subjected to a solids removal unit operation suchas ultrafiltration, settling, centrifugation, and the like. As describedabove, with some systems, it is possible to regenerate the porousmatrices. Alternatively the biocatalyst can provide a concentratedsource of the metal or semi-metal for disposal or recovery.

Representative reducing microorganisms include, but are not limited to,those of genera Saccharomyces; sulfur-reducing bacteria including generaProteus, Campylobacter, Pseudomonas, Salmonella, Desulfuromonas,Desulfovibrio, Desulfonema; phosphorus reducing bacteria includinggenera Acinetobacter, Phormidium, Rhodobacter, and Staphylococcus;uranium reducing bacteria including Desulfovibrio, Deinococcus,Geobacter, Cellulomonas, Shewanella, and Pseudomonas; molybdate reducingorganisms including genera Serratia, Enterobacter, and Escherichia;cadmium reducing bacteria including genera Pseudomonas and Klebsiella.

Some preferred microorganisms for specific types of soluble compoundsare as follows. selenate-reducing bacteria including Enterobactercloacae, Planomicrobium mcmeekinii, Psuedomonas alcaligenes, Psuedomonasdenitrificans, Psueomonas stutzeri, and Roseomonas genomospecies; otherselenium-reducing microorganisms including those disclosed in U.S. Pat.No. 7,815,801, herein incorporated by reference in its entirety;chromate-reducing organisms including Enterobacter cloacae,Desulfovibrio vulgaris, Geobacter sulfurreducens, Psuedomonaschromatophilia, Psuedomonas fluorescens, and Swanella alga; ferric ionreducing microorganisms including those from the genera Ferribacterium,Geobacter, and Geothrix; and arsenate reducing bacteria including thosefrom the genera Geobacter, Corynebacterium, Pseudomonas, Shewanella, andHydrogenophaga.

vii. Taste and Odor Removal from Water

Algal metabolites in sources of drinking water can result in acharacteristic bad flavor and unpleasant odor. It is believed that theflavor and unpleasant odor is due to the presence of 2-methylisoboreal(MIB) and trans-1,10-dimethyl-trans-decalol (geosmin). Humans can detectlevels of MIB as low as 5 to 10 parts per trillion. Geosmin is similarlydetected at very low levels. Other possibilities for objectionabledrinking water are halogenated organic substances, such astrihalomethanes, which are derived from a combination of chlorine andbromine with organic halogenated components of the water. Disinfectionbyproducts such as halogenated organic compounds may also be present,often at higher concentrations. The removal of these halogenated organiccompounds is desirable for organoleptic and public health reasons. Theremoval of the algal metabolites and halogenated components fromdrinking water is particularly problematic due to the low concentrationsto which these impurities must be lowered.

The biocatalysts of this invention are able to treat water containingultra-low concentrations of contaminants including these algalmetabolites and halogenated organic compounds, and reduce theirconcentrations to acceptable levels. Significantly, due to the phenotypealterations of the microorganisms in the biocatalyst, a stable, highpopulation of microorganisms can exist within the without the need forexcessive electron donor to support the microorganism population. Theprocesses for using the biocatalysts of this invention for reducing theconcentration of ultra-low contaminants in a water stream comprise:

-   -   a. continuously passing said water stream to a bioreactor, said        bioreactor being maintained at metabolic conditions including        the presence of the biocatalyst, said biocatalyst having        microorganisms capable of bioconversion of said ultra-low        contaminants irreversibly retained therein;    -   b. contacting said water stream with said biocatalyst for a time        sufficient to reduce the concentration of said ultra-low        contaminants; and    -   c. withdrawing from said bioreactor a treated water stream        having a reduced concentration of said ultra-low contaminants.

Preferably, each of the ultra-low contaminants is present in aconcentration in the water stream the passed to the bioreactor in anamount of at least about 40, say at least about 50, nanograms per liter(ng/L) and less than about 50, often less than about 20, micrograms perliter (mcg/L). The ultra-low contaminants preferably comprise algalmetabolites such as MIB and geosmin. The contaminants may also includehalogenated organic compounds such as disinfection byproducts such astrihalomethanes (THM) and halo-acetic acid (HAA) each of which may bepresent in amounts of 1 to 1000 micrograms per liter. After treatment,the concentration of the ultra-low contaminants in the treated water istypically below about 40, preferably below about 20, and sometimes belowabout 10, nanograms per liter. Frequently, the halogenated organiccompounds in the treated water are at concentrations of less than about70, preferably less than 50, micrograms per liter.

The processes of this invention are suitable for use with anymicroorganism capable of low concentration bioconversions. The preferredmicroorganisms are from the genus Rhodococcus. The genus Rhodococcus isa very diverse group of bacteria that possesses the ability to degrade alarge number of organic compounds. They have a capacity to acquire aremarkable range of diverse catabolic genes and have robust cellularphysiology. Rhodococcus appear to have adopted a strategy ofhyperrecombination associated with a large genome. Notably, they harborlarge linear plasmids that contribute to their catabolic diversity byacting as ‘mass storage’ for a large number of catabolic genes.

In many instances the metabolic conditions do not require the additionof electron donor in order to maintain the metabolic activity of theporous matrices as the ultra-low contaminants and other contaminants inthe water are sufficient to provide the needed electron donor. Whereelectron donor is desired to be added, it is preferably in aconcentration that will be essentially completely metabolized by thebiocatalyst, i.e., the electron donor will be provided in an amountinsufficient to maintain the population of the microorganisms in thebioreactor.

In some instances the average hydraulic residence time of the waterbeing treated in the bioreactor is less than about 5, preferably lessthan about 2, hours, and may be in the range of between about 10 and 50minutes. Often the biocatalyst can retain metabolic activity for atleast about 50, say, at least about 250, days. It is possible that themicroorganisms can be maintained for decades or more. The preferredbiocatalysts can maintain desired metabolic activity (e.g., within about3 to 5 days of restart) after extended periods of shutdown, say, betweenabout 100 and 500 days.

The metabolic processes may be conducted in any suitable manner and maybe under Typical Mesophilic Conditions using Typical Bioreactor Systems.The process may be on a continuous, semi-continuous or batch mode ofoperation, but is preferably continuous. The oxygenation is preferablyat least about 1, more preferably at least about 2, and sometimesbetween about 2 and 10 or more, milligrams of free oxygen per liter. Ifneeded, electron donors can be added to the water to be treated.Electron donors include, but are not limited to, hydrogen,carbohydrates, hydrocarbons, alkanols, aldehydes, carboxylic acids,ketones, aldehydes, glycerides and the like. See, for instance,paragraph 0055 of U.S. Published Patent Application No. 2006/0263869. Ifelectron donors are required, they may be added in any suitable manner.Usually the amount added is sufficient to provide the soughtbiodegradation.

The degradation products may be removed from the water in any suitablemanner including using Typical Separation Techniques.

Example 223

A 4 liter capacity continuously stirred tank bioreactor is filled toabout 30 percent of its volume with biocatalyst substantially asdescribed in Example 72. A water feed stream is continuously passed tothe bioreactor at room temperature (22° C.) at a rate sufficient toprovide an approximate hydraulic residence time of about 30 minutes. Thewater is from a fresh water reservoir which has not been treated. MIBand geosmin are each provided in an amount of about 400 nanograms perliter (adding MIB and geosmin where required to approximate the targetconcentration levels). The fresh water does contain algal metabolites ascan be detected by odor and taste. The water has a pH of about 7 and atleast 4 parts per million by mass of dissolved oxygen per liter. Theconcentration of MIB is reduced to less than 5 nanograms per liter andgeosmin to less than about 20 nanograms per liter. The treated waterfrom the reactor has no detectible odor or taste.

The reactor is shut down for about 6 months (no water flow through thereactor) and maintained at room temperature. Upon restart by passing asimilar water stream through the bioreactor under substantially the sameconditions, within one day, the water discharged from the reactor doesnot have a detectible odor or taste.

viii. 1,4-Dioxane Removal from Water

Animal studies have shown that inhalation and ingestion of 1,4-dioxanecan lead to the formation of nasal cavity and liver carcinomas alongwith neurotoxic effects. 1,4-Dioxane has come into water resourcesprimarily from use as a solvent stabilizer for solvents used in variouscleaning and degreasing applications, especially chlorinated solvents,such as trichloroethane (TCA) and trichloroethylene (TCE). 1,4-Dioxaneis also detected in consumer products, such as shampoos, soaps, waxesand lotions, as a result of contamination of ethoxylated compounds, suchas sodium laureth sulfate. States such as California, Massachusetts,Florida and North Carolina have set drinking water standards for1,4-dioxane at low parts per billion (ppb) levels.

Biodegradation of 1,4-dioxane is problematic. The presence ofchlorinated solvents has an inhibitory effect on microorganismsidentified to degrade 1,4-dioxane; inducing compounds such as propane ortetrahydrofuran (THF) are required for many microorganisms to degrade1,4-dioxane, but are themselves contaminants; and microorganisms that donot require inducing compounds tend to be less robust and slow growing.

The biocatalyst of this invention are particularly attractive for use inprocesses to reduce the concentration of 1,4-dioxane in a water stream.In some instances the use of an inducing compound is not required eventhough the water contains both 1,4-dioxane and a halogenated compound.These processes comprise:

-   a. continuously passing said water stream to a bioreactor, said    bioreactor being maintained at metabolic conditions including    aerobic conditions and the presence of biocatalyst of this invention    containing microorganisms adapted to degrade 1,4-dioxane    metabolically;-   b. contacting said water stream with said biocatalyst for a time    sufficient to reduce the concentration of said 1,4-dioxane in the    water stream; and-   c. withdrawing from said bioreactor a treated water stream having a    reduced concentration of 1,4-dioxane.

The preferred microorganisms used in the biocatalyst are from theRhodococci genus, Pseudonocardia dioxanivorans, and Pseudonocardiabenzenivorans. Preferred processes include those where 1,4-dioxane ispresent in the water stream in an amount less than about 100 microgramsper liter and the treated water stream has a concentration of1,4-dioxane of less than about 10 micrograms per liter. In someinstances, 1,4-dioxane is present in the water stream in an amountgreater than about 10 micrograms per liter and the treated water streamhas a concentration of 1,4-dioxane of less than about 5 micrograms perliter.

In many instances, no additional carbon source is required to maintainthe population of the microorganisms in the biocatalyst due to themicroenvironment and phenotypic alterations. However, at lowconcentrations of 1,4-dioxane in the water to be treated, the additionof minor amounts of carbon source may be advantageous to support theenergetic robustness of the population. Nevertheless, the metabolicactivity of the biocatalysts can be sufficient to assure thatsubstantially no biodegradable carbon is contained in the treated water.

The metabolic processes may be conducted in any suitable mannerincluding Typical Mesophilic Conditions and using Typical BioreactorSystems. The process may be on a continuous, semi-continuous or batchmode of operation, but is preferably continuous. The oxygenation ispreferably at least about 1, more preferably at least about 2, andsometimes between about 2 and 10 or more, milligrams of free oxygen perliter. If needed, electron donors can be added to the water to betreated. Electron donors include, but are not limited to, hydrogen,carbohydrates, hydrocarbons, alkanols, aldehydes, carboxylic acids,ketones, aldehydes, glycerides and the like. Acetone or glucose is aconvenient electron donor. See, for instance, paragraph 0055 of U.S.Published Patent Application No. 2006/0263869. If electron donors arerequired, they may be added in any suitable manner.

The degradation products may be removed from the water in any suitablemanner including using Typical Separation Techniques.

Example 224

A 4 liter, airlift, downflow bioreactor with a perforated plate equippedwith diffusers to provide uniform aeration of the bioreactor is loadedwith 3000 grams of the biocatalyst of example 48. An air pump providesair to the bioreactor below the perforated plate in an amount sufficientto maintain the biocatalyst suspended. Water to be treated iscontinuously added to the liquid phase above the perforated plate usinga variable-speed pump.

The water to be treated is deionized water to which components areadded. Acetone, ammonium chloride and dipotassium biphosphate are addedas necessary to maintain an atomic ratio of carbon:nitrogen:phosphorusin the water of 100:3:1. The atomic carbon is calculated as the totalcarbon in the components added to the water. The dissolved oxygen in thebioreactor is between about 5 and 7 milligrams per liter (as determinedby an Oakton DO6 Acorn Series meter and probe). The bioreactor isoperated at room temperature (about 21° to 25° C.) and an averagehydraulic residence time of 5 hours, and a pH of between about 7 and 8is maintained in the bioreactor.

The water is first spiked with about 71,000 micrograms per liter of1,4-dioxane. After completion with that run, the water is spiked with100 micrograms per liter of 1,4-dioxane and 50 micrograms of acetone perliter. The concentration of 1,4-dioxane in the efflux is determined bygas chromatography and is in both instances is below the non-detectlimit of the gas chromatograph of about 2 micrograms per liter.

Additionally, unfiltered effluent from the bioreactor is plated on agarplates (LBB+glucose). After a 5-day incubation, colonies (if any) werecounted. Substantially no colonies are observed indicating that themicroorganisms are substantially irreversibly retained in thebiocatalyst.

The results are indicative that the biocatalysts require very littleinduction time before effective removal of 1,4-dioxane occurs and thatthe 1,4-dioxane concentration can be reduced to non-detect levels atboth higher and lower initial concentrations.

ix. Succinic Acid

The biocatalysts of this invention can be used to convert sugars tosuccinic acid. In the broad aspects, the processes for the bioconversionof sugar and optionally carbon dioxide using a biocatalyst containingsuccinic acid-producing microorganism comprise:

-   a. contacting an aqueous medium with said biocatalyst under    metabolic conditions including temperature and the presence of sugar    and other nutrients for the microorganism for a time sufficient to    produce succinate anion and provide a succinate anion-containing    aqueous medium;-   b. removing at least a portion of said succinate anion-containing    aqueous medium and said biocatalyst;-   c. reusing in step (a) said biocatalyst from which at least a    portion of said succinate anion-containing aqueous medium has been    removed; and-   d. recovering succinate anion from said succinate anion-containing    aqueous medium.

Examples of succinic anion-producing microorganisms heretofore disclosedinclude, but are not limited to, natural or genetically modifiedmicroorganisms such as Mannheimia succiniciproducens, Anaerobiospirillumsucciniciproducens, Actinobacillus succinogenes, Alcaligenes eutrophus,Aspergillus niger, Bacillus, Bacteroides fragilis, Bacteroidesruminicola, Bacteroides amylophilus, Brevibacterium ammoniagenes,Brevibacterium lactofermentum, Candida brumtii, Candida catenulate,Candida mycoderma, Candida zeylanoides, Candida paludigena, Candidsonorensis, Candida utilis, Candida zeylanoides, Citrobactor freundii,Corynebacterium glutamicum, Debaryomeces hansenii, Enterococcusfaecalis, Escherichia coli (E. coli strains SB550 MG pHL 413, KJ122 andTG400), Fibrobacter succinogenes, Fusarium oxysporum, Gluconobacteroxydans, Glyconobacter asaii, Humical lanuginosa, Kloeckera apiculata,Kluyveromyces lactic, Kluyveromyces wickerhamii, Paecilomcyes varioti,Penicillum simplicissimum, Pichia anomala, Pichia besseyi, Pichia media,Picha guiliermondii, Pichia inositovora, Pichia stipidis, Rhizobium,Saccharomyces cerevisiae, Saccharomyces bayanus, Schizosaccharommyces,Schizosaccharomyces pombe, Torulopsos candida, Veillonella parvula,Wollinella succinogenes and Yarrowia lipolytica.

The metabolic processes may be conducted in any suitable manner. Thesubstrate comprises carbohydrate, including C₅ and C₆ sugars, and mayinclude carbon dioxide. Due to the use of the biocatalyst, sugars lesspreferred for bioconversion may be effectively used by themicroorganisms. The concentration of sugars used in the aqueous mediummay fall within a wide range. Generally, sugars are present in aconcentration in the aqueous medium of at least about 0.5, say, betweenabout 1 and 200, grams per liter. Preferably, the amount of sugarprovided in the aqueous medium is such that at least about 90, morepreferably, at least about 95, mass percent is consumed during themetabolic process.

The carbon dioxide may be obtained from any suitable source; however,components that are unduly deleterious to the microorganisms should beremoved prior to contact with the aqueous medium containing thebiocatalyst. Generally carbon dioxide is supplied in gaseous form,although carbonate and bicarbonate salts can be used. Where supplied asa gas, the carbon dioxide concentration in the gas is typically therange of about 40 to 100, say, 70 to 100, volume percent. Sources ofcarbon dioxide include, but are not limited to, off gases fromindustrial and fermentation processes, exhaust gases from combustion offuels and waste materials, natural gas streams containing carbondioxide, streams from the gasification of biomass, e.g., to producesyngas, and the like.

The aqueous medium contains water which may be provided from anysuitable source including, but not limited to, water, demineralizedwater, distilled water, and process or waste water streams. Any suitablemetabolic conditions can be used including Typical MesophilicConditions. Where gaseous substrates are used, higher pressures tend toincrease the amount of substrate dissolved in the culture liquid andthus enhance mass transfer. Often the pH is between about 3 and 8.5,say, 3.5 to 7. The metabolic conditions for the bioconversion of sugarsand carbon dioxide to succinate anion are typically anaerobic, andpreferably, the aqueous medium has a dissolved molecular oxygenconcentration of less than about 0.5 milligrams per liter. Where thebiocatalyst is cycled to different aqueous media, and one of the aqueousmedia is intended to provide metabolic activities to enhance theviability of the microorganisms, the dissolved molecular oxygenconcentration may be in excess of about 2, say, about 2 to 10,milligrams per liter.

The duration of contact between the aqueous medium and biocatalyst canalso fall within a wide range and will depend, in part, upon theconcentration of substrate, the concentration of succinate anion soughtin the aqueous medium, the type of bioreactor, the other metabolicconditions used, the nature of the microorganism used, and the type ofmicroorganism and cell density in the biocatalyst. For batch operations,the contact is often in the range of about 5 minutes to 100 hours, say,about 1 to 50, hours, and in continuous operations, the liquid hourlyspace velocity is typically in the range of about 0.01 to 50 hr⁻¹.

The bioconversion may be on a continuous, semi-continuous or batch modeof operation. Any suitable bioreactor design may be used includingTypical Bioreactor Systems.

In preferred aspects, the biocatalyst is subjected to two or moreaqueous environments to enhance the bioconversion of sugars, reduce thepresence of non-consumed sugars in the succinic acid-containingfermentation product, and enhance the use of carbon dioxide as aco-substrate.

In one embodiment of the preferred processes, the contacting of theaqueous medium with the biocatalyst occurs in at least two reactionzones having different metabolic conditions. In one aspect of thisembodiment, aqueous medium from a first reaction zone containing thebiocatalyst is passed to a subsequent reaction zone for further contactwith biocatalyst. Substantially no additional sugar is added to theaqueous medium either immediately prior to passing to the subsequentreaction zone or during its residence time in the subsequent reactionzone. Thus, the sugar concentration in the aqueous medium is furtherdepleted in the subsequent reaction zone, preferably to less than about1, say, less than about 0.5, mass percent based upon the mass ofsuccinate anion in the aqueous medium. Preferably, the first reactionzone and the subsequent reaction zone are cycled. In some instances, itmay be desired to supply carbon dioxide substrate to the aqueous mediumin the subsequent reaction zone to convert additionalphosphoenolpyruvate in the microorganisms to succinate anion.

In another aspect of this preferred embodiment, a reaction zonecontaining the biocatalyst is cycled between using an aqueous sugarsubstrate and an aqueous or gaseous carbon dioxide substrate. Forinstance, sugar is provided in a first aqueous medium contacting theporous matrices in a the first reaction zone, which may be underconditions sufficient to generate phosphoenolpyruvate in themicroorganisms under conditions not favoring conversion of thephosphoenolpyruvate to succinate anion which conditions may comprisemicro-aerobic or aerobic conditions. The first aqueous medium iswithdrawn. A second aqueous medium or gas is introduced into the firstreaction zone under anaerobic conditions, including the presence ofcarbon dioxide, sufficient to bioconvert phosphoenolpyruvate tosuccinate anion. As the biocatalyst provides environments retainingnutrients for the microorganisms in the metabolic activity of themicroorganisms in the second zone can be maintained. Preferably thesecond zone uses an aqueous medium that is substantially water such thatsuccinate anion product passing into the second aqueous medium can moreeasily be recovered. Most preferably, the concentration of the succinateanion in the second aqueous medium is at least about 150, say, at leastabout 200 to as much as 300 or 400, grams per liter of aqueous medium.The second aqueous medium containing succinate anion is removed from thefirst reaction zone for recovery of the succinate anion. In someinstances, succinic acid of high purity can be obtained by reducing thetemperature of the aqueous medium sufficient to crystallize a succinicacid. After removal of the second aqueous medium, the first reactionzone can be contacted with a first aqueous medium. In some instances, athird or even further stages can be used. For example, after the removalof the second aqueous medium the first reaction zone can be contactedwith a first aqueous medium from it or another reaction zone andmaintained under conditions to reduce metabolites in the aqueous mediumand generate more phosphoenolpyruvate. If desired, multiple reactionzones can be used in order to provide a semi-continuous process.

The succinic acid product may be recovered from the aqueous medium inany suitable manner. Various methods for recovery of succinic acidinclude precipitation, and membrane separations, sorption and ionexchange, electro dialysis, and liquid-liquid extraction. See, forinstance, Davidson, et al., Succinic Acid Adsorption from FermentationBroth and Regeneration, Applied Biochemistry and Biotechnology, Spring2004, pages 653-669, for a discussion of sorbents for succinic acidrecovery from fermentation broths. See also, Li, et al., Separation ofSuccinic Acid from Fermentation Broth Using Weak Alkaline Anion ExchangeAdsorbents, Ind. Eng. Chem. Res., 2009, 48, pages 3595-3599. See, forinstance, a multiple crystallization method for recovery of succinicacid disclosed in U.S. Patent Application Publication No. 2011/0297527.Hepburn, in his Masters thesis at the Queen's University, The Synthesisof Succinic Acid and its Extraction from Fermentation Broth Using aTwo-Phase Partitioning Bioreactor (April 2011), discloses a processwhere such cynic acid is produced to inhibitory levels, and then the pHof the system was suggested below the pK_(A2) of succinic acid usingdissolved carbon dioxide gas to create undissociated product. Polymerswith an affinity for succinic acid absorbed from the solution, and thenthe pH was returned to operational levels.

A general understanding of this process may be facilitated by referenceto the FIGS. 10 and 11. With reference to FIG. 10, apparatus 1000 issuitable for the biological production of succinic acid on a continuousbasis. Apparatus 1000 is depicted as having a primary bioreactor 1002and a polishing bioreactor 1004. Both bioreactors are fluidized bedreactors containing biocatalyst, e.g., substantially s described inExample 175. An aqueous stream containing sugar and other nutrients issupplied by line 1006 to bioreactor 1002. Carbon dioxide-containing gasis supplied to the apparatus 1000 via line 1008. A portion of the carbondioxide-containing gas is passed by line 1010 to line 1006 intobioreactor 1002. Bioreactor 1002 is maintained under metabolicconditions sufficient for conversion of sugar and carbon dioxide tosuccinate anion. Off gases are removed from bioreactor 1002 by line1012. A continuous stream of the aqueous medium in bioreactor 1002 iswithdrawn by line 1014 and passed to a bioreactor 1004. Bioreactor 1002is provided with a screen or other device to essentially preventbiocatalyst passing into line 1014. To bioreactor 1004 is providedcarbon dioxide-containing gas from line 1008 and line 1016.

In a typical operation of apparatus 1000, the aqueous medium withdrawnfrom bioreactor 1002 via line 1014 contains unreacted sugars andmetabolites that can be further bioconverted by the microorganisms.Bioreactor 1004 is operated to further reduce the concentration of theunreacted sugars and these metabolites and thus no additional sugarsubstrate is provided to a bioreactor 1004 in such an operation. Itshould be readily understood that if desired, additional sugar substratecould be added to the aqueous medium in bioreactor 1004.

Bioreactor 1004 is operated under metabolic conditions sufficient toconvert substrate to succinate anion. Unreacted gases are withdrawn frombioreactor 1004 through line 1018. A continuous stream of aqueous mediumfrom bioreactor 1004 is withdrawn via line 1020. Bioreactor 1004 isprovided with a screen or other device to essentially preventbiocatalyst from being passed into line 1020. The withdrawn aqueousmedium is directed to filtration assembly 1022 by line 1020. As theaqueous medium is substantially devoid of solids, it is practical forfiltration assembly 1022 to be an ultrafiltration assembly. The aqueousmedium is then passed from filtration assembly 1022 via line 1024 todistillation column assembly 1026. In the event that bioreactors 1002and 1004 are operated substantially unbuffered, distillation columnassembly 1026 serves to concentrate the aqueous medium to facilitatecrystallization of the succinic acid. Where an ammonium hydroxide bufferis used, distillation column assembly 1026 also serves to convertammonium salts of succinate anion to succinic acid with ammonia beingreleased. Distillation column assembly 1026 may comprise one or moreunit operations including neutralization and filtration of precipitates,intermediate crystallization and re-solvation such as disclosed in U.S.Patent Application Publication No. 2011/0297527, and the like.

As shown, the overhead from distillation column assembly 1026 exits vialine 1028. A purge can be taken via line 1030 and the remaining overheadrecycled to one or both of bioreactors 1002 and 1004 via lines 1034 and1032, respectively. Where ammonium hydroxide buffer is used, the recyclereduces the amount of ammonium hydroxide required to be externallyprovided. It is also possible to operate bioreactor 1004 at a lower pHthan that used in bioreactor 1002. Thus, in a buffered system, thepredominant portion of the succinate anion will be the mono salt.

The bottoms stream from distillation column 1026 is passed via line 1036to crystallization unit 1038. Typically, the concentration of succinicacid in the bottoms stream is greater than about 30%. The bottoms streampassing to the crystallization unit is often cooled to a temperaturebelow about 15° C., say, between about 0° and 10° C. Crystallinesuccinic acid is removed from crystallization unit 1038 via line 1040.The supernatant liquid is removed via line 1042.

FIG. 11 depicts an apparatus 1100 having three bioreactors 1102, 1104,and 1106 that are operated on a sequential, cyclic routine to bioconvertsugar and carbon dioxide to succinic acid. Each of the reactors containporous matrices having succinic acid-producing microorganismsirreversibly retained therein. The bioreactors have an internal liquidrecycle system to be operated as fluid bed reactors.

Apparatus 1100 is provided with four headers: header 1108 which providesfresh aqueous medium containing sugar and other nutrients; header 1110which provides carbon dioxide-containing gas; header 1112 which providesoxygen-containing gas and header 1114 which provides for fluid transportbetween the bioreactors. Line assemblies 1116, 1118, and 1120 connecteach of the four headers 1108, 1110, 1112, and 1114 with bioreactors1102, 1104, and 1106, respectively. Each of bioreactors 1102, 1104 and1106 are provided with lines 1122, 1124 and 1126, respectively, topermit the egress of gas and are provided with lines 1128, 1134 and1138, respectively, to drained aqueous medium from the bioreactors. Thedrained aqueous medium from a bioreactor is directed either to header1132 or header 1114. For bioreactor 1102 line 1128 is in flowcommunication with line 1130 which is adapted to direct the aqueousmedium to one of these headers. For bioreactor 1104 line 1134 is in flowcommunication with line 1136 which is adapted to direct the aqueousmedium to one of these headers. For bioreactor 1106 line 1138 is in flowcommunication with line 1140 which is adapted to direct the aqueousmedium to one of these headers.

Each of bioreactors 1102, 1104 and 1106 are sequenced between amicroaerobic stage, an anaerobic, sugar conversion stage, and a carbondioxide conversion stage. In the microaerobic stage, fresh aqueousmedium is supplied to a bioreactor that has completed the carbon dioxideconversion stage and has been drained of aqueous medium for purposes ofsuccinic acid recovery. In this regard, small amounts ofoxygen-containing gas, e.g., air, are provided from header 1112.

At the conclusion of the microaerobic stage, supply of oxygen-containinggas from header 1112 is ceased and the bioreactor enters the anaerobic,sugar conversion stage. The anaerobic, sugar conversion stage may beconducted with or without the addition of carbon dioxide from header1110. The anaerobic, sugar conversion stage is conducted under metabolicconditions suitable for the production of succinate anion. In someembodiments, the metabolic conditions during the microaerobic stage andthe anaerobic, sugar conversion stage enhance the formation ofphosphoenolpyruvate with relatively little succinate anion being passedfrom the porous matrices into the surrounding aqueous medium.

The reactor then passes from the anaerobic, sugar conversion stage tothe carbon dioxide conversion stage. In the carbon dioxide conversionstage carbon dioxide is supplied from header 1112 in an amountsufficient to enhance a portion of the succinate anion being derivedfrom carbon dioxide substrate through the conversion ofphosphoenolpyruvate. The bioreactor is maintained under metabolicconditions favoring the bioconversion of carbon dioxide substrate. Atthe conclusion of the carbon dioxide conversion stage, the aqueousmedium is drained from the bioreactor and is passed to header 1132 forsuccinic acid recovery. The reactor then cycles back to the microaerobicstage.

As with the apparatus depicted in FIG. 10, apparatus 1100 passes theaqueous medium withdrawn from the bioreactor having gone through thecarbon dioxide conversion stage to filtration assembly 1142 and then vialine 1144 to distillation assembly 1146. The overhead from distillationassembly 1146 exits via line 1148 for recycle to header 1108. A purge istaken via line 1150. The bottoms stream from distillation assembly 1146is passed via line 1152 to crystallization assembly 1154. Succinic acidis withdrawn via line 1156, and the supernatant liquid is removed vialine 1158.

Apparatus 1100 can also be operated using a different sequence ofstages. One such sequence uses water having a substantial absence ofsugars and other nutrients in the carbon dioxide conversion stage. Fordescription of this sequence, reference is made to header 1108 a whichsupplies such a water stream.

In the microaerobic stage, the aqueous medium is supplied by anotherbioreactor that has completed the anaerobic, sugar conversion stage. Atthe conclusion of the microaerobic stage the bioreactor enters into theanaerobic, sugar conversion stage as described above, but underconditions that minimize the accumulation of succinate anion in theaqueous medium. Sugar and other nutrients are provided to the bioreactorvia header 1108. The sugar and other nutrients are preferably dissolvedor slurry in an aqueous medium at a sufficient concentration to maintainthe sought amount of aqueous medium in the bioreactor as well assufficient concentrations of the sugars and other nutrients for themetabolic activity of the microorganisms.

At the completion of the anaerobic, sugar conversion stage, the aqueousmedium is withdrawn and passed to a bioreactor entering into themicro-aerobic stage. The aqueous medium is replaced with water having asubstantial absence of sugar and other nutrients. In the carbon dioxideconversion stage, sufficient carbon dioxide is provided to provide,under metabolic conditions, succinate anion. Succinic anion passes intothe water phase which will have reduced concentrations of sugars, othernutrients, and other metabolites as compared to the aqueous medium inthe anaerobic, sugar conversion stage. Thus, the ability to obtain highpurity succinic acid is facilitated. Moreover, by recycling the aqueousmedium from the bioreactor completing the anaerobic, sugar conversionstage to the microaerobic stage, certain metabolites such as acetateanion may be consumed by the microorganisms for metabolic purposesthereby enhancing the conversion of sugars to succinate anion.

In this sequence, a purge stream is taken from header 1114 via line 1114a to prevent undue buildup of undesired components in the aqueousmedium, and overhead from distillation assembly 1146 can be used to makeup at least part of the water for the water supplied by header 1108 avia line 1148 a.

x. Botyrococci

Botryococcus, including, but not limited to, Botryococcus braunii, havebeen proposed for the photosynthetic conversion of carbon dioxide tovarious hydrocarbon and oxygenated organic compound bioproducts, oftenof 8 or 10 to 50 carbon atoms, and sometimes between about 20 and 40,carbon atoms (“oils”). Botryococcus species have been reported that haveup to 75 percent of the dry mass of the microalgae constitutinghydrocarbons whereas other microalgae may only contain up to about 10mass percent hydrocarbons. Botryococcus species often have a highproductivity of bioproducts. The bioproducts may be expressed from thecells and depending on the strain or race of the species can includeodd-numbered hydrocarbons, n-alkadienes, trienes, triterpenehydrocarbons, and tetraterpene hydrocarbons. The hydrocarbons cancontain oxygen in various functional groups.

Although Botryococcus species offer significant potential as a source ofbiochemicals and biofuels, the practical difficulties associated withproviding and maintaining a sufficient population of Botryococcusspecies have hindered their adoption on a commercial scale. Thesedifficulties include having:

-   -   a very slow growth rate;    -   an oil secretion is primarily in the non-growing phase thus        proposals have been made to harvest the algae once a sufficient        population has been obtained for oil recovery;    -   sensitivity to strong light causing chlorophyll degeneration        which may be long lasting or permanent;    -   thick cell walls that are resistant to chemical degradation and        hinder oil extraction;    -   sensitivity to hydrodynamic shear; and    -   an impracticability to use a bioreactor of sufficient size to be        competitive for supplying oils free of contaminating        microorganisms that may consume oils, compete for nutrients and        produce algaecides.

The biocatalysts of this invention that contain Botryococcus speciestake advantage of the metabolic activity of Botryococcus species toprovide enhanced process viability. In the broad aspects, the processesfor the bioconversion of carbon dioxide to bioproducts using biocatalystof this invention which contains microalgae comprising a species ofBotryococcus comprises:

-   a. maintaining the biocatalyst in an aqueous medium, said aqueous    medium being at metabolic conditions including temperature and the    presence of nutrients for the microalgae;-   b. contacting the aqueous medium with carbon dioxide for the    bioconversion wherein the microalgae secretes bioproduct;-   c. irradiating the aqueous medium with light at a frequency and    intensity sufficient for the microalgae to photosynthesize carbon    dioxide to bioproduct; and-   d. removing bioproduct from the aqueous medium.

The bioconversion may be photosynthetic or heterotrophic where themicroalgae have the ability to operate in such an environment, or both.Preferably the biocatalyst has a smallest dimension of less than about15, preferably less than about 2, millimeters, say, between about 100microns and 2 millimeters.

The processes of this invention use microalgae comprising species ofBotryococcus. Preferably the microalgae consist essentially of speciesof Botryococcus, i.e., a monocultural environment exists for thephotosynthetic conversion of carbon dioxide to bioproduct, or amulticultural environment with bacteria that can enhance the performanceof Botryococcus species such as disclosed in Wang, et al., Effect ofnutrient conditions on the growth of Botryococcus braunii, ChineseJournal of Process Engineering, 3:141-145 (1996), hereby incorporated byreference in its entirety. The species of Botryococcus can be a wildtype (naturally occurring) or a recombinant microalgae. Examples ofspecies of Botryococcus include, but are not limited to, Botryococcusbraunii. Numerous strains of Botryococcus braunii are known such ashorridus, minor, perarmatus, validus, Showa and Ninsei. Other species ofBotryococcus include, B. australis, B. calcareous, B. canadensis, B.comperei, B. fernanoi, B. giganteus, B. miromorus, B. neglectus and B.pila. Strains can be further categorized into races such as Botryococcusbraunii race A, Botryococcus braunii race B, and Botryococcus brauniirace L. Strains of Botryococcus braunii are typically preferred due tobioproduct production and rates, especially those of the A and B races,and strains of Botryococcus braunii race B are most preferred wherebioproducts not containing oxygen atoms are desired.

One advantageous species of Botryococcus comprises genetically modifiedBotryococcus containing enzyme for metabolizing carbohydrates source,such as sugar, for heterotrophic growth. This genetic modificationfacilitates obtaining a large population of Botryococcus to beincorporated into the biocatalyst. The population increase may befacilitated through the use of alternative carbon sources such ascarbohydrates where the microalgae contain suitable enzymes andtransporters. Botryococcus braunii typically have transporters forglucose.

The biocatalysts of this invention are used in photosynthetic processesto bioconvert carbon dioxide to bioproducts. The composition of thebioproducts can vary depending upon the strain of Botryococcus used, andcan be branched or cyclic hydrocarbons, including but not limited toterpenoids of 10 to 50 carbons, and may be substituted with oxygencontaining moieties such as hydroxyl, alkoxy, acyl, and carboxyl. Thebioproducts can include biodiesel and other glycerides. The bioproductsare expressed from the microalgae, and pass from the porous matricesinto the aqueous medium containing the porous matrices. A solvent can beused to facilitate collection of the bioproducts. A preferred solvent isone that is immiscible with water, solubilizes the hydrocarbons or otherbioproducts, has a low boiling point, has a density significantlydifferent than water, is readily available and inexpensive, is reusableand recyclable, and is not extremely toxic to the organisms. Heptane isan example of such a solvent.

The metabolic processes may be conducted in any suitable manner. Thesubstrate comprises carbon dioxide and may include carbohydrate,including C₅ and C₆ sugars. The carbon dioxide may be obtained from anysuitable source; however, components that are unduly deleterious to themicroalgae should be removed prior to contact with the biocatalyst.Generally carbon dioxide is supplied in gaseous form, although carbonateand bicarbonate salts can be used but are less preferred. Where suppliedas a gas, the carbon dioxide concentration in the gas is typically therange of about 40 to 100, say, 70 to 100, volume percent. Sources ofcarbon dioxide include, but are not limited to, off gases fromindustrial and fermentation processes, exhaust gases from combustion offuels and waste materials, natural gas streams containing carbondioxide, streams from the gasification of biomass, e.g., to producesyngas, and the like.

Suitable metabolic conditions using light radiation in an intensitysufficient to provide photo-biocatalytic activity include culture liquidcan be used including Typical Mesophilic Conditions. The light intensitycan vary, but is preferably relatively strong, e.g., at least about 20,say, between about 20 and 200 or more, microEinsteins per square meterper second, for light within the wave range of 400 to 800 nanometers.The pressure is not critical and may be ambient, reduced or elevatedpressure. Where gaseous substrates are used, higher pressures tend toincrease the amount of substrate dissolved in the culture liquid andthus enhance mass transfer. Often the pH is between about 6.5 and 8.5,say, 6.5 to 8.0. The metabolic conditions may include the presence ofmolecular oxygen, and if present, in an amount of between about 5 to 50volume percent based upon the volume of carbon dioxide fed to theaqueous medium.

Usually, the bioconversion activity can be maintained for at least about30, and often for at least about, 300 or more days.

The chemical product may be recovered from the culture liquid in anysuitable manner. Continuous or frequent discontinuous removal of thebioproduct is preferred as the bioproduct.

xi. Butanol

The biocatalyst of this invention is attractive for the conversion ofsubstrate to butanol which may be isobutanol or n-butanol. Both isomersof butanol are toxic at relatively low concentrations to microorganismsproducing butanol, typically less than about 3 percent by mass per literof aqueous medium. The processes using the biocatalyst of this inventionpermit higher titers of butanol to be produced thereby reducing costs ofthe water/butanol separation. See, for instance, Tracy, “ImprovingButanol Fermentation to Enter the Advanced Biofuel Market, mbio.asm.org,vol. 3, 6, November/December 2012, and Kaminski, et al.,Biobutanol—Production and Purification Methods, Ecological Chemistry andEngineering S, 18:1, pp. 31-37 (2011).

In the broad aspects, the processes for bioconverting substrate tobutanol comprise:

-   a. contacting an aqueous medium with a biocatalyst of this    invention, said biocatalyst containing microorganisms capable of    bioconverting said substrate to butanol, wherein said aqueous medium    is maintained under metabolic conditions including the presence of    nutrients for said microorganisms and contains said substrate;-   b. maintaining the contact between the aqueous medium and    biocatalyst for a time sufficient to bioconvert at least a portion    of said substrate to butanol; and-   c. recovering butanol from said aqueous medium.

The butanol may be either isobutanol or n-butanol depending upon themicroorganism used in the process. The microorganism to be used willalso define the substrate. Substrates that have found application inproducing butanol include carbon dioxide, sugars, glycerol and syngas.Microorganisms capable to producing butanol are butyrogens and include,but are not limited to, wild-type or recombinant Clostridia, such as C.acetobutylicum, C. beijerinckii, C. pasteurianum, C. saccharobutylicum,C. saccharoperbutylacetonicum; Oeneococcus oeni; and Ralstonia eutropha,and recombinant microorganisms such as E. coli into which pathways formaking butanol have been added. See, for instance, United Statespublished patent application no 20100143993 for a more extensivediscussion of other microorganisms for making butanol. Geneticallyenhanced photoautotrophic cyanobacteria, algae, and otherphotoautotrophic organisms have been adapted to bioconvert carbohydratesinternal to the microorganism directly to butanol. For example,genetically modified cyanobacteria having constructs comprising DNAfragments encoding pyruvate decarboxylase (pdc) and alcoholdehydrogenase (adh) enzymes are described in U.S. Pat. No. 6,699,696.

Bioconversion conditions are often within Typical MesophilicBioconversion Conditions, and Typical Bioreactor Systems can be used.Continuous processes are preferred especially since the biocatalysts ofthis invention can provide high cell densities and thus, together withthe enhanced bioconversion rate, provide for high conversionefficiencies of substrate with relatively brief average residence timesin the bioreactor, e.g., often less than about 3 or 4 hours, andsometimes less than about 30 minutes.

One aspect of this process is further illustrated in FIG. 12 which is aschematic depiction of a bioreactor assembly 1200 for the production ofn-butanol. A sugar-containing feedstock is provided via line 1202 tofirst bioreactor 1204 which is an up-flow bioreactor containing anaqueous fermentation medium and biocatalyst for the bioconversion ofsugar to n-butanol. The biocatalyst contains. In bioreactor 1204, thesupply of sugar is such that only a portion is bioconverted to butanoland thus provides an aqueous medium containing about 6 to 8 volumepercent butanol. Aqueous medium from first bioreactor 1204 is passed vialine 1206 to second bioreactor 1208 where the remaining sugars arebioconverted. Second bioreactor 1208 is a fluidized bed bioreactor.Second bioreactor 1208 contains an aqueous medium with biocatalystcontaining Clostridia acetobutyricum. In second bioreactor, some of theremaining sugar is bioconverted to provide an aqueous medium containingabout 10 volume percent butanol. Due to the higher concentration ofbutanol in second reactor 1208, the bioconversion rate to butanol isless than about 50 percent of that in first bioreactor 1204. Aqueousmedium is withdrawn from second bioreactor 1208 and passed to decanter1214 to provide an upper phase containing n-butanol which is passed vialine 1216 to product recovery. The high concentration of butanol in line1216 facilitates the recovery of butanol with a substantial saving inenergy costs.

A butanol-saturated aqueous phase is returned via line 1218 fromdecanter 1214 to second bioreactor 1208 and contains about 7 to 8 volumepercent butanol and unreacted sugars, ethanol and acetone. A purge isremoved via line 1220 to maintain steady-state conditions. This streamcan be used for product recovery to obtain ethanol, acetone and butanol.Second bioreactor 1208 can be operated such that with the recycle rateof the aqueous medium, only a portion of the sugar is bioconverted, butthat converted to butanol goes to a butanol phase for recovery. Ifrequired, additional water and nutrients can be provided to firstbioreactor 1204 via line 1222.

The bioreactor assembly, while described in connection with makingn-butanol, is useful for the bioconversion of substrates where thebioconversion activity of the biocatalyst decreases with increasedbioproduct concentration in the aqueous medium and where the bioproductcan form a separate liquid phase. In its broad aspects, these continuousprocesses for the bioconversion of substrate to bioproduct using amicroorganism capable of such bioconversion wherein the bioproduct istoxic to the microorganism comprise:

-   a. continuously supplying substrate and aqueous medium to at least    one first bioreactor containing aqueous medium, said at least one    first bioreactor having therein biocatalyst of this invention    comprising said microorganism;-   b. maintaining said at least one first bioreactor under metabolic    conditions and continuously withdrawing a first reactor effluent    from said at least one first bioreactor at a rate sufficient to    maintain steady-state conditions and provide a hydraulic residence    time sufficient to bioconvert a portion of the substrate, said a    first bioreactor effluent containing unconsumed substrate and    bioproduct, wherein the bioconversion activity to said bioproduct in    said at least one first bioreactor is at a first rate;-   c. continuously supplying the withdrawn first bioreactor effluent to    at least one subsequent bioreactor containing aqueous medium, said    at least one subsequent bioreactor having therein biocatalyst of    this invention comprising said microorganism;-   d. maintaining said at least one subsequent bioreactor under    metabolic conditions and continuously withdrawing a subsequent    bioreactor effluent from said at least one subsequent bioreactor at    a rate sufficient to maintain steady-state conditions and provide a    hydraulic residence time sufficient to bioconvert at least a portion    of the substrate, said a subsequent bioreactor effluent containing    bioproduct, wherein the bioconversion activity to said bioproduct in    said at least one subsequent bioreactor is at a second rate which is    lower than the first rate;-   e. continuously separating a bioproduct-rich stream from said    withdrawn subsequent bioreactor effluent for product recovery and    provide a residual aqueous stream; and-   f. continuously recycling at least a portion of the residual aqueous    stream to at least one subsequent bioreactor.

In many instances the subsequent bioreactor effluent contains substrate.In preferred aspects of this process, the at least one subsequentbioreactor comprises a fluidized bed bioreactor. The separation of step(e) may be by any suitable separation technique, including but notlimited to, Typical Separation Techniques. In preferred aspects, thebioproduct is capable of forming a separate liquid phase in the aqueousmedium and at least in the at least one subsequent bioreactor, theconcentration of the bioproduct forms a separate liquid phase and thesubsequent bioreactor effluent is subjected to phase separation toprovide a bioproduct-containing phase and the residual aqueous phase. Insome preferred aspects, especially where the bioproduct forms a separateliquid phase, the subsequent bioreactor effluent and the recycle of theresidual aqueous stream are at rates sufficient to maintain a desiredsecond rate of bioconversion activity and form the second liquid phase.Often, only a portion of the substrate is bioconverted in said at leastone subsequent bioreactor, and a sufficient concentration of substrateis maintained in the aqueous medium in the at least one subsequentbioreactor to enhance the rate of conversion of substrate to bioproduct.

Examples 225 to 231

A series of seven batch fermentation experiments are conducted using thefollowing general procedure. In each experiment, a biocatalystsubstantially as described in Example 93 is used which has a nominaldiameter of about 4 millimeters and is maintained under an anaerobicenvironment of nitrogen. A batch medium is prepared in accordance withATCC® Medium 2107, a modified reinforced Clostridial agar/broth medium,as follows:

-   -   Combine 38 grams of reinforced clostridial medium BD 218081        (ATCC, Manassas, Va.); 14.5 g of agar and 1000 milliliters of        deionized water and boil to dissolve the agar,    -   Separately prepare a solution of 10 grams of peptone, 10 grams        of beef extract, 3 grams of yeast extract, 5 grams of dextrose,        5 grams of sodium chloride, 1 gram of soluble starch, 0.5 gram        of L-cysteine hydrochloride, 3 grams of sodium acetate and 4        milliliters of Resazurin (0.025%) in 1000 milliliters of        deionized water, and    -   Combine the solutions.        Glucose is added to the combined solution at either 60 or 120        grams per liter, and the solution is adjusted to a pH of about        5.5 with 5N sodium hydroxide. The batch medium is then made        anaerobic by autoclaving at 121° C. for 20 minutes while        sparging with nitrogen that had been passed through a 0.2 micron        filer. Each batch fermentation is conducted in a sealed tank        reactor and about 2 milliliters of the batch medium is used per        gram of biocatalyst. Into some of the reactors, n-butanol is        injected to determine the effect of n-butanol on the        biocatalysts and the fermentation. The fermentations are        conducted at a temperature of about 37° C., and samples of the        fermentation broth are taken periodically and analyzed by gas        chromatography. The fermentations continue for 48 hours. The        data are summarized in Table VI.

TABLE VI Glucose n-Butanol added, added, Example g/L vol % Comments 225120 0 Butanol being produced 226 120 2 Butanol being produced 227 120 5Butanol being produced 228 120 10 Butanol being produced at reducedrate, two phases in broth 229 60 10 Butanol being produced at reducedrate, two phases in broth 230 120 15 Butanol being produced at reducedrate, two phases in broth 231 120 22 Butanol being produced at reducedrate, two phases in broth

xii. Ethanol

The biocatalyst of this invention is attractive for the conversion ofsubstrate to ethanol. The maximum titer of ethanol in fermentationbroths using yeasts is typically about 15 to 18 percent, and theconversion efficiency of substrate such as sugars and syngas to ethanolin commercial processes using yeasts is typically less than about 95percent of theoretical. With other ethanol-producing microorganisms suchas cyanobacteria and Clostridia, their sensitivity to ethanolconcentrations may be much greater than those of yeasts. For instance,it has been reported that 1.5 volume percent ethanol causes a 50 percentgrowth decrease in Synechocystis sp. PCC 6803. Hence, processes usingthese alternative microorganisms generate very dilute ethanol-containingbroths. U.S. Pat. No. 7,682,821 B2 discloses a closed photobioreactorusing daily ambient temperature swings as a means to reduce the cost ofethanol separation. The processes using the biocatalyst of thisinvention permit higher titers of ethanol to be produced therebyreducing costs of the water/ethanol separation, and the conversionefficiency approaches nearly the theoretical efficiency due to thephenotypic changes to the microorganism in the biocatalysts of thisinvention.

In the broad aspects, the processes for bioconverting substrate toethanol comprise:

-   a. contacting an aqueous medium with a biocatalyst of this    invention, said biocatalyst containing microorganisms capable of    bioconverting said substrate to ethanol, wherein said aqueous medium    is maintained under metabolic conditions including the presence of    nutrients for said microorganisms and contains said substrate;-   b. maintaining the contact between the aqueous medium and    biocatalyst for a time sufficient to bioconvert at least a portion    of said substrate to ethanol; and-   c. recovering ethanol from said aqueous medium.

The microorganism to be used will define the substrate. Substrates thathave found application in producing ethanol include carbon dioxide,sugars and syngas. Microorganisms capable to producing ethanol included,but are not limited to, wild-type or recombinant bacteria and yeasts,e.g., Clostridia, such as C. ljungdahlii, Clostridium aceticum, and C.thermoaceticum, Acetogenium kivui, Acetobacterium woodii,Acetoanaerobium noterae, Butyribacterium methylotrophicum, Eubacteriumlimosum, Zymomonas mobilis, Zymomonas palmae, mesophilic yeasts such asPichia stipitis, Pichia segobiensis, Candida shehatae, Candidatropicalis, Candida boidinii, Candida tenuis, Pachysolen tannophilus,Hansenula polymorpha, Candida famata, Candida parapsilosis, Candidarugosa, Candica sonorensis, Issatchenkia terricola, Kloeckera apis,Pichia barkeri, Pichia cactophila, Pichia deserticola, Pichianorvegensis, Pichia membranefaciens, Pichia mexicana, Sacchrimycescervisea and Torulaspora delbrueckii and thermophilic yeasts such asCandida bovina, Candida picachoensis, Candida emberorum, Candidapintolopesii, Candida thermophila, Kluyveromyces marxianus,Kluyveromyces fragilis, Kazachstania telluris, Issatchenkia orientalisand Lachancea thermotolerans. Thermophylic bacteria include, amongothers, Clostridium thermocellum, Clostridium thermohydrosulphuricum,Clostridium thermosaccharolyticum, Thermoanaerobium brockii,Thermobacteroides acetoethylicus, Thermoanaerobacter ethanolicus,Clostridium thermoaceticum, Clostridium thermoautotrophicum, Acetogeniumkivui, Desulfotomaculum nigrificans and Desulvovibrio thermophilus,Thermoanaerobacter tengcongensis, Bacillus stearothermophilus andThermoanaerobacter mathranii. Genetically enhanced photoautotrophiccyanobacteria, algae, and other photoautotrophic organisms have beenadapted to bioconvert carbohydrates internal to the microorganism toethanol. For example, genetically modified cyanobacteria havingconstructs comprising DNA fragments encoding pyruvate decarboxylase(pdc) and alcohol dehydrogenase (adh) enzymes are described in U.S. Pat.No. 6,699,696. cyanobacteria are photosynthetic bacteria which requirelight, inorganic elements, water, and a carbon source, generally carbondioxide, to metabolize and grow. The production of ethanol usinggenetically engineered cyanobacteria has also been described in PCTPublished Patent Application WO 2007/084477. See also United Statespublished patent application no. 20120301937 for a listing ofethanol-producing microorganisms.

Bioconversion conditions are often within Typical MesophilicBioconversion Conditions, and Typical Bioreactor Systems can be used.Continuous processes are preferred especially since the biocatalysts ofthis invention can provide high cell densities and thus, together withthe enhanced bioconversion rate, provide for high conversionefficiencies of substrate with relatively brief average residence timesin the bioreactor, e.g., often less than about 3 or 4 hours, andsometimes less than about 30 minutes.

For photosynthetic processes, the combination of high concentrations ofcells per unit volume of liquid culture medium, the essential absence ofdebris from the microorganisms thus providing a clearer culture mediumand the phenotypic changes associated with the biocatalysts of thisinvention, enables a significant increase in ethanol that can begenerated per unit time per unit surface area. Hence, smaller footprintsare required for the photobioreactors, and the closed processes such asdisclosed in U.S. Pat. No. 7,682,821 can generated even higherconcentrations of ethanol in the condensate. Additionally, since in situsterilization can be used, more reliable operations can occur as thepopulation of any contaminating microorganisms can be controlled. Thephotobioreactor can contain a liquid culture medium with thebiocatalysts therein. The substrate, e.g., carbon dioxide, can bedissolved in the culture medium, or the biocatalyst can be contactedwith gaseous substrate and then ethanol can be removed from thebiocatalyst, for instance, by evaporation or by contact with anextractant for ethanol such as water.

Example 232

A fluidized bed bioreactor is charged to about 75 volume percent of itscapacity with biocatalyst substantially as described in example 147. Acontinuous flow of water containing glucose at a concentration of either120 grams per liter or 250 grams per liter is provided to the bioreactorat various rates to provide hydraulic residence times of either 4 or 10hours. The bioreactor is maintained at a temperature of about 37° C. Theeffluent from the bioreactor is periodically analyzed for ethanol andglucose concentrations. At the 4 hour hydraulic retention time, theconversion of sugars yields about 95 to 97 percent of theoreticalethanol production at each glucose concentration. At the 10 hourhydraulic retention time, the conversion of sugars yields about 98 to 99percent of theoretical ethanol production at each glucose concentration.

xiii. Anaerobic Digestion

As discussed above, municipal wastewater is often subjected to anaerobic bioconversion. Supplying oxygen to the bioreactor is asignificant expense, even is air is used as the oxygen-containing gas,to the municipal wastewater facility and often is at least about 30percent of the overall costs. Moreover, where tertiary treatment isrequired, an anaerobic bioconversion is used, and thus the oxygenconcentration in the water being treated must be lowered. To meetregulatory requirements established in a number of jurisdictions, thewastewater treatment must reduce the organic content as well as reduceor substantially eliminate pathogens.

Mesophilic anaerobic digestion has been proposed. While eliminating thecosts of oxygen supply, such processes suffer from a number ofdrawbacks. Maintaining effective populations of microorganisms hasproven difficult, especially since both acidogenesis and methanogenesismust be supported. The residence time is long, often in the range of 15days, and the process often does not provide sufficient reduction ofpathogens.

Thermophilic anaerobic digestion does provide an advantage of a shorterresidence time and a better ability to treat pathogens. See, forinstance, United States published patent application no. 2013010539.Maintaining the population of microorganisms still remains problematic,and the wastewater must be brought up to and maintained at a temperatureof at least 45° C. for operation of the thermophilic microorganisms.

The biocatalysts of this invention provide for improvements in theanaerobic digestion of wastewater in that not only can the thermophilicmicroorganisms be targeted for the biocatalyst as opposed toconventional systems where the microorganisms are often derived from thesludge, but also the biocatalyst can provide a high concentration of thethermophilic microorganisms per unit of bioreactor volume. The rate ofbioconversion, and thus the hydraulic residence time, can be reduced.More importantly, since the thermophilic anaerobic bioconversion isexothermic, the high concentration of microorganisms effectively servesas a heat source to obtain and maintain thermophilic bioconversiontemperatures. Also, as the thermophiles are in the biocatalyst of thisinvention, the processes are useful even for treating waste water havinga low organic content.

The processes for thermophilic anaerobic digestion of wastewatercontaining organic compound comprise:

-   a. contacting under thermophilic conditions said wastewater with    biocatalyst of this invention containing thermophilic microorganisms    suitable for the bioconversion of organic compounds to methane,    preferably said thermophilic conditions comprise a temperature of at    least about 45° C., say, between about 47° C. and 65° C. or 70° C.,    for a time sufficient to reduce the concentration of organic    compound, preferably to a BOD of less than about 10, preferably less    than about 4, milligrams of oxygen per liter, to provide a treated    water and a biogas,-   b. separating the biogas from the wastewater and-   c. separating the treated water from the biocatalyst.

Preferably the microorganism used in the biocatalyst comprises amethanogen, especially one or more of the following microorganismsMethanosarcina acetivorans, Methanothermobacter thermautotrophicus,Methanobrevibacter smithii, Methanospirillum hungatei, CandidatusBrocadia anammoxidans, Kuenenia sp., Anammoxoglobus sp., Jettenia sp.,and Scalindua sp. The cell concentration in the biocatalyst ispreferably at least about 100 or 200 grams per liter. Usually thebioconversion conditions include maintaining a pH in the range of about6.5 to 9, say, about 7 to 8.5. Often the oxygen concentration in thewastewater to be contacted with the biocatalyst is less than about 2milligrams per liter. Any suitable bioreactor configuration can be usedincluding, but not limited to, Typical Bioreactor Systems. Preferablythe bioreactor contains sufficient biocatalyst to provide at least about100 grams of cells per liter of capacity.

xiv. Other Applications

The properties of the biocatalysts of this invention enable a wide rangeof specific applications. For instance, the ability to achieve a highpopulation of microorganisms with a stable population make thebiocatalysts of this invention useful for biological detection devices;coatings including but not limited to, antifouling paint and coatingssuch as for ship hulls and other surfaces immersed in surface water; andfilters to remove undesirable components from gases and liquids. Thebiocatalysts can be used in biological fuel cells.

The biocatalysts of this invention can be used for producing hydrogen orhydrogen equivalents using mesophilic or thermophilic, anaerobic orfacultative anaerobic microorganisms. The hydrogen can be recovered orused in another chemical or metabolic process. In one such process,methane can be used to produce hydrogen and then the hydrogen used toreduce sulfate to sulfide using sulfate-reducing microorganisms. Sincethe microorganisms are irreversibly retained in the biocatalysts,co-cultures, either in the same or different biocatalysts, can bemaintained.

The biocatalysts of this invention can find application inmethanogenesis of carbonaceous substrates especially to methane. Themicroorganisms having this bioactivity are typically syntrophs, and thebiocatalyst enhances the stability of the syntrophic system.

The biocatalysts of this invention can be used to produce alkenes suchas ethylene, propylene, butene, butadiene and styrene from, e.g.,carbohydrates such as sugars, syngas, and carbon dioxide. See, forinstance, United States published patent application 20130122563.

The biocatalysts of this invention can be used for treatment of variousground, surface, municipal wastewater and industrial water streams asset forth above. Additionally, beneficial applications include anaerobicdigestion, removal of sulfate and sulfite anions, and as a layeredcatalyst for conducting aerobic wastewater treatment.

APPENDIX A

Representative microorganisms include, without limitation, Acetobactersp., Acetobacter aceti, Achromobacter, Acidiphilium, Acidovoraxdelafieldi P4-1, Acinetobacter sp. (A. calcoaceticus), Actinomadura,Actinoplanes, Actinomycetes, Aeropyrum pernix, Agrobacterium sp.,Alcaligenes sp. (A. dentrificans), Alloiococcus otitis, Ancylobacteraquaticus, Ananas comosus (M), Arthrobacter sp., Arthrobacter sulfurous,Arthrobacter sp. (A. protophormiae), Aspergillus sp., Aspergillus niger,Aspergillus oryze, Aspergillus melleus, Aspergillus pulverulentus,Aspergillus saitoi, Aspergillus sojea, Aspergillus usamii, Bacillusalcalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacilluscirculans, Bacillus clausii, Bacillus cereus, Bacillus lentus, Bacilluslicheniformis, Bacillus macerans, Bacillus stearothermophilus, Bacillussubtilis, Beijerinckia sp., Bifidobacterium, Brevibacterium sp. HL4,Brettanomyces sp., Brevibacillus brevis, Burkholderia cepacia,Campylobacter jejuni, Candida sp., Candida cylindracea, Candida rugosa,Carboxydothermus (Carboxydothermus hydrogenoformans), Carica papaya (L),Cellulosimicrobium, Cephalosporium, Chaetomium erraticum, Chaetomiumgracile, Chlorella sp., Citrobacter, Clostridium sp., Clostridiumbutyricum, Clostridium acetobutylicum, Clostridium kluyveri, Clostridiumcarboxidivorans, Clostridium thermocellum, Cornynebacterium sp. strainm15, Corynebacterium (glutamicum), Corynebacterium efficiens,Deinococcus radiophilus, Dekkera, Dekkera bruxellensis, Escherichiacoli, Enterobacter sp., Enterococcus, Enterococcus faecium, Enterococcusgallinarium, Enterococcus faecalis, Erwinia sp., Erwinia chrysanthemi,Gliconobacter, Gluconacetobacter sp., Hansenula sp., Haloarcula,Humicola insolens, Humicola nsolens, Kitasatospora setae, Klebsiellasp., Klebsiella oxytoca, Klebsiella pneumonia, Kluyveromyces sp.,Kluyveromyces fragilis, Kluyveromyces lactis, Kocuria, Lactlactis,Lactobacillus sp., Lactobacillus fermentum, Lactobacillus sake,Lactococcus, Lactococcus lactis, Leuconostoc, Methylosinus trichosporumOB3b, Methylosporovibrio methanica 812, Methanothrix sp. Methanosarcinasp., Methanomonas sp., Methylocystis, Methanospirilium, Methanolobussiciliae, Methanogenium organophilum, Methanobacerium sp.,Methanobacterium bryantii, Methanococcus sp., Methanomicrobium sp.,Methanoplanus sp., Methanosphaera sp., Methanolobus sp., Methanoculleussp., Methanosaeta sp., Methanopyrus sp., Methanocorpusculum sp.,Methanosarcina, Methylococcus sp., Methylomonas sp., Methylosinus sp.,Microbacterium imperiale, Micrococcus sp., Micrococcus lysodeikticus,Microlunatus, Moorella (e.g., Moorella (Clostridium) thermoacetica),Moraxella sp. (strain B), Morganella, Mucor javanicus, Mycobacterium sp.strain GP1, Myrothecium, Neptunomonas naphthovorans, Nitrobacter,Nitrosomonas (Nitrosomonas europea), Nitzchia sp., Nocardia sp.,Pachysolen sp., Pantoea, Papaya carica, Pediococcus sp., Pediococcushalophilus, Penicillium, Penicillium camemberti, Penicillium citrinum,Penicillium emersonii, Penicillium roqueforti, Penicillum lilactinum,Penicillum multicolor, Phanerochaete chrysoporium, Pichia sp., Pichiastipitis, Paracoccus pantotrophus, Pleurotus ostreatus,Propionibacterium sp., Proteus, Pseudomonas (P. pavonaceae, PseudomonasADP, P. stutzeri, P. putida, Pseudomonas Strain PS1, P. cepacia G4, P.medocina KR, P. picketti PK01, P. vesicularis, P. paucimobilis,Pseudomonas sp. DLC-P11, P. mendocina, P. chichhori, strain IST 103),Pseudomonas fluorescens, Pseudomonas denitrificans, Pyrococcus,Pyrococcus furiosus, Pyrococcus horikoshii, Ralstonia sp., Rhizobium,Rhizomucor miehei, Rhizomucor pusillus Lindt, Rhizopus, Rhizopusdelemar, Rhizopus japonicus, Rhizopus niveus, Rhizopus oryzae, Rhizopusoligosporus, Rhodococcus, (R. erythropolis, R. rhodochrous NCIMB 13064),Salmonella, Saccharomyces sp., Saccharomyces cerevisiae, Schizochytriusp., Sclerotina libertina, Serratia sp., Shigella, Sphingobacteriummultivorum, Sphingobium (Sphingbium chlorophenolicum), Sphingomonas (S.yanoikuyae, S. sp. RW1), Streptococcus, Streptococcus thermophilus Y-I,Streptomyces, Streptomyces griseus, Streptomyces lividans, Streptomycesmurinus, Streptomyces rubiginosus, Streptomyces violaceoruber,Streptoverticillium mobaraense, Synechococcus sp., Synechocystis sp.,Tetragenococcus, Thermus, Thiosphaera pantotropha, Trametes, Trametesversicolor, Trichoderma, Trichoderma longibrachiatum, Trichodermareesei, Trichoderma viride, Trichosporon sp., Trichosporon penicillatum,Vibrio alginolyticus, Xanthomonas, Xanthobacter sp. (X. autotrophicusGJ10, X flavus), yeast, Yarrow lipolytica, Zygosaccharomyces rouxii,Zymomonas sp., Zymomonus mobilis, Geobacter sulfurreducens, Geobacterlovleyi, Geobacter metallireducens, Bacteroides succinogens,Butyrivibrio fibrisolvens, Clostridium cellobioparum, Ruminococcusalbus, Ruminococcus flavefaciens, Eubacterium cellulosolvens,Clostridium cellulosolvens, Clostridium cellulovorans, Clostridiumthermocellum, Bacteroides cellulosolvens, and Acetivibrio cellulolyticusGliricidia sp., Albizia sp., or Parthenium sp. Cupriavidus basilensis,Cupriavidus campinensis, Cupriavidus gilardi, Cupriavidus laharsis,Cupriavidus metallidurans, Cupriavidus oxalaticus, Cupriavidus pauculus,Cupriavidus pinatubonensis, Cupriavidus respiraculi, Cupriavidustaiwanensis, Oligotropha carboxidovorans, Thiobacillus sp., Thiobacillusdenitrificans, Thiobacillus thioxidans, Thiobacillus ferrooxidans,Thiobacillus concretivorus, Acidithiobacillus albertensis,Acidithiobacillus caldus, Acidithiobacillus cuprithermicus,Rhodopseudomonas, Rhodopseudomonas palustris, Rhodobacter sphaeroides,Rhodopseudomonas capsulate, Rhodopseudomonas acidophila,Rhodopseudomonas viridis, Desulfotomaculum, Desulfotomaculumacetoxidans, Desulfotomaculum kuznetsovii, Desulfotomaculum nigrificans,Desulfotomaculum reducens, Desulfotomaculum carboxydivorans,Methanosarcina barkeri, Methanosarcina acetivorans, Moorellathermoacetica, Carboxydothermus hydrogenoformans, Rhodospirillum rubrum,Acetobacterium woodii, Butyribacterium methylotrophicum, Clostridiumautoethanogenum, Clostridium ljungdahlii, Eubacterium limosum, Oxobacterpfennigii, Peptostreptococcus productus, Rhodopseudomonas palustris P4,Rubrivivax gelatinosus, Citrobacter sp Y19, Methanosarcina acetivoransC2A, Methanosarcina barkeri, Desulfosporosinus orientis, Desulfovibriodesulfuricans, Desulfovibrio vulgaris, Moorella thermoautotrophica,Carboxydibrachium pacificus, Carboxydocella thermoautotrophica,Thermincola carboxydiphila, Thermolithobacter carboxydivorans,Thermosinus carboxydivorans, Methanothermobacter thermoautotrophicus,Desulfotomaculum carboxydivorans, Desulfotomaculum kuznetsovii,Desulfotomaculum nigrificans, Desulfotomaculum thermobenzoicum subsp.thermosyntrophicum, Syntrophobacter fumaroxidans, Clostridium acidurici,Desulfovibrio africanus, C. pasteurianum, C. pasteurianum DSM 525,Paenibacillus polymyxa, Acanthoceras, Acanthococcus, Acaryochloris,Achnanthes, Achnanthidium, Actinastrum, Actinochloris, Actinocyclus,Actinotaenium, Amphichrysis, Amphidinium, Amphikrikos, Amphipleura,Amphiprora, Amphithrix, Amphora, Anabaena, Anabaenopsis, Aneumastus,Ankistrodesmus, Ankyra, Anomoeoneis, Apatococcus, Aphanizomenon,Aphanocapsa, Aphanochaete, Aphanothece, Apiocystis, Apistonema,Arthrodesmus, Artherospira, Ascochloris, Asterionella, Asterococcus,Audouinella, Aulacoseira, Bacillaria, Balbiania, Bambusina, Bangia,Basichlamys, Batrachospermum, Binuclearia, Bitrichia, Blidingia,Botrdiopsis, Botrydium, Botryococcus, Botryosphaerella, Brachiomonas,Brachysira, Brachytrichia, Brebissonia, Bulbochaete, Bumilleria,Bumilleriopsis, Caloneis, Calothrix, Campylodiscus, Capsosiphon,Carteria, Catena, Cavinula, Centritractus, Centronella, Ceratium,Chaetoceros, Chaetochloris, Chaetomorpha, Chaetonella, Chaetonema,Chaetopeltis, Chaetophora, Chaetosphaeridium, Chamaesiphon, Chara,Characiochloris, Characiopsis, Characium, Charales, Chilomonas,Chlainomonas, Chlamydoblepharis, Chlamydocapsa, Chlamydomonas,Chlamydomonopsis, Chlamydomyxa, Chlamydonephris, Chlorangiella,Chlorangiopsis, Chlorella, Chlorobotrys, Chlorobrachis, Chlorochytrium,Chlorococcum, Chlorogloea, Chlorogloeopsis, Chlorogonium, Chlorolobion,Chloromonas, Chlorophysema, Chlorophyta, Chlorosaccus, Chlorosarcina,Choricystis, Chromophyton, Chromulina, Chroococcidiopsis, Chroococcus,Chroodactylon, Chroomonas, Chroothece, Chrysamoeba, Chrysapsis,Chrysidiastrum, Chrysocapsa, Chrysocapsella, Chrysochaete,Chrysochromulina, Chrysococcus, Chrysocrinus, Chrysolepidomonas,Chrysolykos, Chrysonebula, Chrysophyta, Chrysopyxis, Chrysosaccus,Chrysophaerella, Chrysostephanosphaera, Clodophora, Clastidium,Closteriopsis, Closterium, Coccomyxa, Cocconeis, Coelastrella,Coelastrum, Coelosphaerium, Coenochloris, Coenococcus, Coenocystis,Colacium, Coleochaete, Collodictyon, Compsogonopsis, Compsopogon,Conjugatophyta, Conochaete, Coronastrum, Cosmarium, Cosmioneis,Cosmocladium, Crateriportula, Craticula, Crinalium, Crucigenia,Crucigeniella, Cryptoaulax, Cryptomonas, Cryptophyta, Ctenophora,Cyanodictyon, Cyanonephron, Cyanophora, Cyanophyta, Cyanothece,Cyanothomonas, Cyclonexis, Cyclostephanos, Cyclotella, Cylindrocapsa,Cylindrocystis, Cylindrospermum, Cylindrotheca, Cymatopleura, Cymbella,Cymbellonitzschia, Cystodinium Dactylococcopsis, Debarya, Denticula,Dermatochrysis, Dermocarpa, Dermocarpella, Desmatractum, Desmidium,Desmococcus, Desmonema, Desmosiphon, Diacanthos, Diacronema, Diadesmis,Diatoma, Diatomella, Dicellula, Dichothrix, Dichotomococcus,Dicranochaete, Dictyochloris, Dictyococcus, Dictyosphaerium,Didymocystis, Didymogenes, Didymosphenia, Dilabifilum, Dimorphococcus,Dinobryon, Dinococcus, Diplochloris, Diploneis, Diplostauron,Distrionella, Docidium, Draparnaldia, Dunaliella, Dysmorphococcus,Ecballocystis, Elakatothrix, Ellerbeckia, Encyonema, Enteromorpha,Entocladia, Entomoneis, Entophysalis, Epichrysis, Epipyxis, Epithemia,Eremosphaera, Euastropsis, Euastrum, Eucapsis, Eucocconeis, Eudorina,Euglena, Euglenophyta, Eunotia, Eustigmatophyta, Eutreptia, Fallacia,Fischerella, Fragilaria, Fragilariforma, Franceia, Frustulia, Curcilla,Geminella, Genicularia, Glaucocystis, Glaucophyta, Glenodiniopsis,Glenodinium, Gloeocapsa, Gloeochaete, Gloeochrysis, Gloeococcus,Gloeocystis, Gloeodendron, Gloeomonas, Gloeoplax, Gloeothece, Gloeotila,Gloeotrichia, Gloiodictyon, Golenkinia, Golenkiniopsis, Gomontia,Gomphocymbella, Gomphonema, Gomphosphaeria, Gonatozygon, Gongrosia,Gongrosira, Goniochloris, Gonium, Gonyostomum, Granulochloris,Granulocystopsis, Groenbladia, Gymnodinium, Gymnozyga, Gyrosigma,Haematococcus, Hafniomonas, Hallassia, Hammatoidea, Hannaea, Hantzschia,Hapalosiphon, Haplotaenium, Haptophyta, Haslea, Hemidinium, Hemitoma,Heribaudiella, Heteromastix, Heterothrix, Hibberdia, Hildenbrandia,Hillea, Holopedium, Homoeothrix, Hormanthonema, Hormotila,Hyalobrachion, Hyalocardium, Hyalodiscus, Hyalogonium, Hyalotheca,Hydrianum, Hydrococcus, Hydrocoleum, Hydrocoryne, Hydrodictyon,Hydrosera, Hydrurus, Hyella, Hymenomonas, Isthmochloron,Johannesbaptistia, Juranyiella, Karayevia, Kathablepharis, Katodinium,Kephyrion, Keratococcus, Kirchneriella, Klebsormidium, Kolbesia,Koliella, Komarekia, Korshikoviella, Kraskella, Lagerheimia, Lagynion,Lamprothamnium, Lemanea, Lepocinclis, Leptosira, Lobococcus, Lobocystis,Lobomonas, Luticola, Lyngbya, Malleochloris, Mallomonas, Mantoniella,Marssoniella, Martyana, Mastigocoleus, Gastogloia, Melosira,Merismopedia, Mesostigma, Mesotaenium, Micractinium, Micrasterias,Microchaete, Microcoleus, Microcystis, Microglena, Micromonas,Microspora, Microthamnion, Mischococcus, Monochrysis, Monodus,Monomastix, Monoraphidium, Monostroma, Mougeotia, Mougeotiopsis,Myochloris, Myromecia, Myxosarcina, Naegeliella, Nannochloris,Nautococcus, Navicula, Neglectella, Neidium, Nephroclamys, Nephrocytium,Nephrodiella, Nephroselmis, Netrium, Nitella, Nitellopsis, Nitzschia,Nodularia, Nostoc, Ochromonas, Oedogonium, Oligochaetophora, Onychonema,Oocardium, Oocystis, Opephora, Ophiocytium, Orthoseira, Oscillatoria,Oxyneis, Pachycladella, Palmella, Palmodictyon, Pnadorina, Pannus,Paralia, Pascherina, Paulschulzia, Pediastrum, Pedinella, Pedinomonas,Pedinopera, Pelagodictyon, Penium, Peranema, Peridiniopsis, Peridinium,Peronia, Petroneis, Phacotus, Phacus, Phaeaster, Phaeodermatium,Phaeophyta, Phaeosphaera, Phaeothamnion, Phormidium, Phycopeltis,Phyllariochloris, Phyllocardium, Phyllomitas, Pinnularia, Pitophora,Placoneis, Planctonema, Planktosphaeria, Planothidium, Plectonema,Pleodorina, Pleurastrum, Pleurocapsa, Pleurocladia, Pleurodiscus,Pleurosigma, Pleurosira, Pleurotaenium, Pocillomonas, Podohedra,Polyblepharides, Polychaetophora, Polyedriella, Polyedriopsis,Polygoniochloris, Polyepidomonas, Polytaenia, Polytoma, Polytomella,Porphyridium, Posteriochromonas, Prasinochloris, Prasinocladus,Prasinophyta, Prasiola, Prochlorphyta, Prochlorothrix, Protoderma,Protosiphon, Provasoliella, Prymnesium, Psammodictyon, Psammothidium,Pseudanabaena, Pseudenoclonium, Psuedocarteria, Pseudochate,Pseudocharacium, Pseudococcomyxa, Pseudodictyosphaerium,Pseudokephyrion, Pseudoncobyrsa, Pseudoquadrigula, Pseudosphaerocystis,Pseudostaurastrum, Pseudostaurosira, Pseudotetrastrum, Pteromonas,Punctastruata, Pyramichlamys, Pyramimonas, Pyrrophyta, Quadrichloris,Quadricoccus, Quadrigula, Radiococcus, Radiofilum, Raphidiopsis,Raphidocelis, Raphidonema, Raphidophyta, Peimeria, Rhabdoderma,Rhabdomonas, Rhizoclonium, Rhodomonas, Rhodophyta, Rhoicosphenia,Rhopalodia, Rivularia, Rosenvingiella, Rossithidium, Roya, Scenedesmus,Scherffelia, Schizochlamydella, Schizochlamys, Schizomeris, Schizothrix,Schroederia, Scolioneis, Scotiella, Scotiellopsis, Scourfieldia,Scytonema, Selenastrum, Selenochloris, Sellaphora, Semiorbis,Siderocelis, Diderocystopsis, Dimonsenia, Siphononema, Sirocladium,Sirogonium, Skeletonema, Sorastrum, Spermatozopsis, Sphaerellocystis,Sphaerellopsis, Sphaerodinium, Sphaeroplea, Sphaerozosma,Spiniferomonas, Spirogyra, Spirotaenia, Spirulina, Spondylomorum,Spondylosium, Sporotetras, Spumella, Staurastrum, Stauerodesmus,Stauroneis, Staurosira, Staurosirella, Stenopterobia, Stephanocostis,Stephanodiscus, Stephanoporos, Stephanosphaera, Stichococcus,Stichogloea, Stigeoclonium, Stigonema, Stipitococcus, Stokesiella,Strombomonas, Stylochrysalis, Stylodinium, Styloyxis, Stylosphaeridium,Surirella, Sykidion, Symploca, Synechococcus, Synechocystis, Synedra,Synochromonas, Synura, Tabellaria, Tabularia, Teilingia, Temnogametum,Tetmemorus, Tetrachlorella, Tetracyclus, Tetradesmus, Tetraedriella,Tetraedron, Tetraselmis, Tetraspora, Tetrastrum, Thalassiosira,Thamniochaete, Thorakochloris, Thorea, Tolypella, Tolypothrix,Trachelomonas, Trachydiscus, Trebouxia, Trentepholia, Treubaria,Tribonema, Trichodesmium, Trichodiscus, Trochiscia, Tryblionella,Ulothrix, Uroglena, Uronema, Urosolenia, Urospora, Uva, Vacuolaria,Vaucheria, Volvox, Volvulina, Westella, Woloszynskia, Xanthidium,Xanthophyta, Xenococcus, Zygnema, Zygnemopsis, Zygonium, Chloroflexus,Chloronema, Oscillochloris, Heliothrix, Herpetosiphon, Roseiflexus,Thermomicrobium, Chlorobium, Clathrochloris, Prosthecochloris,Allochromatium, Chromatium, Halochromatium, Isochromatium,Marichromatium, Rhodovulum, Thermochromatium, Thiocapsa,Thiorhodococcus, Thiocystis, Phaeospirillum, Rhodobaca, Rhodobacter,Rhodomicrobium, Rhodopila, Rhodopseudomonas, Rhodothalassium,Rhodospirillum, Rodovibrio, Roseospira, Nitrobacteraceae sp.,Nitrobacter sp., Nitrospina sp., Nitrococcus sp., Nitrospira sp.,Nitrosomonas sp., Nitrosococcus sp., Nitrosospira sp., Nitrosolobus sp.,Nitrosovibrio sp., Thiovulum sp., Thiobacillus sp., Thiomicrospira sp.,Thiosphaera sp., Thermothrix sp., Hydrogenobacter sp., Siderococcus sp.,Aquaspirillum sp. Methanobacterium sp., Methanobrevibacter sp.,Methanothermus sp., Methanococcus sp., Methanomicrobium sp.,Methanospirillum sp., Methanogenium sp., Methanosarcina sp.,Methanolobus sp., Methanothrix sp., Methanococcoides sp., Methanoplanussp., Thermoproteus sp., Pyrodictium sp., Sulfolobus sp., Acidianus sp.,Bacillus subtilis, Saccharomyces cerevisiae, Streptomyces sp., Ralstoniasp., Rhodococcus sp., Corynebacteria sp., Brevibacteria sp.,Mycobacteria sp., oleaginous yeast, Arabidopsis thaliana, Panicumvirgatum, Miscanthus giganteus, Zea mays (plants), Botryococcus braunii,Chlamydomonas reinhardtii and Dunaliela salina (algae), Synechococcus spPCC 7002, Synechococcus sp. PCC 7942, Synechocystis sp. PCC 6803,Thermosynechococcus elongatus BP-1 (cyanobacteria), Chlorobium tepidum(green sulfur bacteria), Chloroflexus auranticusl, Chromatium tepidumand Chromatium vinosum (purple sulfur bacteria), Rhodospirillum rubrum,Rhodobacter capsulatus, and Rhodopseudomonas palusris (purple non-sulfurbacteria).

1.-92. (canceled)
 93. A biocatalyst comprising: a solid structure ofhydrated hydrophilic polymer defining an interior structure having aplurality of interconnected major cavities having a smallest dimensionof between about 5 and 100 microns and an HEV of at least about 1000 anda population of microorganisms substantially irreversibly retained inthe interior structure, said population of microorganisms being in aconcentration of at least about 60 grams per liter based upon the volumedefined by the exterior of the solid structure when fully hydrated,wherein the microorganisms maintain a their population substantiallystable.
 94. The biocatalyst of claim 93 in which the HEV is at leastabout 20,000 and the concentration of microorganisms in the interior ofthe solid structure is at least about 100 grams per liter based upon thevolume defined by the exterior of the solid structure.
 95. Thebiocatalyst of claim 94 in which the solid structure defines an externalskin having pores of an average diameter between about 1 and 10 micronsand comprise about 1 to 30 percent of the surface area of the externalskin.
 96. The biocatalyst of claim 93 in which the major cavities arequiescent.
 97. The biocatalyst of claim 93 which contains an exo-networkof said microorganisms.
 98. The biocatalyst of claim 93 in which thebiocatalyst further comprises polysaccharide.
 99. The biocatalyst ofclaim 93 in which the biocatalyst further comprises a solid sorbent.100. The biocatalyst of claim 93 in which the microorganism is aphotosynthetic microorganism and further comprises a phosphorescentmaterial.
 101. The biocatalyst of claim 93 in which the biocatalystfurther comprises at least one isolated enzyme.
 102. The biocatalyst ofclaim 93 in which the microorganism population exhibits at least onephenotypic change.
 103. A method for making a biocatalyst of claim 93comprising: a. forming a liquid dispersion of solubilized precursor forhydrophilic polymer and microorganisms for said biocatalyst wherein theconcentration of microorganisms in the liquid dispersion is at leastabout 60 grams per liter; b. subjecting said dispersion tosolidification conditions to form a solid structure of the hydrophilicpolymer wherein the solid structure has an interior structure having aplurality of interconnected major cavities containing saidmicroorganisms, said major cavities having a smallest dimension ofbetween about 5 and 100 microns and wherein the solid structure has anHEV of at least about 1000 said solidification conditions not undulyadversely affecting the population of said microorganisms; and c.maintaining the solid structure containing microorganisms underconditions that do not adversely affect the population of saidmicroorganisms in the interior of the solid structure for a timesufficient to enable the microorganisms to undergo a phenotypicalteration to maintain their population substantially stable and tobecome substantially irreversibly retained in the interior of the solidstructure.
 104. A metabolic process comprising subjecting thebiocatalyst of claim 93 to metabolic conditions including the presenceof substrate to bioconvert said substrate to bioproduct.
 105. Themetabolic process of claim 104 wherein a toxin is present and thebiocatalyst exhibits increased tolerance to the toxin.
 106. A processfor catabolizing dissolved organic carbon and ammonium cation in awastewater stream comprising: a. continuously passing said wastewaterstream to a bioreactor containing biocatalyst of claim 93 havingsubstantially irreversibly retained therein microorganisms forcatabolizing dissolved organic carbon to carbon dioxide and ammoniumcation to nitrate anion; b. contacting in said bioreactor saidwastewater stream with said biocatalyst in the presence of oxygen for atime sufficient to provide an oxidized effluent containing less thanabout 5 by mass of ammonium cation and having a biochemical oxygendemand (BOD) of less than about 10 milligrams per liter, whereinsubstantially no solids pass from the biocatalyst to the oxidizedeffluent.
 107. A process for the biological reduction of solublephosphate in water comprising: a. contacting said water in a bioreactorwith biocatalyst of claim 93 having substantially irreversibly retainedtherein phosphate accumulating microorganisms under phosphateaccumulating conditions for a time sufficient to reduce theconcentration of phosphate in said water and provide a biocatalystcontaining phosphate laden microorganism wherein said phosphateaccumulating conditions comprise the presence of polyhydroxyalkanoatewithin said microorganisms and the presence of aerobic or anoxicconditions in the water: b. subjecting said biocatalyst containingphosphate laden microorganism to anaerobic conditions in an aqueousmedium sufficient to release phosphate from said microorganisms intosaid aqueous medium to provide a phosphate-rich aqueous medium; and c.separating said biocatalyst from the phosphate-rich aqueous medium foruse and step (a).
 108. A process for treating water containing at leastone soluble compound of metal or semi-metal comprising: (a) continuouslyintroducing said water into a reaction zone containing biocatalyst ofclaim 93 containing microorganism for reducing said soluble compound;(b) contacting the water with said biocatalyst for a time sufficient toreduce the concentration of said at least one soluble compound in thewater; (c) maintaining said biocatalyst under metabolic conditionssufficient to metabolically reduce the oxidation state of the metal orsemi-metal to form elemental metal or semi-metal or precipitatedcompound thereof; and (d) withdrawing water having a reducedconcentration of said at least one soluble compound from the bioreactionzone.
 109. A process for bioconverting substrate contained in a gasphase to bioproduct comprising: a. continuously contacting the gas phasewith biocatalyst of claim 93, said contacting being at a temperaturesuitable for the metabolic bioconversion and for a time sufficient toeffect said bioconversion of at least a portion of the substrate tobioproduct; b. cycling at least a portion of the biocatalyst of step (a)to at least one immersion step in an aqueous medium for a timesufficient to substantially fully hydrate the biocatalyst, andpreferably wherein the aqueous medium for at least one of said immersionstep comprises nutrients for the microorganisms, and said immersion isfor a time sufficient to provide nutrients in said biocatalyst; c.separating the biocatalyst and aqueous medium of the at least oneimmersion step; and d. using at least a portion of the separatedbiocatalyst for step (a).
 110. In a process for bioconverting asubstrate contained in an aqueous medium to bioproduct underbioconversion conditions including the presence of microorganisms forsaid bioconversion, wherein an antimicrobial agent is provided to theaqueous medium in an amount sufficient to control contaminatingmicroorganisms, the improvement comprising attenuating the effect of theantimicrobial agent by using a biocatalyst of claim
 93. 111. A devicecontaining the biocatalyst of claim 93.